Processing 00000000.tx.1: Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin Aleister J. 

Phrase: "Genetic association of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1328885:genetic association [Occupation or Discipline]
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with multiple polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in alpha-2-macroglobulin Aleister J."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
Processing 00000000.tx.2: Saunders1,,, Lars Bertram1,, Kristina Mullin1, Andrew J. 

Phrase: "Saunders1,"

Phrase: ",,"

Phrase: "Lars Bertram1,"

Phrase: ", Kristina Mullin1,"

Phrase: "Andrew J."
Processing 00000000.tx.3: Sampson1, Khushal Latifzai1, Sanjay Basu1, Jennifer Jones1, Devon Kinney1, Laura MacKenzie-Ingano1, Stephen Yu1, Marilyn S. 

Phrase: "Sampson1,"

Phrase: "Khushal Latifzai1,"

Phrase: "Sanjay Basu1,"

Phrase: "Jennifer Jones1,"

Phrase: "Devon Kinney1,"

Phrase: "Laura MacKenzie-Ingano1,"

Phrase: "Stephen Yu1,"

Phrase: "Marilyn S."
Processing 00000000.tx.4: Albert2,3, Thomas J. 

Phrase: "Albert2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Thomas J."
Processing 00000000.tx.5: Moscarillo3, Rodney C.P. 

Phrase: "Moscarillo3,"

Phrase: "Rodney"

Phrase: "C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.6: Go4, Susan S. 

Phrase: "Go4,"

Phrase: "Susan S."
Processing 00000000.tx.7: Bassett5, Mark J. 

Phrase: "Bassett5,"

Phrase: "Mark J."
Processing 00000000.tx.8: Daly6, Nan M. 

Phrase: "Daly6,"

Phrase: "Nan M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Laird7, Xin Wang8, Gonul Velicelebi8, Steven L. 

Phrase: "Laird7,"

Phrase: "Xin Wang8,"

Phrase: "Gonul Velicelebi8,"

Phrase: "Steven L."
Processing 00000000.tx.10: Wagner8, David K. 

Phrase: "Wagner8,"

Phrase: "David K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.11: Becker8, Rudolph E. 

Phrase: "Becker8,"

Phrase: "Rudolph E."
Processing 00000000.tx.12: Tanzi1,* and Deborah Blacker3,9 1Genetics and Aging Research Unit, Center for Aging, Genetics, and Neurodegeneration, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA, 2Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA, 3Gerontology Research Unit, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA, 4Department of Epidemiology, School of Public Health, University of Alabama, Birmingham, AL, USA, 5Department of Psychiatry and Behavioral Sciences, Johns Hopkins University Medical Institutions, Baltimore, MD, USA, 6Whitehead Institute for Biomedical Research, Cambridge, MA, USA, 7Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA, 8Neurogenetics Inc., La Jolla, CA, USA and 9Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA Received June 12, 2003; 

Phrase: "Tanzi1,"

Phrase: "*"

Phrase: "and"

Phrase: "Deborah Blacker3,"

Phrase: "9 1Genetics"

Phrase: "and"

Phrase: "Aging Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Center for Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205099:Center [Spatial Concept]

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "Neurodegeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Charlestown,"

Phrase: "MA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "2Department of Neurology,"

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Charlestown,"

Phrase: "MA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "3Gerontology Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Department of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587494:Psychiatry department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Charlestown,"

Phrase: "MA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "4Department of Epidemiology,"

Phrase: "School of Public Health,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0036382:School, Public Health [Health Care Related Organization,Manufactured Object]
   819   C0036370:School Health [Health Care Activity]
   819   C0557800:Public school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Alabama,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001895:Alabama [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551894:Alabama [Language]
   827   C2825084:Alabama [Eukaryote]

Phrase: "Birmingham,"

Phrase: "AL,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "5Department of Psychiatry"

Phrase: "and"

Phrase: "Behavioral Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004940:Behavioral Sciences [Occupation or Discipline]
   861   C0004927:Behavioral [Individual Behavior]
   861   C0036397:Sciences [Occupation or Discipline]
   861   C2986890:Behavioral [Idea or Concept]

Phrase: "Johns Hopkins University Medical Institutions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C1272753:institutions [Idea or Concept]
   771 E C0018704:Institution [Health Care Related Organization,Manufactured Object]
   771 E C2607850:Institution [Health Care Related Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "6Whitehead Institute for Biomedical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Cambridge,"

Phrase: "MA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "7Department of Biostatistics,"

Phrase: "Harvard School of Public Health,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0036382:School, Public Health [Health Care Related Organization,Manufactured Object]
   797   C0036370:School Health [Health Care Activity]
   797   C0557800:Public school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "8Neurogenetics Inc.,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "9Department of Epidemiology,"

Phrase: "Harvard School of Public Health,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0036382:School, Public Health [Health Care Related Organization,Manufactured Object]
   797   C0036370:School Health [Health Care Activity]
   797   C0557800:Public school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA Received June 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.13: Accepted August 28, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alpha-2-Macroglobulin (A2M) is a highly plausible candidate gene for Alzheimer's disease (AD) in a region of chromosome 12 that has numerous independent reports of genetic linkage. 

Phrase: "Accepted August 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alpha-2-Macroglobulin (A2M)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "a highly plausible candidate gene for Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   767   C0079429:A Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   739   C1416989:MAL gene [Gene or Genome]

Phrase: "(AD) in a region of chromosome 12"

Phrase: "that"

Phrase: "has"

Phrase: "numerous independent reports of genetic linkage."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0684224:Reports [Intellectual Product]
   753   C0700287:reports [Health Care Activity]
   720   C2919603:Original report [Intellectual Product]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.14: We previously reported that a 5bp deletion in A2M was associated with AD in a subset of the National Institute of Health (NIMH) Genetics Initiative AD family sample. 

Phrase: "We previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a 5bp deletion in A2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "was"

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of the National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]

Phrase: "(NIMH"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
  1000   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   911   C0027468:national institute health [Health Care Related Organization]
   840   C0025353:mental health [Mental Process]
   840   C1555896:Mental Health [Intellectual Product]
   804   C0018684:Health [Idea or Concept]
   804   C0021622:institute [Organization]
   804   C0229992:mental [Mental Process]
   804   C1272753:Institute [Idea or Concept]
   804   C3245503:national [Intellectual Product]
   721 E C0229993:Psychic [Functional Concept]
   704 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C0031206:healthiness [Finding]
   704 E C0042241:DIAPHRAGM [Medical Device]
   704 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C1705367:Diaphragm [Medical Device]

Phrase: ")"

Phrase: "Genetics Initiative AD family sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0370003:Sample [Substance]
   804   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.15: Efforts to replicate this association finding in case  control samples have been largely negative, while those in family samples have been more positive. 

Phrase: "Efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "this association finding in case  control samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0681690:case finding [Occupational Activity]
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "largely negative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "while"

Phrase: "those in family samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:Family [Family Group]
   770   C1704727:Family [Conceptual Entity]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "more positive."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.16: We hypothesized that variable findings regarding this deletion, along with variable reports of association with V1000I, another polymorphism in the gene, result from linkage disequilibrium in the area as well as ascertainment differences between family-based and casecontrol studies. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that variable findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "regarding"

Phrase: "this deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "along with variable reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "of association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with V1000I,"

Phrase: "another polymorphism in the gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0678951:gene polymorphism [Genetic Function]
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "result from linkage disequilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "as well as"

Phrase: "ascertainment differences between family-based"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "casecontrol studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.17: Thus, we resequenced the A2M locus to identify novel polymorphisms to test for genetic association with AD. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "resequenced"

Phrase: "the A2M locus to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1708726:Locus [Gene or Genome]
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "identify"

Phrase: "novel polymorphisms to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "test for genetic association"
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
   833   C1328885:genetic association [Occupation or Discipline]
   819   C0679560:Genetic test [Laboratory Procedure]
   770   C0004083:Association [Mental Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0314603:Genetic [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "with AD."
Processing 00000000.tx.18: We identified seven novel polymorphisms and tested them in the full NIMH sample of 1439 individuals in 437 families. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "seven novel polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "them in the full NIMH sample of 1439 individuals"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   802   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   763   C0027468:health national institute [Health Care Related Organization]
   750   C0025353:mental health [Mental Process]
   750   C1555896:Mental Health [Intellectual Product]
   735   C0018684:Health [Idea or Concept]
   735   C0021622:institute [Organization]
   735   C0229992:mental [Mental Process]
   735   C0370003:Sample [Substance]
   735   C0443225:Full [Qualitative Concept]
   735   C1272753:Institute [Idea or Concept]
   735   C2347026:Sample [Conceptual Entity]
   735   C3245503:national [Intellectual Product]
   702   C0027361:Individual [Population Group]
   702   C0237401:Individual [Human]

Phrase: "in 437 families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.19: We found significant genetic association of the 5bp deletion and two novel polymorphisms with AD. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "significant genetic association of the 5bp deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "two novel polymorphisms with AD."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.20: Substantial linkage disequilibrium was detected across the gene as a whole, and haplotype analysis also showed significant association between AD and groups of A2M polymorphisms. 

Phrase: "Substantial linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "detected across the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Gene [Gene or Genome]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as a whole,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444667:Whole [Quantitative Concept]

Phrase: "and"

Phrase: "haplotype analysis also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association between AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "groups of A2M polymorphisms."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   790   C1979845:Alpha 2 [Qualitative Concept]
   783   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0441865:Group 2 [Intellectual Product]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0439095:Alpha [Intellectual Product]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C2003941:Alpha [Intellectual Product]
   753   C2350010:Alpha [Qualitative Concept]
   719 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.21: Several of these polymorphisms and haplotypes remain significantly associated with AD even after correction for multiple testing. 

Phrase: "Several of these polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "remain"

Phrase: "significantly"

Phrase: "associated with AD even"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after"

Phrase: "correction for multiple testing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705565:CORRECTION [Intellectual Product]
   770   C1947976:Correction [Functional Concept]
Processing 00000000.tx.22: Taken together, these findings, and the positive reports in other family-based studies, continue to support a potential role for A2M or a nearby gene in AD. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "the positive reports in other family-based studies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C1317750:reports studies [Intellectual Product]
   744   C0684224:Reports [Intellectual Product]
   744   C0700287:reports [Health Care Activity]
   734 E C1831145:Study report [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a potential role for A2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "a nearby gene in AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0079429:A Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.23: However, the negative casecontrol studies suggest that any underlying pathogenic polymorphisms have a modest effect, and may operate primarily among individuals with a family history of AD.  

Phrase: "However,"

Phrase: "the negative casecontrol studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "any"

Phrase: "underlying"

Phrase: "pathogenic polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "a modest effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "may"

Phrase: "operate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242339:operate [Functional Concept]

Phrase: "primarily among individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with a family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "of AD."
Processing 00000000.tx.24: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Alzheimer's disease (AD) is one of the greatest public health problems in the USA, and its impact will only increase with demographic changes anticipated in the coming decades. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "one of the greatest public health problems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "in the USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "its impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "will"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "increase with demographic changes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C0681668:Demographic change [Qualitative Concept]
   770   C0011298:demographic [Occupation or Discipline]
   770   C0392747:changes [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "anticipated in the coming decades."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.25: Our growing understanding of AD genetics has been central to the explosion in knowledge of AD biology. 

Phrase: "Our growing understanding of AD genetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "central to the explosion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Central [Spatial Concept]
   770   C1879652:Central - [Laboratory Procedure]

Phrase: "in knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "of AD biology."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.26: Although APOE-4 is well established as a potent susceptibility gene for late-onset AD, a recent segregation analysis estimated that 90% of the total genetic variance for the disease remains unknown, and that four to seven additional AD genes of at least moderate effect remain to be discovered (1). 

Phrase: "Although"

Phrase: "APOE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "well established as a potent susceptibility gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C0443211:Established [Qualitative Concept]
   748   C1272684:Established [Qualitative Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "for late-onset AD,"

Phrase: "a recent segregation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that 90% of the total genetic variance"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0042333:genetic variance [Natural Phenomenon or Process]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0314603:Genetic [Functional Concept]
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   746   C0551759:Births.total [Clinical Attribute]
   746   C0552336:Births.total [Organism Attribute]

Phrase: "for the disease remains"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "that four to seven additional AD genes of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0017337:Genes [Gene or Genome]
   744   C0205450:Four [Quantitative Concept]
   744   C0205453:Seven [Quantitative Concept]
   744   C1524062:Additional [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "moderate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]
   944 E C1553901:Mitigate [Idea or Concept]

Phrase: "effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "discovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880355:Discover [Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.27: In an effort to identify these unknown AD susceptibility genes, the authors and others are looking for candidate genes to test for association with the disease. 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "identify"

Phrase: "these unknown AD susceptibility genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0919453:Susceptibility Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "are"

Phrase: "looking for candidate genes to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]
   726   C0233426:look [Organism Attribute]

Phrase: "test for association"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0004083:Association [Mental Process]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:test [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.28: Genetic, neuropathological and biochemical evidence indicates that excessive amyloidogenic processing of the -amyloid precursor protein, generating excessive -amyloid (A) peptide, plays a fundamental role in the pathogenesis of AD, so genes coding for proteins that are involved in A production or degradation pathways are compelling biological candidates for AD. 

Phrase: "Genetic, neuropathological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   789   C1540677:neuropathology [Pathologic Function]
   789   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "biochemical evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that excessive amyloidogenic processing of the -amyloid precursor protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "generating"

Phrase: "excessive -amyloid (A) peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a fundamental role in the pathogenesis of AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "so"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "coding for proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009219:Coding [Occupational Activity]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C0805701:Code [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "involved in A production"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0033268:production [Occupational Activity]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "degradation pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1511758:Degradation Pathway [Conceptual Entity]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "compelling biological candidates for AD."
Processing 00000000.tx.29: One of the most studied candidate genes is alpha-2-macroglobulin (A2M), which is supported both by genetic evidence of linkage to chromosome 12p (29) and biological evidence for the 2-M protein's role in A catabolism, as detailed below. 

Phrase: "One of the most studied candidate genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "alpha-2-macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "(A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "both by genetic evidence of linkage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0332120:Evidence of [Functional Concept]
           Evidence
   783   C0023745:genetic linkage [Molecular Function]
           linkage
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0238767:Both [Spatial Concept]
   753   C0314603:Genetic [Functional Concept]
   753   C1706086:Both [Qualitative Concept]

Phrase: "to chromosome 12p"

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "biological evidence for the 2-M protein's role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "in A catabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0543484:catabolism [Functional Concept]
   861   C0699900:Catabolism [Organism Function]
   861   C1516314:Catabolism [Physiologic Function]

Phrase: "as"

Phrase: "detailed below."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1522508:Detailed [Qualitative Concept]
   799 E C1561567:detail [Functional Concept]
Processing 00000000.tx.30: We initially reported significant genetic association of a splice site deletion in exon 18 of A2M with AD (10) in 104 families of the NIMH Genetics Initiative sample. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "significant genetic association of a splice site deletion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1328885:genetic association [Occupation or Discipline]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "in exon 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "with AD (10"

Phrase: ")"

Phrase: "in 104 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "of the NIMH Genetics Initiative sample."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   723   C0027466:National Institute of Mental Health [Health Care Related Organization]
Processing 00000000.tx.31: Here we describe the results of testing this polymorphism and an additional seven A2M polymorphisms in the complete NIMH Genetics Initiative sample of 437 families. 

Phrase: "Here"

Phrase: "we"

Phrase: "describe"

Phrase: "the results of testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "this polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "an additional seven A2M polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0032529:polymorphisms [Genetic Function]
   766 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the complete NIMH Genetics Initiative sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0370003:Sample [Substance]
   791   C2347026:Sample [Conceptual Entity]
   707   C0027466:National Institute of Mental Health [Health Care Related Organization]

Phrase: "of 437 families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.32: 2-M and its potential role in AD pathogenesis 2-M is a 718kDa glycoprotein found at high concentrations in the serum (11) and cerebrospinal fluid. 

Phrase: "2-M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "its potential role in AD pathogenesis 2-M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "a 718kDa glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "found at high concentrations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0086045:Concentrations [Mental Process]
   770   C0150312:Found [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0243095:Find [Finding]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "cerebrospinal fluid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]
Processing 00000000.tx.33: The best-studied function of 2-M is its pan-protease inhibitory activity (12). 

Phrase: "The best-studied function of 2-M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "its pan-protease inhibitory activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1150095:protease activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.34: A variety of proteases cleave any of a number of susceptible peptide bonds in the bait region (residues 666706) of the 2-M tetramer (1214). 

Phrase: "A variety of proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "cleave"

Phrase: "any of a number of susceptible peptide bonds"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0231204:Susceptible [Functional Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1552551:Any [Qualitative Concept]
   744   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   744   C3272371:ANY [Intellectual Product]
   737   C0678595:peptide bond [Natural Phenomenon or Process]

Phrase: "in the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(residues 666706"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "of the 2-M tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039686:Tetramere [Eukaryote]

Phrase: "(1214"

Phrase: ")."
Processing 00000000.tx.35: Cleavage triggers a large conformational change in the 2-Mprotease complex, referred to as activation, which results in entrapment of the protease within the tetramer (11). 

Phrase: "Cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a large conformational change in the 2-Mprotease complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0301641:Conformational change [Molecular Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "results in entrapment of the protease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1274040:Result [Functional Concept]
   753   C1285497:Entrapment [Finding]
   753   C1546471:Result [Idea or Concept]
   753   C1880516:ENTRAPMENT [Phenomenon or Process]
   753   C1947941:Protease [Enzyme]
   753   C2825142:Result [Finding]

Phrase: "within the tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.36: Unable to dissociate from 2-M, proteases are still able to cleave small peptide substrates (15,16). 

Phrase: "Unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "dissociate from 2-M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "are"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "cleave"

Phrase: "small peptide substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.37: Protease-mediated activation also results in exposure of the 2-M receptorLRP binding domain (17). 

Phrase: "Protease-mediated activation also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "results in exposure of the 2-M receptorLRP binding domain"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   757   C1704625:Exposure Domain [Idea or Concept]
   739   C0243122:binding [Functional Concept]
   739   C0274281:Exposure, NOS [Injury or Poisoning]
   739   C0332157:Exposure [Clinical Attribute]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C2825142:Result [Finding]
   739   C3541951:Domain [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.38: Exposure of this LRP binding domain is a prerequisite for LRP-mediated endocytosis of 2-M/ligand complexes (11). 

Phrase: "Exposure of this LRP binding domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1704625:Exposure Domain [Idea or Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "is"

Phrase: "a prerequisite for LRP-mediated endocytosis of 2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0679209:prerequisite [Idea or Concept]

Phrase: "M/"

Phrase: "ligand complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.39: Internalization of 2-Mligand complexes can be targeted for degradation in the lysosome. 

Phrase: "Internalization of 2-Mligand complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871786:internalization [Mental Process]

Phrase: "can"

Phrase: "be"

Phrase: "targeted for degradation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the lysosome."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024369:Lysosome [Cell Component]
  1000   C2984253:Lysosome [Functional Concept]
   928 E C0521450:Lysosomal [Body Location or Region]
Processing 00000000.tx.40: In addition to inhibiting a variety of proteases, 2-M binds the A peptide specifically and tightly (18,19). 

Phrase: "In addition to inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "a variety of proteases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "2-M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the A peptide specifically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tightly"

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.41: There are three biological manifestations of the A2-M interactions that may be directly relevant to the etiology of AD. 

Phrase: "There"

Phrase: "are"

Phrase: "three biological manifestations of the A2-M interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1280464:Manifestation of [Qualitative Concept]
           manifestations
   744   C0205319:manifestations [Functional Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "directly relevant to the etiology of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.42: First, the interaction between 2M and A prevents A fibril formation and fibril associated neurotoxicity (18,19). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the interaction between 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "A fibril formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3544412:amyloid fibril formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.43: Second, protease activation of 2-M/A complexes or protease activation of 2-M followed by A binding can promote the protease-mediated degradation of 2-M-bound A (15). 

Phrase: "Second, protease activation of 2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "M/"

Phrase: "A complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "or"

Phrase: "protease activation of 2-M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "followed by A binding"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0243122:binding [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the protease-mediated degradation of 2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "M-"

Phrase: "bound A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.44: Because of its small size, A is accessible to the encaged protease, permitting proteolysis. 

Phrase: "Because of its small size, A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0748864:small size [Finding]

Phrase: "is"

Phrase: "accessible to the encaged protease,"

Phrase: "permitting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0023636:Permit [Regulation or Law]
   966   C0329040:Permit [Fish]

Phrase: "proteolysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.45: Third, protease activated 2m/A complexes may undergo LRP-mediated endocytosis followed by trafficking of A to the lysosome for degradation (20). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "2m/A complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "may"

Phrase: "undergo"

Phrase: "LRP-mediated endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014139:Endocytosis [Cell Function]
   827   C2984285:Endocytosis [Functional Concept]

Phrase: "followed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332283:Followed by [Temporal Concept]
           followed
   799 E C1719822:Follow [Intellectual Product]

Phrase: "trafficking of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0599896:trafficking [Cell Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to the lysosome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024369:Lysosome [Cell Component]
  1000   C2984253:Lysosome [Functional Concept]
   928 E C0521450:Lysosomal [Body Location or Region]

Phrase: "for degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.46: The established late-onset risk factor ApoE-4 accelerates A deposition (21), and ApoE is found in a complex with 2-M in plasma (22). 

Phrase: "The established late-onset risk factor ApoE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   795   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0523511:APOE [Laboratory Procedure]
   795   C1412481:APOE [Gene or Genome]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "A deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "found in a complex"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]
   737 E C0243095:Find [Finding]

Phrase: "with 2-M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.47: Taken together, these findings indicate that A2M is a superb biological candidate gene for AD. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "a superb biological candidate gene for AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1332838:Candidate Gene [Gene or Genome]
   774   C0079429:A Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.48: Genetic linkage findings in the vicinity of A2M There have been numerous reports of genetic linkage of AD to loci on chromosome 12 (29). 

Phrase: "Genetic linkage findings in the vicinity of A2M There"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   738   C2607943:findings [Functional Concept]
   738   C2926606:Findings [Clinical Attribute]
   738   C3539655:Findings [Intellectual Product]
   737   C0730319:Genetic finding [Laboratory or Test Result]
   709 E C0559563:Birth finding [Finding]
   704 E C0037088:Finding [Sign or Symptom]
   704 E C0243095:Finding [Finding]
   704 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "numerous reports of genetic linkage of AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0684224:Reports [Intellectual Product]
   748   C0700287:reports [Health Care Activity]
   714 E C3273238:Report [Intellectual Product]
   711   C2919603:Original report [Intellectual Product]

Phrase: "to loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "on chromosome 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.49: The reported linkage peaks cluster into two distinct regions. 

Phrase: "The reported linkage peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: "cluster into two distinct regions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205448:Two [Quantitative Concept]
   760   C1555715:Cluster [Idea or Concept]
   760   C1704332:Cluster [Quantitative Concept]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
Processing 00000000.tx.50: One region is located at the p-ter, from 6 to 30cM, in the same vicinity as the A2M gene (located at 20cM) (2,3,6,9). 

Phrase: "One region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "located at the p-ter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1415273:TER [Gene or Genome]
   760   C3157085:TER [Cell Component]

Phrase: "from 6"

Phrase: "to 30cM,"

Phrase: "in the same vicinity"

Phrase: "as the A2M gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1537647:ALPHA GENE [Gene or Genome]
   902   C2985256:Alpha Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "located at 20cM"

Phrase: ")"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.51: The other region is peri-centromeric, from 48 to 68cM, in the same vicinity as the LRP gene (68cM) (4,68). 

Phrase: "The"

Phrase: "other region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "peri-centromeric,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0347985:Peri [Temporal Concept]

Phrase: "from 48"

Phrase: "to 68cM,"

Phrase: "in the same vicinity"

Phrase: "as the LRP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(68cM"

Phrase: ")"

Phrase: "(4,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.52: In general, evidence for linkage increases slightly in all studies when analyses are limited to families without an APOE-4 allele. 

Phrase: "In general, evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "slightly in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750482:Slightly [Idea or Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "when"

Phrase: "analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "are"

Phrase: "limited to families"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0015576:Families [Family Group]
   790   C0439801:Limited [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   790   C3542948:Limited [Intellectual Product]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "without an APOE-4 allele."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   827   C0002085:Allele [Gene or Genome]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.53: Of note, although earlier reports (3,9) using a subset of the NIMH data report linkage in the vicinity of A2M, our recent genome screen of the full NIMH sample does not show a signal in this region (23). 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "although"

Phrase: "earlier reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "9"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a subset of the NIMH data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515021:Subset [Classification]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "linkage in the vicinity of A2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0023745:linkage [Molecular Function]

Phrase: "our recent genome screen of the full NIMH sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   749   C0220908:health screen [Health Care Activity]
           screen
   735   C1305399:screen [Functional Concept]
   735   C1705053:Screen [Medical Device]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a signal in this region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.54: Prior association findings for A2M Based on the biological and genetic data above, we and others have tested polymorphisms in A2M for genetic association with AD (Table 1). 

Phrase: "Prior association findings for A2M"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]

Phrase: "Based on the biological"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205460:biological [Qualitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "genetic data above,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   830   C3641102:Data Origin [Idea or Concept]
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "tested polymorphisms in A2M"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for genetic association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1328885:genetic association [Occupation or Discipline]
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "with AD (Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: Family-based association studies have been largely supportive of genetic association between A2M and AD. 

Phrase: "Family-based association studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C0199236:family studies [Diagnostic Procedure]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "largely supportive of genetic association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521721:Supportive [Conceptual Entity]

Phrase: "between A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.56: Our group initially reported an association between AD and an intronic deletion polymorphism adjacent to exon 18, A2M-18i (referred to as A2M-2 in our original report) (10), in a sample of 104 discordant sibships ascertained through the NIMH Genetics Initiative, and this finding held up in an enlarged 120-sibship subset from the NIMH sample as well (24). 

Phrase: "Our group initially"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an association between AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "an intronic deletion polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "adjacent to exon 18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "A2M-18i"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1552184:18i [Medical Device]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "A2M-2 in our original report"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   770   C1979845:Alpha 2 [Qualitative Concept]
   770   C2919603:Original report [Intellectual Product]
   767   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0205313:Original [Idea or Concept]
   744   C0439095:Alpha [Intellectual Product]
   744   C0684224:Report [Intellectual Product]
   744   C0700287:Report [Health Care Activity]
   744   C2003941:Alpha [Intellectual Product]
   744   C2347409:Original [Occupational Activity]
   744   C2350010:Alpha [Qualitative Concept]
   744   C3273238:Report [Intellectual Product]

Phrase: ")"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "in a sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "of 104 discordant sibships"

Phrase: "ascertained through the NIMH Genetics Initiative,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   777   C0027468:health national institute [Health Care Related Organization]
   760   C0025353:mental health [Mental Process]
   760   C1555896:Mental Health [Intellectual Product]
   739   C0017398:Genetics [Biomedical Occupation or Discipline]
   739   C0017399:genetics [Biologic Function]
   739   C0018684:Health [Idea or Concept]
   739   C0021622:institute [Organization]
   739   C0229992:mental [Mental Process]
   739   C0424093:Initiative [Mental Process]
   739   C1272753:Institute [Idea or Concept]
   739   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "held up"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C1948036:held [Idea or Concept]
   833   C2987518:hELD [Amino Acid, Peptide, or Protein]
   799 E C1553387:Hold [Idea or Concept]
   799 E C1948035:Hold [Activity]

Phrase: "in an enlarged 120-sibship subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1515021:Subset [Classification]

Phrase: "from the NIMH"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
  1000   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   911   C0027468:national institute health [Health Care Related Organization]
   840   C0025353:mental health [Mental Process]
   840   C1555896:Mental Health [Intellectual Product]
   804   C0018684:Health [Idea or Concept]
   804   C0021622:institute [Organization]
   804   C0229992:mental [Mental Process]
   804   C1272753:Institute [Idea or Concept]
   804   C3245503:national [Intellectual Product]
   721 E C0229993:Psychic [Functional Concept]
   704 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C0031206:healthiness [Finding]
   704 E C0042241:DIAPHRAGM [Medical Device]
   704 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C1705367:Diaphragm [Medical Device]

Phrase: "sample as well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205170:Well [Qualitative Concept]
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   790   C3146287:Well [Manufactured Object]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.57: As can be seen in Table 1, three of the remaining four reported family-based samples also gave some evidence for association (2528). 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Table 1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0205397:Seen [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "three of the remaining four"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205449:Three [Quantitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1527428:Remaining [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "family-based samples also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "some evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "(2528"

Phrase: ")."
Processing 00000000.tx.58: On the other hand, casecontrol association studies of AD and this deletion polymorphism have been largely negative. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "casecontrol association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "studies of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "this deletion polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "largely negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.59: As can be seen in Table 1, of the 32 published casecontrol studies, only five report positive association findings (2933), a figure only slightly larger than the number expected by chance (even without accounting for publication bias). 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Table 1, of the 32 published casecontrol studies,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   739   C0034037:Published [Occupational Activity]
   739   C0039224:Table [Manufactured Object]
   739   C0205397:Seen [Qualitative Concept]
   739   C0947630:studies [Laboratory Procedure]
   739   C1704324:Published [Intellectual Product]
   739   C1706073:Table [Medical Device]
   739   C1706074:Table [Intellectual Product]
   706 E C0042789:see [Organism Function]
   706 E C0557651:Study [Manufactured Object]
   706 E C1947903:See [Activity]
   706 E C2603343:Study [Research Activity]

Phrase: "only five report positive association findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C1514241:Positive Finding [Finding]
   799   C2607943:findings [Functional Concept]
   799   C2926606:Findings [Clinical Attribute]
   799   C3539655:Findings [Intellectual Product]
   766 E C0037088:Finding [Sign or Symptom]
   766 E C0243095:Finding [Finding]
   766 E C2825141:Finding [Finding]

Phrase: "(2933"

Phrase: ")"

Phrase: ","

Phrase: "a figure only slightly larger than the number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0443228:larger [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C1704243:Larger [Quantitative Concept]

Phrase: "expected by chance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237506:Chance [Qualitative Concept]
   790   C1517001:Expected [Idea or Concept]

Phrase: "(even without accounting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0000938:Accounting [Occupational Activity]

Phrase: "for publication bias"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0206086:Publication Bias [Qualitative Concept]
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: ")."
Processing 00000000.tx.60: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.61: Reported A2M association finding  A second polymorphism in A2M, a non-synonymous SNP in exon 24 (A2M-24e) that results in Val to Ile substitution at amino acid position 1000, has also been widely investigated in association studies (Table 1). 

Phrase: "Reported A2M association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0004083:Association [Mental Process]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "A second polymorphism in A2M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "a non-synonymous SNP in exon 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0752046:SNP [Nucleotide Sequence]
   748   C1527094:SNP [Conceptual Entity]

Phrase: "(A2M-24e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "that"

Phrase: "results in Val"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "to Ile substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "at amino acid position 1000,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0733755:Position [Spatial Concept]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "widely"

Phrase: "investigated in association studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C0947630:studies [Laboratory Procedure]
   770   C1292732:investigated [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.62: Six casecontrol studies report some evidence of association between AD and A2M-24e (25,29,3437). 

Phrase: "Six casecontrol studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "some evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between AD"

Phrase: "and"

Phrase: "A2M-24e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(25,"

Phrase: "29,"

Phrase: "3437"

Phrase: ")."
Processing 00000000.tx.63: Ten other casecontrol studies did not find significant association, nor did three family-based association studies (25,27,38). 

Phrase: "Ten"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014518:TEN [Disease or Syndrome]
  1000   C0205456:Ten [Quantitative Concept]

Phrase: "other casecontrol studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "significant association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "nor"

Phrase: "did"

Phrase: "three family-based association studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C0199236:family studies [Diagnostic Procedure]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "(25,"

Phrase: "27,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.64: Finally, one report analyzed both the A2M-18i and -24e polymorphisms together as a haplotype and found significant haplotypic association (39). 

Phrase: "Finally,"

Phrase: "one report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "both the A2M-18i"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1552184:18i [Medical Device]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "24e polymorphisms together as a haplotype"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "found significant haplotypic association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0004083:Association [Mental Process]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.65: For both casecontrol and family-based studies, and for both the 18i deletion and the 24e substitution, stratification on APOE status, age and neuropathological confirmation of AD do not generally affect the evidence for association. 

Phrase: "For both casecontrol"

Phrase: "and"

Phrase: "family-based studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C0199236:family studies [Diagnostic Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "and for both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "the 18i deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "the 24e substitution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "stratification on APOE status,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514983:Stratification [Research Activity]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "neuropathological confirmation of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "do"

Phrase: "not generally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the evidence for association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.66: In an effort to further clarify these inconsistent association findings, and to identify a possible pathogenic polymorphism underlying the association signal, we resequenced the A2M locus and then tested six novel polymorphisms, the 24e polymorphism, and the original 18i deletion polymorphism for association with AD in the full NIMH AD Genetics Initiative sample of 437 families (40). 

Phrase: "In an effort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Effort [Organism Function]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "these inconsistent association findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "a possible pathogenic polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "underlying"

Phrase: "the association signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "we"

Phrase: "resequenced"

Phrase: "the A2M locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1708726:Locus [Gene or Genome]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "then tested six novel polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "the 24e polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the original 18i deletion polymorphism for association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032529:Polymorphism [Genetic Function]
   748   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with AD"

Phrase: "in the full NIMH AD Genetics Initiative sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]

Phrase: "of 437 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.67: To obtain maximum information from the data, we use family-based association tests, haplotype analyses and conditional logistic regression.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "maximum information from the data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "we"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "family-based association tests,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   839   C0544093:Association, familial [Finding]
   812   C0004083:Association [Mental Process]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]
   779 E C0039593:Test [Functional Concept]

Phrase: "haplotype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "conditional logistic regression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]
Processing 00000000.tx.68: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Polymorphism discovery We resequenced the A2M locus in 29 individuals that carry at least one copy of the A2M-18i deletion polymorphism. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Polymorphism discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880355:Discovery [Activity]

Phrase: "We"

Phrase: "resequenced"

Phrase: "the A2M locus in 29 individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "carry at least one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C0206243:Carry [Activity]
   770   C0699809:carry [Finding]

Phrase: "copy of the A2M-18i deletion polymorphism."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   764   C1979845:Alpha 2 [Qualitative Concept]
   762   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0032529:Polymorphism [Genetic Function]
   742   C0439095:Alpha [Intellectual Product]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1552184:18i [Medical Device]
   742   C1880274:Deletion [Activity]
   742   C1882417:Polymorphism [Qualitative Concept]
   742   C1948062:Copy [Manufactured Object]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.69: Seven novel SNPs were identified and genotyped (Table 2). 

Phrase: "Seven novel SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0752046:SNPs [Nucleotide Sequence]
   793 E C1527094:SNP [Conceptual Entity]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.70: None of these novel SNPs code for amino acid changes: two are synonymous SNPs, and five are in the non-coding region of the gene. 

Phrase: "None of these novel SNPs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205314:Novel [Temporal Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C0679622:novel [Intellectual Product]
   760   C0752046:SNPs [Nucleotide Sequence]
   726 E C1527094:SNP [Conceptual Entity]

Phrase: "code for amino acid changes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   845   C1953353:Amino acid change [Finding]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0009219:code [Occupational Activity]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0805701:Code [Intellectual Product]
   726 E C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "are"

Phrase: "synonymous SNPs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "are in the non-coding region of the gene."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0079941:Coding Region [Gene or Genome]
   742   C0009219:Coding [Occupational Activity]
   742   C0017337:Gene [Gene or Genome]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1518422:Non [Functional Concept]
   742   C1551058:Are [Quantitative Concept]
   708 E C0805701:Code [Intellectual Product]
Processing 00000000.tx.71: Interestingly, the SNP in intron 21 (A2M-21i) is found within the 5' splice site of exon 21. 

Phrase: "Interestingly,"

Phrase: "the SNP in intron 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1710092:Intronic SNP [Nucleotide Sequence]
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1527094:SNP [Conceptual Entity]

Phrase: "(A2M-21i"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1552191:21i [Medical Device]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "is"

Phrase: "found within the 5' splice site of exon 21."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C2945843:Site of [Qualitative Concept]
   742   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0150312:Found [Quantitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
   708 E C0243095:Find [Finding]
Processing 00000000.tx.72: One of these, a synonymous SNP in exon 20, A2M-20e, was genotyped in approximately half of the full NIMH sample (800 subjects) and found to have a minor allele frequency of only 4%, so we elected not to pursue it further. 

Phrase: "One of these,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "a synonymous SNP in exon 20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0752046:SNP [Nucleotide Sequence]
   753   C1527094:SNP [Conceptual Entity]

Phrase: "A2M-20e,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "genotyped in approximately half of the full NIMH sample"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   802   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   763   C0027468:health national institute [Health Care Related Organization]
   750   C0025353:mental health [Mental Process]
   750   C1555896:Mental Health [Intellectual Product]
   735   C0018684:Health [Idea or Concept]
   735   C0021622:institute [Organization]
   735   C0229992:mental [Mental Process]
   735   C0332232:Approximately [Qualitative Concept]
   735   C0370003:Sample [Substance]
   735   C0443225:Full [Qualitative Concept]
   735   C1272753:Institute [Idea or Concept]
   735   C2347026:Sample [Conceptual Entity]
   735   C2825407:Half [Quantitative Concept]
   735   C3245503:national [Intellectual Product]
   702   C0017431:Genotype [Organism Attribute]

Phrase: "(800 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a minor allele frequency of only 4%,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "so"

Phrase: "we"

Phrase: "elected"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "pursue"

Phrase: "it further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.73: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.74: Sequence location, context, and primer sequences used in polymorphism genotyping  Association of individual A2M SNPs with AD The six novel polymorphisms and the two previously identified polymorphisms (18i and 24e) were genotyped in the full NIMH Genetics Initiative sample. 

Phrase: "Sequence location,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "and"

Phrase: "primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "used in polymorphism genotyping  Association of individual A2M SNPs"
Meta Candidates (Total=25; Excluded=5; Pruned=0; Remaining=20)
   775   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   756   C1979845:Alpha 2 [Qualitative Concept]
   754   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0004083:Association [Mental Process]
   738   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0027361:Individual [Population Group]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0237401:Individual [Human]
   738   C0439095:Alpha [Intellectual Product]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]
   738   C0752046:SNPs [Nucleotide Sequence]
   738   C1273517:used [Finding]
   738   C1285573:Genotyping [Laboratory Procedure]
   738   C1882417:Polymorphism [Qualitative Concept]
   738   C2003941:Alpha [Intellectual Product]
   738   C2350010:Alpha [Qualitative Concept]
   737   C1524063:Use of [Functional Concept]
   704 E C0017431:Genotype [Organism Attribute]
   704 E C0042153:use [Functional Concept]
   704 E C0457083:Use [Functional Concept]
   704 E C1527094:SNP [Conceptual Entity]
   704 E C1947944:Use [Intellectual Product]

Phrase: "with AD"

Phrase: "The six novel polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the two previously identified polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "and"

Phrase: "24e"

Phrase: ")"

Phrase: "were"

Phrase: "genotyped in the full NIMH Genetics Initiative sample."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   810   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   767   C0027468:health national institute [Health Care Related Organization]
   753   C0025353:mental health [Mental Process]
   753   C1555896:Mental Health [Intellectual Product]
   736   C0017398:Genetics [Biomedical Occupation or Discipline]
   736   C0017399:genetics [Biologic Function]
   736   C0018684:Health [Idea or Concept]
   736   C0021622:institute [Organization]
   736   C0229992:mental [Mental Process]
   736   C0370003:Sample [Substance]
   736   C0424093:Initiative [Mental Process]
   736   C0443225:Full [Qualitative Concept]
   736   C1272753:Institute [Idea or Concept]
   736   C2347026:Sample [Conceptual Entity]
   736   C3245503:national [Intellectual Product]
   703   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.75: Association results, reported in Table 3, were generated using the Family Based Association Test Package (FBAT) using phenotype information from affected subjects only or from both affected and unaffected subjects (see Methods). 

Phrase: "Association results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "reported in Table 3,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Family Based Association Test Package (FBAT)"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   803   C0544093:Association, familial [Finding]
   799   C0004083:Association [Mental Process]
   799   C0013194:Package [Medical Device]
   799   C0015576:Family [Family Group]
   799   C0022885:Test [Laboratory Procedure]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]
   799   C1527178:Based [Functional Concept]
   799   C1704727:Family [Conceptual Entity]
   799   C1705938:Based [Idea or Concept]
   799   C2700580:Package [Manufactured Object]
   766 E C0002055:base [Inorganic Chemical]
   766 E C0178499:Base [Chemical Viewed Functionally]
   766 E C1880279:Base [Biomedical or Dental Material]
   727 E C0241888:Familial [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phenotype information from affected subjects only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "or from both"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "unaffected subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: Analyses including phenotype information on unaffecteds generally gave greater evidence of association than the affecteds only analyses, as would be expected given the use of more of information. 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "phenotype information on unaffecteds generally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "greater evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "than the affecteds only analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the use of more of information."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
Processing 00000000.tx.77: In general, the late-onset stratum (all sampled affecteds with onset ages 65, see Methods) displayed increased evidence for association. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "the late-onset stratum"

Phrase: "("

Phrase: "all sampled affecteds with onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0392760:Affected [Functional Concept]
   726   C1314939:Affected [Functional Concept]

Phrase: "ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "increased evidence for association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.78: We also tested for differences by APOE-4, stratifying based on whether a family has at least one APOE-44 homozygote with AD, and then on whether a family has at least one APOE-4 carrier with AD (see Methods). 

Phrase: "We also"

Phrase: "tested for differences"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "by APOE-4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "stratifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:stratifying [Qualitative Concept]

Phrase: "based on"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C1527178:Based [Functional Concept]
   833   C1705938:Based [Idea or Concept]
   799 E C0002055:base [Inorganic Chemical]
   799 E C0178499:Base [Chemical Viewed Functionally]
   799 E C1880279:Base [Biomedical or Dental Material]

Phrase: "whether"

Phrase: "a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "has at least one APOE-44 homozygote"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0019904:Homozygote [Organism Attribute]
   748   C0205447:One [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C3539897:Has [Qualitative Concept]

Phrase: "with AD,"

Phrase: "and"

Phrase: "then on"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1883708:Then [Temporal Concept]

Phrase: "whether"

Phrase: "a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "has at least one APOE-4 carrier"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007294:Carrier [Finding]
   748   C0205447:One [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0560175:Carrier [Finding]
   748   C1412481:APOE [Gene or Genome]
   748   C1706209:Carrier [Medical Device]
   748   C3273162:Carrier [Intellectual Product]
   748   C3539897:Has [Qualitative Concept]

Phrase: "with AD ("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: In both cases the larger stratum [APOE-44-negative (67.5% of the sample) and APOE-4 positive (84.4% of the sample)] gave results similar to those in the total sample (although with somewhat lower levels of statistical significance given the reduction in sample size), and the smaller stratum [APOE-44 positive (32.5% of the sample) and APOE-4 negative (15.6% of the sample)] was entirely negative: P>0.25 for all individual polymorphisms (data not shown). 

Phrase: "In both cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the larger stratum"

Phrase: "[APOE-44-negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]

Phrase: "(67.5% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "APOE-4 positive"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: "(84.4% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "]"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "similar to those in the total sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "("

Phrase: "although with somewhat lower levels of statistical significance"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   770   C1709380:Statistical Significance [Quantitative Concept]
   767   C0814896:levels significance [Research Activity]
   744   C0038215:Statistical [Occupation or Discipline]
   744   C0441889:Levels [Qualitative Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C0750502:Significance [Idea or Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]
   744   C2984079:Somewhat [Intellectual Product]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the reduction in sample size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the smaller stratum"

Phrase: "[APOE-44 positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "(32.5% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "APOE-4 negative"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205160:Negative [Qualitative Concept]
   827   C1513916:Negative [Finding]
   827   C2825415:Negative [Conceptual Entity]
   827   C2825491:Negative [Qualitative Concept]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: "(15.6% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "]"

Phrase: "was"

Phrase: "entirely negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: ":"

Phrase: "P>0.25 for all individual polymorphisms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0027361:Individual [Population Group]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0237401:Individual [Human]
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: Thus, the apparent discrepancies are likely to be due to the increased power of the larger subsamples, and not to the APOE-4 genotype per se. 

Phrase: "Thus,"

Phrase: "the apparent discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:discrepancies [Finding]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be due to the increased power of the larger subsamples,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0032863:Power [Human-caused Phenomenon or Process]
   739   C0205217:Increased [Quantitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0443228:larger [Quantitative Concept]
   739   C0549177:Larger [Quantitative Concept]
   739   C1704243:Larger [Quantitative Concept]
   739   C2987476:Be [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not to the APOE-4 genotype"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017431:Genotype [Organism Attribute]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1518422:Not [Functional Concept]

Phrase: "per se."
Processing 00000000.tx.81: This is in agreement with the results of conditional logistic regression analyses that gave no evidence for interactions between APOE-4 and any of the associated polymorphisms in A2M (see below). 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "of conditional logistic regression analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analyses [Intellectual Product]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "no evidence for interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "between APOE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "any of the associated polymorphisms"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0332281:Associated [Qualitative Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.82: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.83: Results of association analyses of individual polymorphismsa  Consistent with our previous report, the 18i deletion polymorphism is associated in the total sample (Pnominal=0.02 for affecteds only, and 0.0059 with unaffected phenotypes included) and more strongly associated in the late-onset sample (Pnominal=0.0033 for affecteds only, and 0.0023 with unaffected phenotypes included). 

Phrase: "Results of association analyses of individual polymorphismsa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "Consistent with our previous report,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the 18i deletion polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "associated in the total sample"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0332281:Associated [Qualitative Concept]
   760   C0370003:Sample [Substance]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Pnominal"

Phrase: "=0.02 for affecteds only,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C0392760:Affected [Functional Concept]
   726   C1314939:Affected [Functional Concept]

Phrase: "and"

Phrase: "0.0059 with unaffected phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C2986417:Unaffected [Conceptual Entity]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ")"

Phrase: "and"

Phrase: "more strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "associated in the late-onset sample"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C0332281:Associated [Qualitative Concept]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Pnominal"

Phrase: "=0.0033 for affecteds only,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C0392760:Affected [Functional Concept]
   726   C1314939:Affected [Functional Concept]

Phrase: "and"

Phrase: "0.0023 with unaffected phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C2986417:Unaffected [Conceptual Entity]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ")."
Processing 00000000.tx.84: The previously reported exon 24 non-synonymous SNP (24e; Val 1000 Ile) displays a trend towards association in most analyses, and reaches significance in the late-onset stratum when unaffected phenotypes are included in the analysis (Pnominal=0.037). 

Phrase: "The previously reported exon 24 non-synonymous SNP (24e"

Phrase: "; Val 1000 Ile)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022192:Ile [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0523728:ILE [Laboratory Procedure]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a trend towards association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "in most analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "significance in the late-onset stratum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "when"

Phrase: "unaffected phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "included in the analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "(Pnominal"

Phrase: "=0.037"

Phrase: ")."
Processing 00000000.tx.85: Association analyses of the six novel polymorphisms extend our original association findings. 

Phrase: "Association analyses of the six novel polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C0796451:polymorphism analysis [Diagnostic Procedure]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our original association findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]
Processing 00000000.tx.86: Depending on the sample used and whether unaffected phenotype information is included, from two to four of these give significant evidence for association. 

Phrase: "Depending on the sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   737   C0725813:depend [Medical Device]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "whether"

Phrase: "unaffected phenotype information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "from two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "to four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "of these"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "significant evidence for association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.87: Strongly significant nominal association results were obtained for the synonymous SNP found in exon 12 (12e) in the total sample (Pnominal=0.0018 for affecteds, only and 0.0008 with unaffected phenotypes included), with slightly less significant results in the late-onset stratum. 

Phrase: "Strongly significant nominal association results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1274040:Result [Functional Concept]
   771   C1546471:Result [Idea or Concept]
   771   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for the synonymous SNP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1301820:Obtained [Functional Concept]
   760   C1527094:SNP [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "found in exon 12"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "(12e"

Phrase: ")"

Phrase: "in the total sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(Pnominal"

Phrase: "=0.0018 for affecteds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392760:Affected [Functional Concept]
   737   C1314939:Affected [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "0.0008 with unaffected phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C2986417:Unaffected [Conceptual Entity]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ")"

Phrase: ","

Phrase: "with slightly less significant results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "in the late-onset stratum."
Processing 00000000.tx.88: Second, the SNP in the intron immediately adjacent to exon 21 (21i) was significantly associated in the total sample (Pnominal=0.041 for affecteds only, and 0.019 with unaffected phenotypes included), with more significant results in the late-onset stratum. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the SNP in the intron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1710092:Intronic SNP [Nucleotide Sequence]
   760   C0752046:SNP [Nucleotide Sequence]
   760   C1527094:SNP [Conceptual Entity]

Phrase: "immediately adjacent to exon 21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "(21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "significantly"

Phrase: "associated in the total sample"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0332281:Associated [Qualitative Concept]
   760   C0370003:Sample [Substance]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Pnominal"

Phrase: "=0.041 for affecteds only,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C0392760:Affected [Functional Concept]
   726   C1314939:Affected [Functional Concept]

Phrase: "and"

Phrase: "0.019 with unaffected phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C2986417:Unaffected [Conceptual Entity]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ")"

Phrase: ","

Phrase: "with more significant results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "in the late-onset stratum."
Processing 00000000.tx.89: The polymorphisms in intron 15 (15i) and intron 28 (28i) only gave significant evidence of association in the late-onset stratum when unaffected phenotypes were included (Pnominal=0.043 for 15i, and 0.037 for 28i), and the polymorphism in intron 7 (7i) displayed only a trend towards association in the same setting (Pnominal=0.067). 

Phrase: "The polymorphisms in intron 15"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(15i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552179:15i [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "intron 28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(28i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552198:28i [Medical Device]

Phrase: ")"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "significant evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the late-onset stratum"

Phrase: "when"

Phrase: "unaffected phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "were"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "(Pnominal"

Phrase: "=0.043 for 15i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552179:15i [Medical Device]

Phrase: "and"

Phrase: "0.037 for 28i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552198:28i [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the polymorphism in intron 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(7i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552171:7i [Medical Device]

Phrase: ")"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a trend towards association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "in the same setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "(Pnominal"

Phrase: "=0.067"

Phrase: ")."
Processing 00000000.tx.90: For the polymorphisms showing at least a trend toward association in FBAT (see Table 3), odds ratios (ORs) for their effect on AD risk were calculated using conditional logistic regression, and are given in Table 4. 

Phrase: "For the polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showing at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "a trend toward association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "in FBAT"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   803   C0544093:Association, familial [Finding]
   799   C0004083:Association [Mental Process]
   799   C0013194:Package [Medical Device]
   799   C0015576:Family [Family Group]
   799   C0022885:Test [Laboratory Procedure]
   799   C0039593:Test [Functional Concept]
   799   C0150312:In [Quantitative Concept]
   799   C0332285:In [Spatial Concept]
   799   C0392366:test [Intellectual Product]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]
   799   C1527178:Based [Functional Concept]
   799   C1704727:Family [Conceptual Entity]
   799   C1705938:Based [Idea or Concept]
   799   C2700580:Package [Manufactured Object]
   766 E C0002055:base [Inorganic Chemical]
   766 E C0178499:Base [Chemical Viewed Functionally]
   766 E C1880279:Base [Biomedical or Dental Material]
   727 E C0241888:Familial [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "odds ratios (ORs) for their effect"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0028873:Odds Ratios [Quantitative Concept]
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "on AD risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "conditional logistic regression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "and"

Phrase: "are"

Phrase: "given in Table 4."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3244317:given [Intellectual Product]
   737 E C1947971:Give [Functional Concept]
Processing 00000000.tx.91: The 95% confidence intervals (CIs) are provided to give an idea of the precision of these estimates, but it should be noted that these CIs are slightly too narrow (see Methods). 

Phrase: "The 95% confidence intervals (CIs)"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "are"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "an idea of the precision of these estimates,"

Phrase: "but"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "these CIs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0009667:Confidence Intervals [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:intervals [Temporal Concept]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "are"

Phrase: "slightly too"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750482:Slightly [Idea or Concept]

Phrase: "narrow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205168:Narrow [Qualitative Concept]
  1000   C0332463:Narrow [Spatial Concept]
  1000   C0333164:Narrow [Quantitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: Carriers of the 12e T allele have a 3-fold increase in risk (OR=3.27, 95% CI=1.74, 6.16). 

Phrase: "Carriers of the 12e T allele"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0007294:carriers [Finding]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719 E C3273162:Carrier [Intellectual Product]

Phrase: "have"

Phrase: "a 3-fold increase in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(OR=3.27,"

Phrase: "95% CI=1.74,"

Phrase: "6.16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825561:6-16 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.93: For the 18i deletion and the 21i A allele, the increase in risk is less than 2-fold (for 18i OR=1.79, 95% CI=1.21, 2.63; for 21i OR=1.73, 95% CI=1.17, 2.56). 

Phrase: "For the 18i deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "the 21i A allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "the increase in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "less than 2-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0439092:Less Than [Intellectual Product]
           less
   770   C0332462:Fold [Spatial Concept]
   770   C0547044:Less [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "("

Phrase: "for 18i OR=1.79,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1552184:18i [Medical Device]

Phrase: "95% CI=1.21,"

Phrase: "2.63"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"

Phrase: "for 21i OR=1.73,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1552191:21i [Medical Device]

Phrase: "95% CI=1.17,"

Phrase: "2.56"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.94: Looking at the genotypic ORs, the point estimates for 12e and 21i suggest a doseresponse relationship, but these values are not stably estimated. 

Phrase: "Looking at the genotypic ORs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0233426:look [Organism Attribute]

Phrase: "the point estimates for 12e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0750572:estimates [Quantitative Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a doseresponse relationship,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678790:dose-response relationship [Biologic Function]
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "but"

Phrase: "these values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "not stably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "estimated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.95: Interestingly, two copies of the 15i insertion or 24e A or 28i G allele might be protective, or, viewed alternatively, being a carrier of the other allele could actually increase risk for AD. 

Phrase: "Interestingly,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "copies of the 15i insertion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1552179:15i [Medical Device]
   760   C1883719:Insertion [Functional Concept]
   760   C1948062:Copies [Manufactured Object]

Phrase: "or"

Phrase: "24e A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "28i G allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Allele [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "protective,"

Phrase: "or"

Phrase: ","

Phrase: "viewed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0449911:View [Spatial Concept]

Phrase: "alternatively,"

Phrase: "being"

Phrase: "a carrier of the"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007294:Carrier [Finding]
   770   C0560175:Carrier [Finding]
   770   C1706209:Carrier [Medical Device]
   770   C3273162:Carrier [Intellectual Product]

Phrase: "other allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "could"

Phrase: "actually"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "risk for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.96: None of the associated polymorphisms in A2M gave any evidence for an interaction with the 4-allele in APOE (data not shown) when included in the CLR analyses. 

Phrase: "None of the associated polymorphisms"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0332281:Associated [Qualitative Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "any evidence for an interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "with the 4-allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "in APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "when"

Phrase: "included in the CLR analyses."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   797   C0681925:logistic regression analysis [Research Activity]
   778   C0034980:Regression Analyses [Intellectual Product]
   778   C0206031:Logistic Regression [Research Activity]
   748   C0242415:logistic [Occupational Activity]
   748   C0332257:included [Functional Concept]
   748   C0684320:Regression [Pathologic Function]
   748   C0684321:Regression [Mental Process]
   748   C1701901:Conditional [Qualitative Concept]
   748   C1963686:Conditional [Functional Concept]
   748   C3538986:INCLUDED [Gene or Genome]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]
   714 E C1552866:include [Idea or Concept]
   714 E C2700399:Include [Activity]
Processing 00000000.tx.97: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.98: Odds ratio from conditional logistic regression  Because of a concern that a few larger families could be driving the association results, we re-ran the association analyses in FBAT and the conditional logistic regression analyses including only one nuclear family per pedigree (see Methods). 

Phrase: "Odds ratio from conditional logistic regression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "Because of a concern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "that"

Phrase: "a few larger families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0424972:Large family [Family Group]
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "the association results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "we"

Phrase: "re-"

Phrase: "ran"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0035953:run [Daily or Recreational Activity]
   966   C0600140:run [Finding]
   966   C1704688:Run [Functional Concept]
   966   C2346414:Run [Finding]

Phrase: "the association analyses in FBAT"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   742   C0004083:Association [Mental Process]
   742   C0013194:Package [Medical Device]
   742   C0015576:Family [Family Group]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]
   742   C1527178:Based [Functional Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C1705938:Based [Idea or Concept]
   742   C2700580:Package [Manufactured Object]
   726   C0544093:Association, familial [Finding]
   708 E C0002055:base [Inorganic Chemical]
   708   C0002778:Analysis [Laboratory Procedure]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the conditional logistic regression analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analyses [Intellectual Product]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only one nuclear family per pedigree"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028574:Nuclear Family [Family Group]
   753   C0015576:Family [Family Group]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.99: None of these analyses resulted in appreciable differences in the results, although P-values were sometimes slightly larger, and confidence intervals slightly wider, in the reduced sample (data not shown). 

Phrase: "None of these analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "resulted in appreciable differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
   737   C2825142:Result [Finding]

Phrase: "in the results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "although"

Phrase: "P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "sometimes slightly larger,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443228:larger [Quantitative Concept]
   827   C0549177:Larger [Quantitative Concept]
   827   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "confidence intervals"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0009667:Confidence Intervals [Quantitative Concept]
   861   C0237529:Confidence [Mental Process]
   861   C1272706:intervals [Temporal Concept]
   861   C1704725:Confidence [Qualitative Concept]
   861   C1704726:Confidence [Mental Process]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]
   789 E C0558095:Confident [Individual Behavior]
   761 E C0009669:confidentiality [Idea or Concept]

Phrase: "slightly wider"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332464:Wide [Spatial Concept]
   777 E C0487742:Wideness [Quantitative Concept]

Phrase: ","

Phrase: "in the reduced sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: Association of A2M haplotypes with AD To gain insight into the haplotype structure underlying the association results in Table 3, we grouped polymorphisms into haplotypes for further analysis in HBAT, the new haplotype program available in the FBAT package (see Methods). 

Phrase: "Association of A2M haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with AD To"

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the haplotype structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:Insight [Mental Process]

Phrase: "underlying"

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "results in Table 3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C2825142:Result [Finding]

Phrase: "we"

Phrase: "grouped"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0439745:Grouped [Spatial Concept]
   966 E C0441833:Group [Idea or Concept]
   966 E C0687744:group [Population Group]
   966 E C1257890:Group [Population Group]
   966 E C1552516:Group [Health Care Related Organization]
   966 E C1705428:Group [Conceptual Entity]
   966 E C1705429:Group [Population Group]

Phrase: "polymorphisms into haplotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0032529:polymorphisms [Genetic Function]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for further analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "in HBAT,"

Phrase: "the new haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "available in the FBAT package"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0470187:Available [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: Combining all eight polymorphisms in one analysis revealed a trend for association in the total sample (Pglobal,nominal=0.08) and nominally significant association in the late-onset families (Pglobal,nominal=0.015). 

Phrase: "Combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "all eight polymorphisms in one analysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0796451:polymorphism analysis [Diagnostic Procedure]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a trend for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "in the total sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "(Pglobal,"

Phrase: "nominal"

Phrase: "=0.08"

Phrase: ")"

Phrase: "and"

Phrase: "nominally significant association in the late-onset families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   725   C0544093:Association, familial [Finding]

Phrase: "(Pglobal,"

Phrase: "nominal"

Phrase: "=0.015"

Phrase: ")."
Processing 00000000.tx.102: To explore which part of the gene contributes most to this overall association, we employed a sliding window approach, where each set of five consecutive polymorphisms was tested for association with AD (Table 5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "which part of the gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "most to this overall association,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004083:Association [Mental Process]
   760   C0205393:Most [Quantitative Concept]
   760   C0282416:Overall [Intellectual Product]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1561607:Overall [Qualitative Concept]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a sliding window approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "where"

Phrase: "each"

Phrase: "set of five consecutive polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0036849:Set [Mental Process]
   760   C0205451:Five [Quantitative Concept]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C1707491:Consecutive [Qualitative Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "tested for association"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0392366:tested [Intellectual Product]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with AD (Table 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: In these analyses, the strongest association signals were observed in the 3' portion of the gene, i.e. in the last two adjacent windows: [(12e, 15i, 18i, 21i, 24e), Pglobal,nominal= 0.046 (total) and 0.011 (late); and (15i, 18i, 21i, 24e, 28i), Pglobal, nominal=0.028 (total) and 0.0036 (late)]. 

Phrase: "In these analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "the strongest association signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "observed in the 3' portion of the gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0017337:Gene [Gene or Genome]
   744   C0449719:Portion [Spatial Concept]
   744   C1441672:Observed [Functional Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the last two adjacent windows"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0557702:windows [Manufactured Object]
   779 E C1272706:Window [Temporal Concept]
   779 E C1704674:Window [Manufactured Object]

Phrase: ":"

Phrase: "["

Phrase: "(12e,"

Phrase: "15i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552179:15i [Medical Device]

Phrase: "18i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "21i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: "24e"

Phrase: ")"

Phrase: ","

Phrase: "Pglobal,"

Phrase: "nominal"

Phrase: "= 0.046"

Phrase: "(total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "0.011"

Phrase: "(late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: ")"

Phrase: ";"

Phrase: "and ("

Phrase: "15i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552179:15i [Medical Device]

Phrase: "18i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "21i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: "24e,"

Phrase: "28i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552198:28i [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "Pglobal,"

Phrase: "nominal"

Phrase: "=0.028"

Phrase: "(total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "0.0036"

Phrase: "(late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.104: These windows also contain, respectively, three (12e, 18i and 21i) and two (18i and 21i) of the individually most significantly associated polymorphisms, and the results for specific haplotype alleles are consistent with this (Table 5). 

Phrase: "These windows also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0557702:windows [Manufactured Object]
   827 E C1272706:Window [Temporal Concept]
   827 E C1704674:Window [Manufactured Object]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: ","

Phrase: "respectively,"

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "(12e,"

Phrase: "18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "and"

Phrase: "21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "(18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "and"

Phrase: "21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: ")"

Phrase: "of the individually most significantly associated polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "the results for specific haplotype alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with this"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Interestingly, it was also across the 3' portion of A2M that two-locus LD assessment showed the highest D' values, although evidence for LD between polymorphisms was generally high across the entire gene (Table 6). 

Phrase: "Interestingly,"

Phrase: "it"

Phrase: "was"

Phrase: "also across the 3' portion of A2M"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   764   C1979845:Alpha 2 [Qualitative Concept]
   762   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439095:Alpha [Intellectual Product]
   742   C0449719:Portion [Spatial Concept]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]

Phrase: "that two-locus LD assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1261322:Assessment [Health Care Activity]
   812   C1516048:Assessment [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the highest D' values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "although"

Phrase: "evidence for LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "between polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "generally high across the entire gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "(Table 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: As with the individual polymorphisms, we re-ran the haplotype analyses in HBAT including only one nuclear family per pedigree, again with no appreciable differences in the results, but with slightly larger P-values consistent with the reduced sample size (data not shown). 

Phrase: "As with the individual polymorphisms,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0027361:Individual [Population Group]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0237401:Individual [Human]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "re-"

Phrase: "ran"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0035953:run [Daily or Recreational Activity]
   966   C0600140:run [Finding]
   966   C1704688:Run [Functional Concept]
   966   C2346414:Run [Finding]

Phrase: "the haplotype analyses in HBAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only one nuclear family per pedigree,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028574:Nuclear Family [Family Group]
   753   C0015576:Family [Family Group]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "again with no appreciable differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in the results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "but with slightly larger P-values"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C1709380:P-Value [Quantitative Concept]
   753   C0042295:Values [Qualitative Concept]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C0443228:larger [Quantitative Concept]
   753   C0549177:Larger [Quantitative Concept]
   753   C0750482:Slightly [Idea or Concept]
   753   C1704243:Larger [Quantitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "consistent with the reduced sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: View this table: [in this window] [in a new window]  Table 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.108: Results of haplotype analysis for A2M polymorphisma  View this table: [in this window] [in a new window]  Table 6. 

Phrase: "Results of haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "for A2M polymorphisma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.109: Pairwise disequilibrium coefficients (D') between A2M polymorphisms   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Findings in the full NIMH sample We originally reported a significant association of an intronic deletion polymorphism (18i) in a subset (104 families) from the NIMH Genetics Initiative sample (10). 

Phrase: "Pairwise disequilibrium coefficients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707429:*Coefficient [Quantitative Concept]

Phrase: "("

Phrase: "D')"

Phrase: "between A2M polymorphisms   DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Findings in the full NIMH"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "We originally"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a significant association of an intronic deletion polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "(18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: ")"

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "(104 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "from the NIMH Genetics Initiative sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   723   C0027466:National Institute of Mental Health [Health Care Related Organization]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.110: The results and analyses presented here, using the complete NIMH Genetics Initiative sample of 437 families, confirm and extend our initial findings. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the complete NIMH Genetics Initiative sample of 437 families,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0370003:Sample [Substance]
   735   C2347026:Sample [Conceptual Entity]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our initial findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]
Processing 00000000.tx.111: Three polymorphisms (12e, 18i and 21i) display nominally significant association in the affecteds only analysis, and three additional polymorphisms [15i (late-onset stratum only), 24e and 28i] are nominally significant when unaffected phenotypes are included (Table 3). 

Phrase: "Three polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(12e,"

Phrase: "18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "and"

Phrase: "21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: ")"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "nominally significant association in the affecteds only analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "three additional polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "[15i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552179:15i [Medical Device]

Phrase: "(late-onset stratum only"

Phrase: ")"

Phrase: ","

Phrase: "24e"

Phrase: "and"

Phrase: "28i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552198:28i [Medical Device]

Phrase: "]"

Phrase: "are"

Phrase: "nominally significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "unaffected phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: Even conservatively accounting for multiple tests using a Bonferroni correction (see Methods), the observed association of AD with A2M-12e remains statistically significant in the total sample (Pcorrected=0.043 in the affecteds only analysis, Pcorrected=0.019 when unaffected phenotypes are used), and association findings for 12e, 18i and 21i in the late-onset sample are consistent with a trend for association (Pcorrected=0.07, 0.08, and 0.09, respectively, in the affecteds-only analyses; and Pcorrected=0.029, 0.055, and 0.074 when unaffected phenotypes are used). 

Phrase: "Even conservatively"

Phrase: "accounting for multiple tests"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0000938:Accounting [Occupational Activity]
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   770   C0439064:Multiple [Quantitative Concept]
   737 E C0039593:Test [Functional Concept]
   737 E C1551359:account [Idea or Concept]
   737 E C2741673:Account # [Clinical Attribute]
   737 E C2981730:Account [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bonferroni correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705565:CORRECTION [Intellectual Product]
   861   C1947976:Correction [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the observed association of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with A2M-12e"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "remains"

Phrase: "statistically significant in the total sample"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0237881:statistically significant [Quantitative Concept]
           significant
   753   C0038215:Statistically [Occupation or Discipline]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   718 E C1709380:Statistical Significance [Quantitative Concept]

Phrase: "(Pcorrected"

Phrase: "=0.043 in the affecteds only analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205171:Only [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1720467:Only [Intellectual Product]
   714   C0392760:Affected [Functional Concept]
   714   C1314939:Affected [Functional Concept]

Phrase: "Pcorrected"

Phrase: "=0.019"

Phrase: "when"

Phrase: "unaffected phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "association findings for 12e,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "18i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552184:18i [Medical Device]

Phrase: "and"

Phrase: "21i in the late-onset sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1552191:21i [Medical Device]

Phrase: "are"

Phrase: "consistent with a trend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "(Pcorrected"

Phrase: "=0.07,"

Phrase: "0.08,"

Phrase: "and"

Phrase: "0.09,"

Phrase: "respectively,"

Phrase: "in the affecteds-only analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: ";"

Phrase: "and"

Phrase: "Pcorrected"

Phrase: "=0.029,"

Phrase: "0.055,"

Phrase: "and"

Phrase: "0.074"

Phrase: "when"

Phrase: "unaffected phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: Two adjacent five-locus haplotypes give strong evidence for nominal association (Pnominal=0.0036), and even after correcting for multiple tests there is a trend towards association (Pcorrected=0.086). 

Phrase: "Two adjacent five-locus haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "strong evidence for nominal association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "(Pnominal"

Phrase: "=0.0036"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "even after correcting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2349182:Correct [Qualitative Concept]

Phrase: "for multiple tests there"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "is"

Phrase: "a trend towards association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "(Pcorrected"

Phrase: "=0.086"

Phrase: ")."
Processing 00000000.tx.114: Examining the individual and haplotype results overall suggests that the stronger LD signal is in the 3' portion of the gene. 

Phrase: "Examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "and"

Phrase: "haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the stronger LD signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "is in the 3' portion of the gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0314622:Is gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0449719:Portion [Spatial Concept]
Processing 00000000.tx.115: The most strongly associated individual SNPs are found in this region, which also includes the bait region and the -Cys--Glu thiol ester bond between Cys-949 and Glu-952. 

Phrase: "The most strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "individual SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0752046:SNPs [Nucleotide Sequence]
   827 E C1527094:SNP [Conceptual Entity]

Phrase: "are"

Phrase: "found in this region,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0150312:Found [Quantitative Concept]
   770   C0205147:Region [Spatial Concept]
   737 E C0243095:Find [Finding]

Phrase: "which also"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the -Cys--Glu thiol ester bond between Cys-949"

Phrase: "and"

Phrase: "Glu-952."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.116: The strength and consistency of this evidence suggests that this association is genuine, but there are several important caveats. 

Phrase: "The strength"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0237897:Strength [Quantitative Concept]
  1000   C0808080:Strength [Idea or Concept]
  1000   C1705922:Strength [Qualitative Concept]
   928 E C0442821:Strong [Qualitative Concept]

Phrase: "and"

Phrase: "consistency of this evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332529:Consistency [Qualitative Concept]
   770   C1547017:Consistency [Quantitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "genuine,"

Phrase: "but"

Phrase: "there"

Phrase: "are"

Phrase: "several important caveats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0871599:Caveat [Governmental or Regulatory Activity]
Processing 00000000.tx.117: Comparison with prior linkage and association findings Our findings are consistent with the generally positive prior findings of family-based association studies of A2M, but not with the primarily negative casecontrol studies. 

Phrase: "Comparison with prior linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "association findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the generally positive prior findings of family-based association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0332290:Consistent with [Idea or Concept]
           Consistent
   701   C0332529:Consistency finding [Qualitative Concept]

Phrase: "studies of A2M,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   806   C1979845:Alpha 2 [Qualitative Concept]
   797   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439095:Alpha [Intellectual Product]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
   760   C2603343:Study [Research Activity]

Phrase: "but"

Phrase: "not with the primarily negative casecontrol studies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0205160:Negative [Qualitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C1513916:Negative [Finding]
   748   C1518422:Not [Functional Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]
Processing 00000000.tx.118: Non-replication of association findings can be due to chance, particularly where there is inadequate power to detect effects of small or moderate magnitude, or, in casecontrol studies, due to bias due to population stratification, but the large number of negative studies argues against both of these possibilities. 

Phrase: "Non-replication of association findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0598312:Replication [Genetic Function]
   760   C1518422:Non [Functional Concept]
   760   C1883725:replication [Qualitative Concept]

Phrase: "can"

Phrase: "be due to chance,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0237506:Chance [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]

Phrase: "particularly where there"

Phrase: "is"

Phrase: "inadequate power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "effects of small"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "moderate magnitude,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449286:magnitude [Quantitative Concept]
   861   C1704240:Magnitude [Quantitative Concept]

Phrase: "or"

Phrase: ","

Phrase: "in casecontrol studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "due to bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0242568:Bias [Idea or Concept]
  1000   C1504315:Bias [Bird]
   966 E C1061346:Bia [Eukaryote]
   966 E C1704746:BIA [Diagnostic Procedure]

Phrase: "due to population stratification,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "but"

Phrase: "the large number of negative studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2825415:Negative Number [Conceptual Entity]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "argues against both of these possibilities."
Processing 00000000.tx.119: The more likely cause of the discrepancy between the family-based and casecontrol studies is differences in ascertainment. 

Phrase: "The more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "cause of the discrepancy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015127:cause [Functional Concept]
   770   C1290905:Discrepancy [Finding]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "between the family-based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1527178:Based [Functional Concept]
   861   C1705938:Based [Idea or Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C0178499:Base [Chemical Viewed Functionally]
   827 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "casecontrol studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "differences in ascertainment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.120: Family-based samples frequently include only families with two or more affected individuals, and thus may identify a more genetically determined form of AD. 

Phrase: "Family-based samples frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "only families with two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "or"

Phrase: "more affected individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "and"

Phrase: "thus"

Phrase: "may"

Phrase: "identify"

Phrase: "a more genetically determined form of AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]
Processing 00000000.tx.121: Casecontrol samples may have fewer genetic determinants to be identified (although they may be more typical of AD in generalunless the case ascertainment excludes individuals with a family history, which leads to an underestimation of family history). 

Phrase: "Casecontrol samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "may"

Phrase: "have"

Phrase: "fewer genetic determinants to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1521761:Determinant [Functional Concept]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "("

Phrase: "although"

Phrase: "they"

Phrase: "may"

Phrase: "be"

Phrase: "more typical of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "in generalunless"

Phrase: "the case ascertainment"

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "individuals with a family history,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "which"

Phrase: "leads to an underestimation of family history"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0241889:Family history [Finding]
   778   C1705495:Family History [Idea or Concept]
   748   C0015576:Family [Family Group]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.122: Thus, the observed difference between casecontrol studies and family-based studies is consistent with the idea that A2M is predominantly a risk factor for late-onset AD with a family history. 

Phrase: "Thus,"

Phrase: "the observed difference between casecontrol studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "family-based studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C0199236:family studies [Diagnostic Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "consistent with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "predominantly"

Phrase: "a risk factor for late-onset AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C0035647:Risk [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "with a family history."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]
Processing 00000000.tx.123: Although other groups, including ones using portions of the NIMH sample, have reported evidence for linkage in this region, we have not been able to detect significant linkage in this region (23), even to marker D12S1695, which is only 65kb from A2M (data not shown). 

Phrase: "Although"

Phrase: "other groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205447:One [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "portions of the NIMH sample,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0449719:Portion [Spatial Concept]

Phrase: "have"

Phrase: "reported evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "in this region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "significant linkage in this region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023745:linkage [Molecular Function]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "even to marker D12S1695,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Marker [Clinical Attribute]

Phrase: "which"

Phrase: "is"

Phrase: "only 65kb from A2M"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: The reason for the discrepancy between our linkage findings in the NIMH sample and those of other groups is unclear, but may reflect the specific sampling scheme for the subsample, analytic strategies, or marker choice. 

Phrase: "The reason for the discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:Reason [Idea or Concept]

Phrase: "between our linkage findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "in the NIMH sample"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0370003:Sample [Substance]
   799   C2347026:Sample [Conceptual Entity]
   780   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   719   C0027468:national institute health [Health Care Related Organization]

Phrase: "and"

Phrase: "those of other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "unclear,"

Phrase: "but"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the specific sampling scheme for the subsample,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1519193:Scheme [Intellectual Product]

Phrase: "analytic strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "or"

Phrase: "marker choice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008300:choice [Individual Behavior]
   861   C1707391:Choice [Activity]
Processing 00000000.tx.125: We were also unable to detect evidence of association between D12S1695 and AD (data not shown). 

Phrase: "We"

Phrase: "were"

Phrase: "also unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between D12S1695"

Phrase: "and"

Phrase: "AD (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: The lack of association across a gap of 65kb was not unexpected, but the lack of linkage findings in an area with a strong association signal in the same sample is more puzzling. 

Phrase: "The lack of association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "across a gap"

Phrase: "of 65kb"

Phrase: "was"

Phrase: "not unexpected,"

Phrase: "but"

Phrase: "the lack of linkage findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in an area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "with a strong association signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "in the same sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "more puzzling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0423995:puzzling [Finding]
Processing 00000000.tx.127: Although it is unusual to detect strong association in the absence of linkage, it is not impossible. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "unusual to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700116:Unusual [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "strong association in the absence of linkage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "not impossible."
Processing 00000000.tx.128: Risch (41) suggests that association analysis can be locally more powerful for detecting small or moderate gene effects than linkage analysis. 

Phrase: "Risch"

Phrase: "(41"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "locally more powerful for detecting"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "or"

Phrase: "moderate gene effects than linkage analysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.129: A similar scenario with the insulin gene and diabetes (42) was part of the motivation for developing the TDT. 

Phrase: "A similar scenario with the insulin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0683579:scenario [Functional Concept]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(42"

Phrase: ")"

Phrase: "was"

Phrase: "part of the motivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "for developing"

Phrase: "the TDT."
Processing 00000000.tx.130: Conclusions Using a large uniformly ascertained and evaluated family-based sample, we report significant individual and haplotypic association between several A2M polymorphisms and AD, including some that remain significant when applying an overlying conservative Bonferoni correction. 

Phrase: "Conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a large uniformly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "ascertained"

Phrase: "and"

Phrase: "evaluated family-based sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0370003:Sample [Substance]
   812   C2347026:Sample [Conceptual Entity]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "significant individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027361:Individual [Population Group]
   861   C0237401:Individual [Human]

Phrase: "and"

Phrase: "haplotypic association between several A2M polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "some that"

Phrase: "remain"

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "when"

Phrase: "applying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0185125:Apply [Health Care Activity]
   966   C1632850:Apply [Functional Concept]
   966   C1879355:Apply [Functional Concept]

Phrase: "an overlying conservative Bonferoni correction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1705565:CORRECTION [Intellectual Product]
   812   C1947976:Correction [Functional Concept]
Processing 00000000.tx.131: While it seems unlikely that any of these associated polymorphisms and/or haplotypes are pathogenic, we are currently exploring the possibility. 

Phrase: "While"

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "any of these associated polymorphisms"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0332281:Associated [Qualitative Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and/or"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "pathogenic,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0450254:Pathogenic [Organism]
   928 E C0030657:pathogenicity [Qualitative Concept]
   928 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "we"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "exploring"

Phrase: "the possibility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.132: A more likely explanation is that these associated polymorphisms are in linkage disequilibrium with a pathogenic polymorphism either in A2M itself or in a nearby gene. 

Phrase: "A more likely explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "these associated polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in linkage disequilibrium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with a pathogenic polymorphism either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "itself"

Phrase: "or in a nearby gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.133: The relatively modest association findings, the lack of confirmation in casecontrol studies, and the inconsistent evidence for linkage suggest that the underlying defect may have only a modest effect. 

Phrase: "The relatively modest association findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C2607943:findings [Functional Concept]
   812   C2926606:Findings [Clinical Attribute]
   812   C3539655:Findings [Intellectual Product]
   779 E C0037088:Finding [Sign or Symptom]
   779 E C0243095:Finding [Finding]
   779 E C2825141:Finding [Finding]

Phrase: "the lack of confirmation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in casecontrol studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the inconsistent evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the underlying defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "have"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a modest effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.134: In particular, the discrepancy between family-based association findings and those in casecontrol studies suggests that the gene may be a risk factor primarily in individuals with a family history, and could either be a gene of modest effect or perhaps a modifier gene. 

Phrase: "In particular,"

Phrase: "the discrepancy between family-based association findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1290905:Discrepancy [Finding]

Phrase: "and"

Phrase: "those in casecontrol studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "a risk factor primarily in individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035648:Risk factor [Quantitative Concept]
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C0035647:Risk [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "with a family history,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "could"

Phrase: "either"

Phrase: "be"

Phrase: "a gene of modest effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0079429:A Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "or"

Phrase: "perhaps"

Phrase: "a modifier gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3178895:Modifier Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.135: In any case, these new findings, along with prior positive results in family-based studies, suggest that A2M and nearby genes merit further testing in other family-based datasets, and further exploration of its potential biological role in AD.  

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "these new findings,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1268649:New finding [Finding]
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "along with prior positive results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "in family-based studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C0199236:family studies [Diagnostic Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "nearby genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "merit"

Phrase: "further testing in other family-based datasets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0039593:Testing [Functional Concept]
   748   C0392366:testing [Intellectual Product]

Phrase: "and"

Phrase: "further exploration of its potential biological role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "in AD."
Processing 00000000.tx.136: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Subjects The ascertainment and assessment of the AD families collected under the NIMH AD Genetics Initiative Sample are described elsewhere (40). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "The ascertainment"

Phrase: "and"

Phrase: "assessment of the AD families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "collected under the NIMH AD Genetics Initiative Sample"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   810   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   767   C0027468:health national institute [Health Care Related Organization]
   753   C0025353:mental health [Mental Process]
   753   C1555896:Mental Health [Intellectual Product]
   736   C0017398:Genetics [Biomedical Occupation or Discipline]
   736   C0017399:genetics [Biologic Function]
   736   C0018684:Health [Idea or Concept]
   736   C0021622:institute [Organization]
   736   C0229992:mental [Mental Process]
   736   C0370003:Sample [Substance]
   736   C0424093:Initiative [Mental Process]
   736   C1272753:Institute [Idea or Concept]
   736   C1516695:Collected [Idea or Concept]
   736   C1516698:Collected [Functional Concept]
   736   C2347026:Sample [Conceptual Entity]
   736   C3245503:national [Intellectual Product]

Phrase: "are"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.137: Briefly, participants were evaluated following a standardized protocol to ensure that they met NINCDS/ADRDA criteria for AD (43,44). 

Phrase: "Briefly,"

Phrase: "participants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679646:participants [Population Group]
   966 E C2698741:Participant [Classification]

Phrase: "were"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a standardized protocol to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "they"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "NINCDS/ADRDA criteria for AD (43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:criteria [Intellectual Product]

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.138: Of the sampled affected subjects, 29% had a diagnosis of definite (autopsy-confirmed) AD, 64.5% probable AD, and 6.5% possible AD. 

Phrase: "Of the sampled affected subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "29%"

Phrase: "had"

Phrase: "a diagnosis of definite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "(autopsy-confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521093:confirmed [Qualitative Concept]
   861   C0750484:Confirmed [Idea or Concept]
   827 E C1456348:Confirm [Qualitative Concept]

Phrase: ")"

Phrase: "AD,"

Phrase: "64.5% probable AD,"

Phrase: "and"

Phrase: "6.5% possible AD."
Processing 00000000.tx.139: Sixty-eight percent of the sample was female. 

Phrase: "Sixty-eight percent of the sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439165:Percent [Quantitative Concept]

Phrase: "was"

Phrase: "female."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]
Processing 00000000.tx.140: Family structure varied widely. 

Phrase: "Family structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680034:family structure [Family Group]
   861   C0678594:Structure [Spatial Concept]

Phrase: "varied"

Phrase: "widely."
Processing 00000000.tx.141: Most (79%) of the families were nuclear (about half affected sibpairs and half larger sibships of varying sizes), but there were nearly 100 families with more complex structure. 

Phrase: "Most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "(79%"

Phrase: ")"

Phrase: "of the families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "were"

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(about half affected sibpairs"

Phrase: "and"

Phrase: "half larger sibships of varying sizes"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "there"

Phrase: "were"

Phrase: "nearly 100 families with more complex structure."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0680034:family structure [Family Group]
   748   C0015576:Families [Family Group]
   748   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.142: Forty percent of families included an unaffected member. 

Phrase: "Forty percent of families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439165:Percent [Quantitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an unaffected member."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0680022:member [Population Group]
   861   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.143: Families with more complex structure were broken into nuclear families (see below): there were a total of 586 nuclear families when the larger pedigrees were broken down in this way, but not all of them are informative. 

Phrase: "Families with more complex structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0680034:family structure [Family Group]
   760   C0015576:Families [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "broken into nuclear families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028574:Nuclear Families [Family Group]
   819   C0680067:broken family [Group Attribute]
   770   C0015576:Families [Family Group]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1704727:Family [Conceptual Entity]
   737   C1881704:BREAK [Phenomenon or Process]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ":"

Phrase: "there"

Phrase: "were"

Phrase: "a total of 586 nuclear families"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "when"

Phrase: "the larger pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "were"

Phrase: "broken down in this way,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0443161:break down [Qualitative Concept]
   726   C1881704:BREAK [Phenomenon or Process]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "are"

Phrase: "informative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.144: Only families in which all sampled affecteds had onset ages 50 years were included in the present analyses (n=437 families, n=1439 individuals; mean age of onset 72.5, SD 7.7); 

Phrase: "Only families in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "all sampled affecteds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392760:Affected [Functional Concept]
   827   C1314939:Affected [Functional Concept]

Phrase: "had"

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "50 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "were"

Phrase: "included in the present analyses"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0150312:Present [Quantitative Concept]
   760   C0332257:included [Functional Concept]
   760   C0449450:Present [Idea or Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "(n=437 families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "n=1439 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "; mean age of onset 72.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "SD 7.7"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.145: 73% of families were in our late-onset stratum (all sampled affecteds showed an onset at or beyond age 65) and 27% of families were in our early/mixed stratum (at least one sampled affected showed an onset before age 65, but none under age 50). 

Phrase: "73% of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0015576:Families [Family Group]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "were in our late-onset stratum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "("

Phrase: "all sampled affecteds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392760:Affected [Functional Concept]
   827   C1314939:Affected [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an onset at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "or beyond age 65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "27% of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0015576:Families [Family Group]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "were in our early/mixed stratum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205430:Mixed [Functional Concept]
   753   C1279919:Early [Temporal Concept]
   753   C3160715:Mixed [Finding]

Phrase: "("

Phrase: "at least one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "sampled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0441621:sampled [Diagnostic Procedure]
  1000   C0870078:sampled [Idea or Concept]
   966 E C0370003:Sample [Substance]
   966 E C2347026:Sample [Conceptual Entity]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an onset before age 65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0206132:Onset Age [Quantitative Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "but"

Phrase: "none under age 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001779:Age [Organism Attribute]
   827   C0542339:Under [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.146: APOE genotypes were determined for 99.5% of the sample. 

Phrase: "APOE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "determined for 99.5% of the sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.147: We stratified families on APOE status in two ways. 

Phrase: "We"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "families on APOE status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "in two ways."
Processing 00000000.tx.148: First, we stratified based on whether or not a family included an APOE-44 homozygote with AD:120 families (including 832 individuals, 32.5% of the sample) were in the APOE-44-positive stratum (at least one APOE-44 homozygote with AD in the family), and 317 families (1725 individuals, 67.5% of the sample) were in the APOE-44-negative stratum (no APOE-44 homozygotes with AD in the family). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "based on"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C1527178:Based [Functional Concept]
   833   C1705938:Based [Idea or Concept]
   799 E C0002055:base [Inorganic Chemical]
   799 E C0178499:Base [Chemical Viewed Functionally]
   799 E C1880279:Base [Biomedical or Dental Material]

Phrase: "whether"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an APOE-44 homozygote with AD:120 families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019904:Homozygote [Organism Attribute]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "832 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "32.5% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "were in the APOE-44-positive stratum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C2825490:Positive [Qualitative Concept]

Phrase: "("

Phrase: "at least one APOE-44 homozygote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0019904:Homozygote [Organism Attribute]

Phrase: "with AD"

Phrase: "in the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "317 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(1725 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "67.5% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "were in the APOE-44-negative stratum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205160:Negative [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "("

Phrase: "no APOE-44 homozygotes with AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019904:Homozygotes [Organism Attribute]

Phrase: "in the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: ")."
Processing 00000000.tx.149: This stratification, which has been used consistently in prior work in the NIMH sample, makes sense because in this sample the APOE-44 genotype has a much stronger impact on disease risk and age of onset (40), and results in more balanced groups. 

Phrase: "This stratification,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514983:Stratification [Research Activity]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "consistently in prior work"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043227:Work [Occupational Activity]
   770   C0332152:Prior [Temporal Concept]
   770   C2826257:PRIOR [Event]

Phrase: "in the NIMH sample,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0370003:Sample [Substance]
   799   C2347026:Sample [Conceptual Entity]
   780   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   719   C0027468:national institute health [Health Care Related Organization]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "because in this"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "the APOE-44 genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "has"

Phrase: "a much stronger impact on disease risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "results in more balanced groups."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205415:Balanced [Functional Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2825142:Result [Finding]
Processing 00000000.tx.150: For comparison purposes, we repeated our analyses using the more commonly used stratification based on APOE-4 carrier status: 358 families (2159 individuals, 84.4% of the sample) were in our APOE-4-positive stratum (at least one APOE-4 carrier with AD) and 79 families (398 individuals, 15.6% of the sample) were in our APOE-4-negative stratum (no APOE-4 carriers with AD). 

Phrase: "For comparison purposes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "we"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "our analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the more commonly used stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514983:Stratification [Research Activity]

Phrase: "based on APOE-4 carrier status"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   790   C0449439:Carrier status [Finding]
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007294:Carrier [Finding]
   753   C0449438:Status [Qualitative Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C0560175:Carrier [Finding]
   753   C1412481:APOE [Gene or Genome]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C1706209:Carrier [Medical Device]
   753   C3273162:Carrier [Intellectual Product]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: ":"

Phrase: "358 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(2159 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "84.4% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "were in our APOE-4-positive stratum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C2825490:Positive [Qualitative Concept]

Phrase: "("

Phrase: "at least one APOE-4 carrier"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007294:Carrier [Finding]
   804   C0560175:Carrier [Finding]
   804   C1706209:Carrier [Medical Device]
   804   C3273162:Carrier [Intellectual Product]

Phrase: "with AD)"

Phrase: "and"

Phrase: "79 families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(398 individuals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "15.6% of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ")"

Phrase: "were in our APOE-4-negative stratum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205160:Negative [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "("

Phrase: "no APOE-4 carriers with AD"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0007294:carriers [Finding]
   719 E C0560175:Carrier [Finding]
   719 E C1706209:Carrier [Medical Device]
   719 E C3273162:Carrier [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: Polymorphism discovery Querying public databases and direct DNA sequencing were used to identify polymorphisms within the A2M locus. 

Phrase: "Polymorphism discovery Querying public databases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0242356:Databases [Intellectual Product]
   771 E C0993637:Database [Intellectual Product]

Phrase: "and"

Phrase: "direct DNA sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162326:DNA sequencing [Nucleotide Sequence]
   901   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "polymorphisms within the A2M locus."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.152: Specifically we mined for SNPs using three public databases, dbSNP (NCBI), Human SNP database (Whitehead Institute), and the Genetic Annotation Initiative (National Cancer Institute). 

Phrase: "Specifically"

Phrase: "we"

Phrase: "mined for SNPs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0752046:SNPs [Nucleotide Sequence]
   756   C0026175:mine [Occupational Activity]
   756   C0338297:MINE [Therapeutic or Preventive Procedure]
   756 E C1527094:SNP [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three public databases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242356:Databases [Intellectual Product]
   793 E C0993637:Database [Intellectual Product]

Phrase: "dbSNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710090:dbSNP [Intellectual Product]

Phrase: "(NCBI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0995203:NCBI [Intellectual Product]
  1000   C1705803:NCBI [Organization]

Phrase: ")"

Phrase: ","

Phrase: "Human SNP database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242356:Database [Intellectual Product]
   827   C0993637:Data Base [Intellectual Product]

Phrase: "(Whitehead Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Genetic Annotation Initiative"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517505:Genetic Annotation Initiative [Research Activity]
   827   C0424093:Initiative [Mental Process]

Phrase: "(National Cancer Institute"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.153: Using these sources we identified three non-synonymous SNPs in A2M [rs2277413 (A807V), rs1800434 (H704R), rs1802965 (L1431F)]. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "three non-synonymous SNPs in A2M"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0752046:SNPs [Nucleotide Sequence]
   711 E C1527094:SNP [Conceptual Entity]

Phrase: "[rs2277413"

Phrase: "(A807V"

Phrase: ")"

Phrase: ","

Phrase: "rs1800434"

Phrase: "(H704R"

Phrase: ")"

Phrase: ","

Phrase: "rs1802965"

Phrase: "(L1431F"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.154: However, when genotyped in a test sample of 200 subjects, these SNPs were not found to be polymorphic and were therefore excluded from further genotyping efforts. 

Phrase: "However,"

Phrase: "when"

Phrase: "genotyped in a test sample of 200 subjects,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0392366:test [Intellectual Product]
   744   C2347026:Sample [Conceptual Entity]
   711   C0017431:Genotype [Organism Attribute]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "these SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0752046:SNPs [Nucleotide Sequence]
   966 E C1527094:SNP [Conceptual Entity]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "polymorphic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882417:Polymorphic [Qualitative Concept]
   928 E C0027950:Polymorph [Cell]

Phrase: "and"

Phrase: "were"

Phrase: "therefore"

Phrase: "excluded from further genotyping efforts."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1517331:Further [Spatial Concept]
   760   C1554077:Excluded [Idea or Concept]
   760   C2828389:Excluded [Activity]
   726   C0015264:Effort [Organism Function]
   726 E C0017431:Genotype [Organism Attribute]
   726 E C0205108:far [Spatial Concept]
   726 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.155: In direct resequencing of the A2M locus, we sequenced all exons and 150bp of the adjacent introns, as well as 1000bp of the promoter and the 3'-UTR. 

Phrase: "In direct resequencing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511693:Resequencing [Molecular Biology Research Technique]

Phrase: "of the A2M locus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1708726:Locus [Gene or Genome]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "all exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "150bp of the adjacent introns,"

Phrase: "as well as"

Phrase: "1000bp of the promoter"

Phrase: "and"

Phrase: "the 3'-UTR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600600:3' UTR [Biologically Active Substance,Nucleotide Sequence]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]
Processing 00000000.tx.156: These resequencing reactions were performed on DNA from 29 subjects who carried at least one copy of the A2M-18i deletion allele, which we previously reported to be associated with AD (10). 

Phrase: "These resequencing reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed on DNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from 29 subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "carried at least one"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205447:One [Quantitative Concept]
   770   C0206243:carried [Activity]
   770   C0699809:carried [Finding]

Phrase: "copy of the A2M-18i deletion allele,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   764   C1979845:Alpha 2 [Qualitative Concept]
   762   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0002085:Allele [Gene or Genome]
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0439095:Alpha [Intellectual Product]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1552184:18i [Medical Device]
   742   C1880274:Deletion [Activity]
   742   C1948062:Copy [Manufactured Object]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]

Phrase: "which"

Phrase: "we previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with AD (10"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.157: Sequencing was performed and analyzed on an ABI3700 (Perkin-Elmer). 

Phrase: "Sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed on an ABI3700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "(Perkin-Elmer"

Phrase: ")."
Processing 00000000.tx.158: Genotyping The 5bp deletion polymorphism found in intron 18 was newly genotyped using a fluorescence-based detection method, as opposed to the radio-isotope method that we originally reported (10). 

Phrase: "Genotyping"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
   966 E C0017431:Genotype [Organism Attribute]

Phrase: "The 5bp deletion polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "found in intron 18"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "was"

Phrase: "newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorescence-based detection method,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449335:detection method [Intellectual Product]
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "opposed to the radio-isotope method"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0034595:Radioisotope [Element, Ion, or Isotope]
   753   C0022262:Isotope [Element, Ion, or Isotope]
   753   C0025663:Method [Intellectual Product]
   753   C0034546:Radio [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C1304639:Radio [Manufactured Object]

Phrase: "that"

Phrase: "we originally"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.159: A 321 or 326bp PCR product was amplified, using an annealing temperature of 64C, with one fluorescently labeled PCR primer and one unlabeled PCR primer (Table 2). 

Phrase: "A 321"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "326bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an annealing temperature of 64C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]

Phrase: "with one fluorescently labeled PCR primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "one unlabeled PCR primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: Fluorescently labeled insertion (326bp) and deletion (321bp) products were separated and detected using a MegaBACE 1000 (Amersham-Pharmacia). 

Phrase: "Fluorescently labeled insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0021107:Insertion [Therapeutic or Preventive Procedure]
   827   C0441587:Insertion [Health Care Activity]
   827   C1512796:Insertion [Genetic Function]
   827   C1883719:Insertion [Functional Concept]

Phrase: "(326bp"

Phrase: ")"

Phrase: "and"

Phrase: "deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "(321bp"

Phrase: ")"

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a MegaBACE 1000"

Phrase: "(Amersham-Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.161: Allele calling was performed using Genetic Profiler 1.0 (Amersham-Pharmacia) with visual reinspection of all genotype calls. 

Phrase: "Allele calling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0679006:Call [Mental Process]
   827   C1947967:Call [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Genetic Profiler 1.0"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   812   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   812   C0314603:Genetic [Functional Concept]
   756 E C0005615:Birth [Organism Function]
   756 E C0035150:Reproduction [Organism Function]
   756 E C0079946:origin [Classification]
   756 E C0439659:Origin [Temporal Concept]
   756 E C1550512:origin [Intellectual Product]
   756 E C1550722:birth [Idea or Concept]
   756 E C3245487:birth [Intellectual Product]
   729 E C0454729:Natal [Geographic Area]
   729 E C0559522:Genital [Body System]
   729 E C1546649:Genital [Intellectual Product]
   729 E C1550642:Genital [Body Substance]
   719 E C0205313:Original [Idea or Concept]
   719 E C2347409:Original [Occupational Activity]
   701 E C0598240:originality [Mental Process]

Phrase: "(Amersham-Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "with visual reinspection"

Phrase: "of all genotype calls."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0679006:Call [Mental Process]
   827   C1947967:Call [Functional Concept]
Processing 00000000.tx.162: The 3bp insertion/deletion polymorphism in intron 15 was genotyped in a similar fashion. 

Phrase: "The 3bp insertion/deletion polymorphism in intron 15"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0021107:Insertion [Therapeutic or Preventive Procedure]
   744   C0032529:Polymorphism [Genetic Function]
   744   C0441587:Insertion [Health Care Activity]
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1512796:Insertion [Genetic Function]
   744   C1880274:Deletion [Activity]
   744   C1882417:Polymorphism [Qualitative Concept]
   744   C1883719:Insertion [Functional Concept]

Phrase: "was"

Phrase: "genotyped in a similar fashion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2348205:Similar [Qualitative Concept]
   726   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.163: The 194 or 197bp PCR product was amplified at an annealing temperature of 55C. 

Phrase: "The 194"

Phrase: "or"

Phrase: "197bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "amplified at an annealing temperature of 55C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.164: SNPs found in 5'-UTR, intron 7, exon 12, intron 21, exon 24 and intron 28 were genotyped using fluorescent polarization detected single base extension (FP-SBE) (45). 

Phrase: "SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0752046:SNPs [Nucleotide Sequence]
   966 E C1527094:SNP [Conceptual Entity]

Phrase: "found in 5'-UTR,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1420099:UTR [Gene or Genome]
   770   C1540171:UTR [Gene or Genome]
   737 E C0243095:Find [Finding]

Phrase: "intron 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "exon 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "intron 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "exon 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intron 28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescent polarization detected single base extension (FP-SBE)"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   799   C0002055:base [Inorganic Chemical]
   799   C0037179:Single [Population Group]
   799   C0087136:single [Finding]
   799   C0178499:Base [Chemical Viewed Functionally]
   799   C0205171:Single [Quantitative Concept]
   799   C0231448:Extension [Functional Concept]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0442726:Detected [Finding]
   799   C0946292:Polarization [Clinical Attribute]
   799   C1511790:Detected [Therapeutic or Preventive Procedure]
   799   C1880279:Base [Biomedical or Dental Material]
   799   C1880641:Extension [Conceptual Entity]
   727 E C0205112:Basal [Spatial Concept]
   716 E C0016617:Foundation [Organization]
   716 E C1626935:Bases [Quantitative Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.165: PCR primers (Table 2) were designed to yield products between 200 and 400bp in length, and were used at a final concentration of 100300nM (InVitrogen) along with Taq polymerase (0.25 U/reaction; Qiagen) and dNTPs (2.5M/rxn; Amersham-Pharmacia). 

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "products between 200"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1514468:Products [Entity]
   756 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "400bp in length,"

Phrase: "and"

Phrase: "were"

Phrase: "used at a final concentration of 100300nM"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0205088:Final [Temporal Concept]
   748   C1273517:used [Finding]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1546485:Final [Idea or Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(InVitrogen"

Phrase: ")"

Phrase: "along with Taq polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(0.25 U/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "; Qiagen"

Phrase: ")"

Phrase: "and"

Phrase: "dNTPs"

Phrase: "(2.5M/rxn"

Phrase: "; Amersham-Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.166: Human genomic DNA, 10ng, was used as the template for PCR reactions. 

Phrase: "Human genomic DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017428:Genomic [Gene or Genome]
   827   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "10ng,"

Phrase: "was"

Phrase: "used as the template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for PCR reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.167: General PCR cycling conditions were as follows: initial denaturation of 3min at 94C; 

Phrase: "General PCR cycling conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "initial denaturation of 3min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0301642:Denaturation [Molecular Function]

Phrase: "at 94C"

Phrase: ";"
Processing 00000000.tx.168: 30 cycles of 94C for 45s; 

Phrase: "30 cycles of 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 45s"

Phrase: ";"
Processing 00000000.tx.169: primer set specific annealing temperature (see below) for 45s, and 72C for 1min; 

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "specific annealing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "for 45s,"

Phrase: "and"

Phrase: "72C for 1min"

Phrase: ";"
Processing 00000000.tx.170: finally, 6min at 72C. 

Phrase: "finally,"

Phrase: "6min at 72C."
Processing 00000000.tx.171: All PCR producs were visualized on 2% agarose gels to confirm a single product of the correct size. 

Phrase: "All PCR producs"

Phrase: "were"

Phrase: "visualized on 2% agarose gels to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C0234621:Visualized [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "a single product of the correct size."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.172: PCR primers and unincorporated dNTPs were degraded by the direct addition of exonuclease I (0.10.15 U/reaction; New England Biolabs) and shrimp alkaline phosphatase (1U/reaction; Roche) to the PCR reactions and incubated for 1h at 37C, then for 15min at 95C to inactivate the enzymes. 

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "unincorporated dNTPs"

Phrase: "were"

Phrase: "degraded by the direct addition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439851:Direct [Qualitative Concept]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C1883712:Addition [Functional Concept]
   760   C1947931:Direct [Qualitative Concept]

Phrase: "of exonuclease I (0.10.15 U/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0443286:Reaction [Functional Concept]
   795   C1114821:Reaction [Clinical Attribute]

Phrase: "; New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "shrimp alkaline phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1149880:phosphatase [Molecular Function]
   827   C1979842:Alkaline [Qualitative Concept]

Phrase: "(1U/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "; Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "to the PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at 37C,"

Phrase: "then for 15min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883708:Then [Temporal Concept]

Phrase: "at 95C to"

Phrase: "inactivate"

Phrase: "the enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.173: The single base extension step was carried out using Thermosequenase (0.4 U/reaction; Amersham-Pharmacia) and the appropriate mixture (LJL Biosystems Application Note) of R110-ddNTP, TAMRA-ddNTP (3mM; NEN), and all four unlabeled ddNTPs (22 or 25M; Amersham-Pharmacia) to the ExoI/SAP treated PCR product. 

Phrase: "The single base extension step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Thermosequenase"

Phrase: "(0.4 U/reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "; Amersham-Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "the appropriate mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "(LJL Biosystems Application Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1316572:Note [Clinical Attribute]
   812   C1317574:Note [Intellectual Product]
   812   C1369612:Note [Clinical Attribute]

Phrase: ")"

Phrase: "of R110-ddNTP,"

Phrase: "TAMRA-ddNTP"

Phrase: "(3mM"

Phrase: "; NEN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "all four unlabeled ddNTPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1955881:ddNTPs [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(22"

Phrase: "or"

Phrase: "25M"

Phrase: "; Amersham-Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "to the ExoI/SAP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420017:SAP [Gene or Genome]
   861   C1456795:SAP [Gene or Genome]
   861   C2699241:SAP [Gene or Genome]
   861   C2700633:Sap [Plant]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "PCR product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.174: Incorporation of the SNP specific fluorescent base was achieved by subjecting samples to 35 cycles of 94C for 15s and 55C for 30s. 

Phrase: "Incorporation of the SNP specific fluorescent base"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "achieved by subjecting samples"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   737   C0370003:Sample [Substance]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2347026:Sample [Conceptual Entity]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "to 35 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of 94C"

Phrase: "for 15s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552129:15s [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "55C for 30s."
Processing 00000000.tx.175: SBE primers (Table 2) were designed to yield a Tm of 6264C. 

Phrase: "SBE primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "a Tm of 6264C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   770   C3540468:TM [Gene or Genome]
Processing 00000000.tx.176: Fluorescent base incorporation was detected using an LJL Biosystems Analyst AD (Sunnyvale, CA, USA) and measuring fluorescent polarization for R110 (excitation 490nm/emission 520nm) and TAMRA (excitation 550nm/emission 580nm). 

Phrase: "Fluorescent base incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an LJL Biosystems Analyst AD (Sunnyvale,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "measuring fluorescent polarization for R110"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0946292:Polarization [Clinical Attribute]

Phrase: "(excitation 490nm/emission 520nm"

Phrase: ")"

Phrase: "and"

Phrase: "TAMRA"

Phrase: "(excitation 550nm/emission 580nm"

Phrase: ")."
Processing 00000000.tx.177: Genotypes were called manually. 

Phrase: "Genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "manually."
Processing 00000000.tx.178: All genotyping experiments contained at least three samples whose genotypes were known from direct sequencing. 

Phrase: "All genotyping experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "contained at least three samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205449:Three [Quantitative Concept]
   760   C0332256:contained [Functional Concept]
   760   C2700400:Contained [Activity]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "whose genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "known from direct sequencing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205309:Known [Qualitative Concept]
   770   C0439851:Direct [Qualitative Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.179: SNP specific annealing temperature, PCR product lengths, and SBE dye mixtures are given below. 

Phrase: "SNP specific annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0005903:temperature [Organism Attribute]
   812   C0039476:*Temperature [Quantitative Concept]

Phrase: "PCR product lengths,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   827   C1444754:Lengths [Quantitative Concept]
   793 E C1706316:LENGTH [Research Activity]
   743 E C0205166:Long [Qualitative Concept]
   743 E C1522425:Longest [Qualitative Concept]
   743 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "SBE dye mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439962:mixtures [Substance]

Phrase: "are"

Phrase: "given below."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442162:GIVEN [Conceptual Entity]
   833   C1550718:given [Idea or Concept]
   833   C3244317:given [Intellectual Product]
   799 E C1947971:Give [Functional Concept]
Processing 00000000.tx.180: For the 5'-UTR poly-morphism, PCR primers yielded a 344bp product using a 61C annealing temperature, and an R110-ddATP/TAMRA-ddCTP dye mixture was used in the SBE step. 

Phrase: "For the 5'-UTR poly-morphism,"

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 344bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 61C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddATP/TAMRA-ddCTP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.181: For the intron 7 poly-morphism, PCR primers yielded a 380bp product using a 61C annealing temperature, and an R110-ddUTP/TAMRA-ddGTP dye mixture was used in the SBE step. 

Phrase: "For the intron 7 poly-morphism,"

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 380bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 61C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddUTP/TAMRA-ddGTP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.182: For the exon 12 polymorphism, PCR primers yielded a 304bp product using a 64C annealing temperature, and an R110-ddUTP/TAMRA-ddCTP dye mixture was used in the SBE step. 

Phrase: "For the exon 12 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 304bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 64C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddUTP/TAMRA-ddCTP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.183: For the intron 21 polymorphism, PCR primers yielded a 264bp product using a 57.2C annealing temperature, and an R110-ddUTP/TAMRA-ddATP dye mixture was used in the SBE step. 

Phrase: "For the intron 21 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 264bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 57.2C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0005903:temperature [Organism Attribute]
   812   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddUTP/TAMRA-ddATP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.184: For the exon 24 polymorphism, PCR primers yielded a 272bp product using a 54C annealing temperature, and an R110-ddUTP/TAMRA-ddCTP dye mixture was used in the SBE step. 

Phrase: "For the exon 24 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 272bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 54C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddUTP/TAMRA-ddCTP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.185: For the intron 28 polymorphism, PCR primers yielded a 266bp product using a 61C annealing temperature, and an R110-ddUTP/TAMRA-ddCTP dye mixture was used in the SBE step. 

Phrase: "For the intron 28 polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "yielded"

Phrase: "a 266bp product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 61C annealing temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "an R110-ddUTP/TAMRA-ddCTP dye mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "used in the SBE step."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0014122:SBE [Disease or Syndrome]
   760   C1261552:Step [Conceptual Entity]
   760   C1273517:used [Finding]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.186: The polymorphism in exon 20 was genotyped by restriction fragment length polymorphism. 

Phrase: "The polymorphism in exon 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "genotyped by restriction fragment length polymorphism."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0035268:Restriction fragment length polymorphism [Clinical Attribute]
   753   C0032529:Polymorphism [Genetic Function]
   753   C0332255:fragment [Functional Concept]
   753   C0443288:Restriction [Functional Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C1708096:Fragment [Qualitative Concept]
   753   C1882417:Polymorphism [Qualitative Concept]
   719   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.187: PCR primers (Table 2) were used with an annealing temperature of 64C. 

Phrase: "PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used with an annealing temperature of 64C."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   757   C1524063:Use of [Functional Concept]
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]
   748   C1273517:used [Finding]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.188: The PCR amplifications were performed in the presence of [-33P]dATP (1Ci). 

Phrase: "The PCR amplifications"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1517480:Amplification [Molecular Biology Research Technique]
   827   C1521871:Amplification [Phenomenon or Process]
   827   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "performed in the presence of [-33P"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "]dATP (1Ci"

Phrase: ")."
Processing 00000000.tx.189: This polymorphism, a C/T transition, removes a HhaI restriction site. 

Phrase: "This polymorphism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "a C/T transition,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C2700061:Transition [Activity]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]
   708   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "a HhaI restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.190: PCR products were digested with 5U of HhaI (New England Biolabs) for 8h at 37C in the appropriate buffer. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "digested with 5U of HhaI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0868946:digested [Physiologic Function]

Phrase: "(New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")"

Phrase: "for 8h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292429:8H [Temporal Concept]

Phrase: "at 37C"

Phrase: "in the appropriate buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.191: Following digestion, products were denatured for 3min at 94C and then and separated by polyacrylamide gel electrophoresis (Ultra Pure SequaGel-6, National Diagnostics) for 1h at 60W and exposed to film for 24h. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "digestion,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "denatured for 3min"

Phrase: "at 94C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "and"

Phrase: "separated by polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   806   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "(Ultra Pure SequaGel-6,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0728475:ultra [Medical Device]
   812   C2247561:PurE [Molecular Function]
   741 E C1882508:Purity [Quantitative Concept]

Phrase: "National Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 60W"

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film for 24h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0086296:Film [Manufactured Object]
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C1561571:film [Biomedical or Dental Material]
   790   C1561572:film [Substance]
Processing 00000000.tx.192: Genotyping quality control measures To ensure consistent and high-quality genotyping data, the same three control samples of known genotype were included in every genotyping experiment. 

Phrase: "Genotyping quality control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0034378:quality control [Functional Concept]
   901   C1561524:Quality Control [Intellectual Product]
   901   C1610034:Quality Control [Intellectual Product]
   827   C0243148:control [Qualitative Concept]
   827   C0332306:Quality [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332290:Consistent [Idea or Concept]
   928 E C0332529:Consistencies [Qualitative Concept]
   928 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "high-quality genotyping data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0242483:quality data [Qualitative Concept]
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "the same three control samples of known genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "included in every genotyping experiment."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0332257:included [Functional Concept]
   760   C0681814:Experiment [Research Activity]
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1706386:Experiment [Conceptual Entity]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C0017431:Genotype [Organism Attribute]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.193: In addition, 10% of the samples were genotyped in duplicate. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "10% of the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "genotyped in duplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.194: The genotypes of the duplicate samples were checked for consistency. 

Phrase: "The genotypes of the duplicate samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "checked for consistency."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332529:Consistency [Qualitative Concept]
   790   C1283174:Checked [Activity]
   790   C1547017:Consistency [Quantitative Concept]
   718 E C0332290:Consistent [Idea or Concept]
Processing 00000000.tx.195: We found discrepancy rate >0% for only two polymorphisms: 21i (0.63%) and 24e (1.27%). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "discrepancy rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: ">0% for only two polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0205171:Only [Quantitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "21i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552191:21i [Medical Device]

Phrase: "(0.63%"

Phrase: ")"

Phrase: "and"

Phrase: "24e"

Phrase: "(1.27%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.196: In addition, we have very little missing data: we have obtained genotypes for >95% of the samples (Table 3) for all polymorphisms. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "very little missing data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "we"

Phrase: "have"

Phrase: "obtained genotypes for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotypes [Organism Attribute]

Phrase: ">95% of the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "for all polymorphisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.197: Statistical analysis Tests of individual polymorphisms for association with AD were performed in the Family-Based Association Test package (46,47) (FBAT; version 1.2), which puts tests of different models, different sampling designs, different disease phenotypes, missing parents and different null hypotheses all in the same framework. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "Tests of individual polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0022885:Test [Laboratory Procedure]
   770   C0027361:Individual [Population Group]
   770   C0032529:polymorphisms [Genetic Function]
   770   C0039593:Test [Functional Concept]
   770   C0237401:Individual [Human]
   770   C0392366:Tests [Intellectual Product]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "were"

Phrase: "performed in the Family-Based Association Test package"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   744   C0004083:Association [Mental Process]
   744   C0013194:Package [Medical Device]
   744   C0015576:Family [Family Group]
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C0884358:Performed [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1704727:Family [Conceptual Entity]
   744   C1705938:Based [Idea or Concept]
   744   C2700580:Package [Manufactured Object]
   731   C0544093:Association, familial [Finding]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(46,"

Phrase: "47"

Phrase: ")"

Phrase: "(FBAT"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   817   C0544093:Association, familial [Finding]
   804   C0004083:Association [Mental Process]
   804   C0013194:Package [Medical Device]
   804   C0015576:Family [Family Group]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]
   804   C1527178:Based [Functional Concept]
   804   C1704727:Family [Conceptual Entity]
   804   C1705938:Based [Idea or Concept]
   804   C2700580:Package [Manufactured Object]
   771 E C0002055:base [Inorganic Chemical]
   771 E C0178499:Base [Chemical Viewed Functionally]
   771 E C1880279:Base [Biomedical or Dental Material]
   733 E C0241888:Familial [Functional Concept]

Phrase: "; version 1.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "puts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882509:Put [Activity]

Phrase: "tests of different models,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:Tests [Intellectual Product]
   770   C1705242:Different [Qualitative Concept]
   770   C3161035:Models [Intellectual Product]

Phrase: "different sampling designs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0815259:Sampling Design [Intellectual Product]
   793   C1707689:Design [Activity]
   793   C2983265:DESIGN [Intellectual Product]

Phrase: "different disease phenotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "parents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0030551:Parents [Family Group]
   966 E C2699423:Parent [Conceptual Entity]

Phrase: "and"

Phrase: "different null hypotheses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456148:Null [Quantitative Concept]
   793   C1512571:Hypothesis [Idea or Concept]

Phrase: "all in the same framework."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444868:All [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3539085:All [Idea or Concept]
Processing 00000000.tx.198: Like the transmission-disequilibrium test (TDT) and other family-based association tests, this method is not susceptible to bias due to population admixture. 

Phrase: "Like the transmission-disequilibrium test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0392366:test [Intellectual Product]
   827   C0394006:Disequilibrium [Disease or Syndrome]
   827   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(TDT)"

Phrase: "and"

Phrase: "other family-based association tests,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   839   C0544093:Association, familial [Finding]
   812   C0004083:Association [Mental Process]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   812   C0439849:Association [Qualitative Concept]
   812   C0596306:Association [Phenomenon or Process]
   812   C0699792:association [Social Behavior]
   779 E C0039593:Test [Functional Concept]

Phrase: "this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "not susceptible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0231204:Susceptible [Functional Concept]
   827   C1518422:Not [Functional Concept]
   827   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "bias due to population admixture."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0032659:Population [Quantitative Concept]
   760   C0242568:Bias [Idea or Concept]
   760   C1257890:Population [Population Group]
   760   C1504315:Bias [Bird]
   760   C1510816:Admixture [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.199: FBAT uses a generalized score statistic to perform a variety of TDT-type tests (46). 

Phrase: "FBAT"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   817   C0544093:Association, familial [Finding]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "a generalized score statistic to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C2348149:Statistic [Quantitative Concept]
   812   C2828391:Statistic [Quantitative Concept]
   741 E C0038215:Statistical [Occupation or Discipline]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "a variety of TDT-type tests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.200: We used an additive model which performs well under a variety of true genetic models (48). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an additive model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "which"

Phrase: "performs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "well under a variety of true genetic models"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0026343:Models, Genetic [Intellectual Product]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0205170:Well [Qualitative Concept]
   744   C0205238:True [Qualitative Concept]
   744   C0314603:Genetic [Functional Concept]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   744   C3146287:Well [Manufactured Object]
   744   C3161035:Models [Intellectual Product]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.201: We also used the empirical variance option in FBAT (EV-FBAT), which is valid in the presence of linkage (even when extended families are broken into component nuclear families) (49), because of the reports of linkage in this vicinity (29), although linkage in this area was not seen by our group (23). 

Phrase: "We also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the empirical variance option in FBAT (EV-FBAT),"
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   739   C0004083:Association [Mental Process]
   739   C0013194:Package [Medical Device]
   739   C0015576:Family [Family Group]
   739   C0022885:Test [Laboratory Procedure]
   739   C0039593:Test [Functional Concept]
   739   C0392366:test [Intellectual Product]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]
   739   C1518601:Option [Functional Concept]
   739   C1527178:Based [Functional Concept]
   739   C1550456:option [Idea or Concept]
   739   C1704727:Family [Conceptual Entity]
   739   C1705938:Based [Idea or Concept]
   739   C1711260:Variance [Qualitative Concept]
   739   C1880496:Empirical [Qualitative Concept]
   739   C2348152:Variance [Quantitative Concept]
   739   C2700580:Package [Manufactured Object]
   722   C0544093:Association, familial [Finding]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "is"

Phrase: "valid in the presence of linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2349099:Valid [Qualitative Concept]

Phrase: "(even"

Phrase: "when"

Phrase: "extended families"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0015341:Families, Extended [Family Group]
   861   C0015576:Families [Family Group]
   861   C0231448:Extended [Functional Concept]
   861   C0231449:Extended [Spatial Concept]
   861   C0439792:extended [Spatial Concept]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "broken into component nuclear families"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0028574:Nuclear Families [Family Group]
   797   C0680067:broken family [Group Attribute]
   760   C0015576:Families [Family Group]
   760   C0449432:Component [Manufactured Object]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1704727:Family [Conceptual Entity]
   760   C1705248:Component [Conceptual Entity]
   726   C1881704:BREAK [Phenomenon or Process]

Phrase: ")"

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "because of the reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "of linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "in this vicinity"

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "linkage in this area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen by our group"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0205397:Seen [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.202: We performed both the default affecteds-only analyses in FBAT, which uses information from unaffected siblings only to provide information about possible parental genotypes, and analyses using an offset to include phenotypic information from unaffected siblings. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "both the default affecteds-only analyses in FBAT,"
Meta Candidates (Total=27; Excluded=3; Pruned=0; Remaining=24)
   736   C0004083:Association [Mental Process]
   736   C0013194:Package [Medical Device]
   736   C0015576:Family [Family Group]
   736   C0022885:Test [Laboratory Procedure]
   736   C0039593:Test [Functional Concept]
   736   C0205171:Only [Quantitative Concept]
   736   C0238767:Both [Spatial Concept]
   736   C0392366:test [Intellectual Product]
   736   C0439849:Association [Qualitative Concept]
   736   C0596306:Association [Phenomenon or Process]
   736   C0699792:association [Social Behavior]
   736   C1527178:Based [Functional Concept]
   736   C1704727:Family [Conceptual Entity]
   736   C1705938:Based [Idea or Concept]
   736   C1706086:Both [Qualitative Concept]
   736   C1720467:Only [Intellectual Product]
   736   C2700580:Package [Manufactured Object]
   736   C2828024:Default [Classification]
   715   C0544093:Association, familial [Finding]
   703 E C0002055:base [Inorganic Chemical]
   703   C0002778:Analysis [Laboratory Procedure]
   703 E C0178499:Base [Chemical Viewed Functionally]
   703   C0392760:Affected [Functional Concept]
   703   C0936012:Analysis [Research Activity]
   703   C1314939:Affected [Functional Concept]
   703   C1524024:analysis [Functional Concept]
   703 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "information from unaffected siblings only to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "information about possible parental genotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an offset to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711330:Offset [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "phenotypic information from unaffected siblings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]
Processing 00000000.tx.203: The latter approach makes maximal use of the available data. 

Phrase: "The latter approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "maximal use of the available data."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
Processing 00000000.tx.204: We set the offset equal to 0.5 for the affecteds and unaffecteds, which gives equal weight to each group. 

Phrase: "We"

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "the offset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711330:Offset [Quantitative Concept]

Phrase: "equal to 0.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205163:Equal To [Qualitative Concept]
           Equal
   770   C1549782:Equal [Idea or Concept]

Phrase: "for the affecteds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392760:Affected [Functional Concept]
   966   C1314939:Affected [Functional Concept]

Phrase: "and"

Phrase: "unaffecteds,"

Phrase: "which"

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "equal weight to each group."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005910:weight [Organism Attribute]
   760   C0043100:Weight [Quantitative Concept]
   760   C1305866:weight [Diagnostic Procedure]
   760   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.205: In principle, the offset should be equal to the prevalence, but in highly selected samples such as this one this approach works well (5052). 

Phrase: "In principle,"

Phrase: "the offset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711330:Offset [Quantitative Concept]

Phrase: "should"

Phrase: "be"

Phrase: "equal to the prevalence,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205163:Equal To [Qualitative Concept]
           Equal
   770   C1549782:Equal [Idea or Concept]

Phrase: "but in highly selected samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205250:Highly [Qualitative Concept]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   726   C0370003:Sample [Substance]
   726   C1707391:Select [Activity]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "such as this one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "works"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(5052"

Phrase: ")."
Processing 00000000.tx.206: For the nominally associated polymorphisms, we also performed conditional logistic regression (CLR) stratified on family to assess the magnitude of any effect on disease risk (53). 

Phrase: "For the nominally associated polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "conditional logistic regression (CLR)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "stratified on family to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015576:Family [Family Group]
   770   C0205363:Stratified [Qualitative Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the magnitude of any effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "on disease risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1281905:disease risk [Finding]
   861   C0035647:Risk [Qualitative Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.207: We include confidence intervals to provide a rough idea of the precision of these estimates. 

Phrase: "We"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "confidence intervals to"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   901   C0009667:Confidence Intervals [Quantitative Concept]
   827   C0237529:Confidence [Mental Process]
   827   C1272706:intervals [Temporal Concept]
   827   C1704725:Confidence [Qualitative Concept]
   827   C1704726:Confidence [Mental Process]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   755 E C0558095:Confident [Individual Behavior]
   727 E C0009669:confidentiality [Idea or Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a rough idea of the precision of these estimates."
Processing 00000000.tx.208: However, it should be noted that these intervals may be slightly too narrow because CLR may slightly underestimate the standard errors when multiple affected and unaffected subjects are included in each family. 

Phrase: "However,"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "these intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272706:intervals [Temporal Concept]
   966 E C1552654:Interval [Idea or Concept]
   966 E C1552713:Interval [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "slightly too"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750482:Slightly [Idea or Concept]

Phrase: "narrow"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205168:Narrow [Qualitative Concept]
  1000   C0332463:Narrow [Spatial Concept]
  1000   C0333164:Narrow [Quantitative Concept]

Phrase: "because"

Phrase: "CLR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206031:Logistic Regression [Research Activity]
   827   C0242415:logistic [Occupational Activity]
   827   C0684320:Regression [Pathologic Function]
   827   C0684321:Regression [Mental Process]

Phrase: "may"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "underestimate"

Phrase: "the standard errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:errors [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1608199:Error [Functional Concept]

Phrase: "when"

Phrase: "multiple affected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392760:Affected [Functional Concept]
   861   C1314939:Affected [Functional Concept]

Phrase: "and"

Phrase: "unaffected subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "are"

Phrase: "included in each family."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0015576:Family [Family Group]
   770   C0332257:included [Functional Concept]
   770   C1704727:Family [Conceptual Entity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.209: The magnitude of this effect is expected to be small unless genetic effects are very large (54). 

Phrase: "The magnitude of this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "unless"

Phrase: "genetic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "very large"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450093:Very large [Finding]
   861   C0549177:Large [Quantitative Concept]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.210: To gain insight into the underlying haplotype structure of A2M, we combined individual polymorphisms into multilocus haplotypes, assuming no recombination between SNPs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the underlying haplotype structure of A2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:Insight [Mental Process]

Phrase: "we"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "individual polymorphisms into multilocus haplotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "assuming"

Phrase: "no recombination between SNPs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.211: Haplotype analysis is especially useful when the true risk modifying polymorphism has not been identified (which could be expected here owing to conflicting findings from independent studies), as this method should be able to extract more inheritance information from any given set of loci than can be accomplished by testing polymorphisms individually (55,56). 

Phrase: "Haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "especially useful"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "the true risk modifying polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "("

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "here owing to conflicting findings"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0009671:conflicting [Individual Behavior]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C1705242:Conflict [Qualitative Concept]
   726 E C2825141:Finding [Finding]

Phrase: "from independent studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0681367:independent study [Educational Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "more inheritance information from any given set of loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1533716:Information [Idea or Concept]

Phrase: "than"

Phrase: "can"

Phrase: "be"

Phrase: "accomplished by testing polymorphisms individually"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0032529:polymorphisms [Genetic Function]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.212: Here, five-locus haplotypes were reconstructed from the eight genotyped polymorphisms in A2M and tested for excess transmission in affected individuals using the HBAT option (55,57) within the FBAT package. 

Phrase: "Here,"

Phrase: "five-locus haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "reconstructed from the eight genotyped polymorphisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0032529:polymorphisms [Genetic Function]
   753   C0205454:Eight [Quantitative Concept]
   753   C2348043:Reconstructed [Qualitative Concept]
   719   C0017431:Genotype [Organism Attribute]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "tested for excess transmission"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0040722:transmission [Idea or Concept]
   770   C0242781:Transmission [Pathologic Function]
   770   C0392366:tested [Intellectual Product]
   770   C1521797:Transmission [Natural Phenomenon or Process]
   770   C1979886:Excess [Qualitative Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "in affected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HBAT option"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1518601:Option [Functional Concept]
   861   C1550456:option [Idea or Concept]
   789 E C1518600:Optional [Qualitative Concept]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "57"

Phrase: ")"

Phrase: "within the FBAT package."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   793   C0004083:Association [Mental Process]
   793   C0013194:Package [Medical Device]
   793   C0015576:Family [Family Group]
   793   C0022885:Test [Laboratory Procedure]
   793   C0039593:Test [Functional Concept]
   793   C0332285:Within [Spatial Concept]
   793   C0392366:test [Intellectual Product]
   793   C0439849:Association [Qualitative Concept]
   793   C0596306:Association [Phenomenon or Process]
   793   C0699792:association [Social Behavior]
   793   C1527178:Based [Functional Concept]
   793   C1704727:Family [Conceptual Entity]
   793   C1705938:Based [Idea or Concept]
   793   C2700580:Package [Manufactured Object]
   787   C0544093:Association, familial [Finding]
   760 E C0002055:base [Inorganic Chemical]
   760 E C0178499:Base [Chemical Viewed Functionally]
   760 E C1880279:Base [Biomedical or Dental Material]
   721 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.213: We chose five-locus haplotypes because in our experience a window of this size offers maximal informativeness within a reasonable computation time. 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "five-locus haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "because in our"

Phrase: "experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:experience [Mental Process]
  1000   C0596545:Experience [Mental Process]

Phrase: "a window of this size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0557702:Window [Manufactured Object]
   760   C1272706:Window [Temporal Concept]
   760   C1704674:Window [Manufactured Object]

Phrase: "offers"

Phrase: "maximal informativeness within a reasonable computation time."
Processing 00000000.tx.214: Results of preliminary analyses using smaller and larger SNP windows were not appreciably different. 

Phrase: "Results of preliminary analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1548161:Preliminary results [Idea or Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "smaller"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0547044:Smaller [Qualitative Concept]
  1000   C0700321:Smaller [Quantitative Concept]

Phrase: "and"

Phrase: "larger SNP windows"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557702:windows [Manufactured Object]
   793 E C1272706:Window [Temporal Concept]
   793 E C1704674:Window [Manufactured Object]

Phrase: "were"

Phrase: "not appreciably different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.215: The HBAT option in FBAT extends the conditioning algorithm of Rabinowitz and Laird to account for missing phase. 

Phrase: "The HBAT option in FBAT"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   742   C0004083:Association [Mental Process]
   742   C0013194:Package [Medical Device]
   742   C0015576:Family [Family Group]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]
   742   C1518601:Option [Functional Concept]
   742   C1527178:Based [Functional Concept]
   742   C1550456:option [Idea or Concept]
   742   C1704727:Family [Conceptual Entity]
   742   C1705938:Based [Idea or Concept]
   742   C2700580:Package [Manufactured Object]
   726   C0544093:Association, familial [Finding]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the conditioning algorithm of Rabinowitz"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002045:algorithm [Intellectual Product]
   760   C1553907:algorithm [Laboratory Procedure]

Phrase: "and"

Phrase: "Laird to"

Phrase: "account for missing phase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205390:Phase [Temporal Concept]
   770   C1551359:account [Idea or Concept]
   770   C1551393:Missing [Idea or Concept]
   770   C1705492:Missing [Qualitative Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   770   C3272743:MISSING [Qualitative Concept]
Processing 00000000.tx.216: As in FBAT, many pedigrees will be non-informative, because the conditioning places positive probability on only one outcome. 

Phrase: "As in FBAT,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   748   C0004083:Association [Mental Process]
   748   C0013194:Package [Medical Device]
   748   C0015576:Family [Family Group]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1527178:Based [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C1705938:Based [Idea or Concept]
   748   C2700580:Package [Manufactured Object]
   738   C0544093:Association, familial [Finding]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "many pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]

Phrase: "will"

Phrase: "be"

Phrase: "non-informative,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Non [Functional Concept]
   861   C2986490:Informative [Qualitative Concept]

Phrase: "because"

Phrase: "the conditioning places positive probability on only one outcome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033204:Probability [Quantitative Concept]
Processing 00000000.tx.217: That is, families with only one or two affected offspring, no unaffected offspring and no parental genotype data will not contribute to the test statistic. 

Phrase: "That"

Phrase: "is"

Phrase: ","

Phrase: "families with only one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]

Phrase: "or"

Phrase: "two affected offspring,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]

Phrase: "no unaffected offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "and"

Phrase: "no parental genotype data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contribute to the test statistic."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0237913:Statistical Test [Intellectual Product]
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1880177:Contribute [Activity]
   760   C2348149:Statistic [Quantitative Concept]
   760   C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.218: In addition, it uses weights to increase information in the presence of uncertainty about phase. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "weights to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0043100:Weights [Quantitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "information in the presence of uncertainty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "about phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.219: The resulting test statistic is unbiased for testing association even in the presence of admixture and/or population stratification, and under the alternative hypothesis that association is present, it provides good power relative to a setting where phase is known (57). 

Phrase: "The resulting test statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C2348149:Statistic [Quantitative Concept]
   827   C2828391:Statistic [Quantitative Concept]
   755 E C0038215:Statistical [Occupation or Discipline]

Phrase: "is"

Phrase: "unbiased for testing association even"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0004083:Association [Mental Process]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   726 E C0022885:Test [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of admixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510816:Admixture [Qualitative Concept]

Phrase: "and/or"

Phrase: "population stratification,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "and under the alternative hypothesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1512571:Hypothesis [Idea or Concept]
   760   C1515981:And [Idea or Concept]
   760   C1523987:Alternative [Conceptual Entity]

Phrase: "that association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "good power"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "relative to a setting where phase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.220: As described above for FBAT, we used the empirical variance option to account for the reported the reported linkage in the region, which also ensures a valid test when extended pedigrees are broken into nuclear families (49). 

Phrase: "As"

Phrase: "described above for FBAT,"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   744   C0004083:Association [Mental Process]
   744   C0013194:Package [Medical Device]
   744   C0015576:Family [Family Group]
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0392366:test [Intellectual Product]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1527178:Based [Functional Concept]
   744   C1552738:described [Idea or Concept]
   744   C1704727:Family [Conceptual Entity]
   744   C1705938:Based [Idea or Concept]
   744   C2700580:Package [Manufactured Object]
   731   C0544093:Association, familial [Finding]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the empirical variance option to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1518601:Option [Functional Concept]
   812   C1550456:option [Idea or Concept]
   741 E C1518600:Optional [Qualitative Concept]

Phrase: "account for the reported"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "the reported linkage in the region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "which also"

Phrase: "ensures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "a valid test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "when"

Phrase: "extended pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "are"

Phrase: "broken into nuclear families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028574:Nuclear Families [Family Group]
   819   C0680067:broken family [Group Attribute]
   770   C0015576:Families [Family Group]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1704727:Family [Conceptual Entity]
   737   C1881704:BREAK [Phenomenon or Process]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.221: As in FBAT, we used an offset of 0.5 to include phenotypic information from unaffected subjects. 

Phrase: "As in FBAT,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   748   C0004083:Association [Mental Process]
   748   C0013194:Package [Medical Device]
   748   C0015576:Family [Family Group]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1527178:Based [Functional Concept]
   748   C1704727:Family [Conceptual Entity]
   748   C1705938:Based [Idea or Concept]
   748   C2700580:Package [Manufactured Object]
   738   C0544093:Association, familial [Finding]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an offset of 0.5 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1711330:Offset [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "phenotypic information from unaffected subjects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1533716:Information [Idea or Concept]
Processing 00000000.tx.222: Nominal global P-values are reported, along with P-values for individual haplotype alleles with more than 10 informative pedigrees. 

Phrase: "Nominal global P-values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   886   C1264625:Nominal value [Quantitative Concept]
   827   C1709380:P-Value [Quantitative Concept]
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "along with P-values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "for individual haplotype alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "with more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 10 informative pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.223: The haplotype frequencies are obtained from the estimated phased genotype frequencies of the founders. 

Phrase: "The haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "are"

Phrase: "obtained from the estimated phased genotype frequencies of the founders."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   739   C0017431:Genotype [Organism Attribute]
   739   C0205390:Phased [Temporal Concept]
   739   C0263541:founders [Disease or Syndrome]
   739   C0439603:Frequencies [Temporal Concept]
   739   C0750572:Estimated [Quantitative Concept]
   739   C1301820:Obtained [Functional Concept]
   706 E C0376249:frequency [Quantitative Concept]
   706 E C0871396:Frequency [Quantitative Concept]
   706 E C1561548:Frequency [Qualitative Concept]
   706 E C1705502:Frequency [Quantitative Concept]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.224: These latter frequencies maximize the likelihood based on all the genotype data, assuming the null hypothesis of no linkage and no association, and assuming random mating. 

Phrase: "These latter frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "maximize"

Phrase: "the likelihood"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0033204:Likelihood [Quantitative Concept]
   928 E C0332148:Likely [Qualitative Concept]
   928 E C0750492:Likely [Idea or Concept]

Phrase: "based on all"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the genotype data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "assuming"

Phrase: "the null hypothesis of no linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456148:Null [Quantitative Concept]
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: "no association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "assuming random mating."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0034656:RANDOM [Research Activity]
   827   C0439605:Random [Qualitative Concept]
   827   C1160186:mating [Cell Function]
   827   C1260875:mating [Organism Function]
   827   C1748461:mating [Cell Function]
   793 E C0682323:mate [Family Group]
Processing 00000000.tx.225: Because we estimate phased genotype frequencies rather than haplotype frequencies, HardyWeinberg equilibrium is not assumed. 

Phrase: "Because"

Phrase: "we"

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "phased genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "rather than"

Phrase: "haplotype frequencies,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "HardyWeinberg equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014653:Equilibrium [Organism Function]
   861   C1547026:Equilibrium [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assumed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]
Processing 00000000.tx.226: These phased genotype frequencies are used to attach weights to any outcomes with ambiguous phase. 

Phrase: "These phased genotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "are"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "attach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231441:Attach [Finding]
  1000   C1314972:ATTACH [Intellectual Product]

Phrase: "weights to any outcomes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0043100:Weights [Quantitative Concept]
   737 E C0005910:weight [Organism Attribute]
   737 E C1305866:weight [Diagnostic Procedure]
   737 E C1705104:Weight [Idea or Concept]

Phrase: "with ambiguous phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.227: For example if one unphased genotype is compatible with two phased genotypes, then weights summing to one are assigned to each phased genotype, where the weight equals the probability of the phased genotype given the unphased genotype, based on estimated phased genotype probabilities. 

Phrase: "For example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "if"

Phrase: "one unphased genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "is"

Phrase: "compatible with two phased genotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]

Phrase: "then weights"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0043100:Weights [Quantitative Concept]
   827 E C0005910:weight [Organism Attribute]
   827 E C1305866:weight [Diagnostic Procedure]
   827 E C1705104:Weight [Idea or Concept]

Phrase: "summing to one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   756   C1515051:Sum [Quantitative Concept]

Phrase: "are"

Phrase: "assigned to each phased genotype,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017431:Genotype [Organism Attribute]
   760   C0205390:Phased [Temporal Concept]
   760   C1516050:Assigned [Functional Concept]
   760   C1552601:assigned [Intellectual Product]

Phrase: "where"

Phrase: "the weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "equals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205163:Equal [Qualitative Concept]
  1000   C0439089:Equals [Intellectual Product]
  1000   C1549782:Equal [Idea or Concept]

Phrase: "the probability of the phased genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Probability [Quantitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the unphased genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "based on estimated phased genotype probabilities."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0017431:Genotype [Organism Attribute]
   753   C0033204:Probabilities [Quantitative Concept]
   753   C0205390:Phased [Temporal Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.228: Because of a concern that a few larger families could be driving the association findings, we re-ran the individual polymorphism association analyses in FBAT, the conditional logistic regression analyses and the haplotype analyses in HBAT including only one nuclear family per pedigree. 

Phrase: "Because of a concern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "that"

Phrase: "a few larger families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0424972:Large family [Family Group]
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "the association findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "re-"

Phrase: "ran"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0035953:run [Daily or Recreational Activity]
   966   C0600140:run [Finding]
   966   C1704688:Run [Functional Concept]
   966   C2346414:Run [Finding]

Phrase: "the individual polymorphism association analyses in FBAT,"
Meta Candidates (Total=25; Excluded=3; Pruned=0; Remaining=22)
   738   C0004083:Association [Mental Process]
   738   C0013194:Package [Medical Device]
   738   C0015576:Family [Family Group]
   738   C0022885:Test [Laboratory Procedure]
   738   C0027361:Individual [Population Group]
   738   C0032529:Polymorphism [Genetic Function]
   738   C0039593:Test [Functional Concept]
   738   C0237401:Individual [Human]
   738   C0392366:test [Intellectual Product]
   738   C0439849:Association [Qualitative Concept]
   738   C0596306:Association [Phenomenon or Process]
   738   C0699792:association [Social Behavior]
   738   C1527178:Based [Functional Concept]
   738   C1704727:Family [Conceptual Entity]
   738   C1705938:Based [Idea or Concept]
   738   C1882417:Polymorphism [Qualitative Concept]
   738   C2700580:Package [Manufactured Object]
   737   C0796451:polymorphism analysis [Diagnostic Procedure]
   718   C0544093:Association, familial [Finding]
   704 E C0002055:base [Inorganic Chemical]
   704   C0002778:Analysis [Laboratory Procedure]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704   C0936012:Analysis [Research Activity]
   704   C1524024:analysis [Functional Concept]
   704 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the conditional logistic regression analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analyses [Intellectual Product]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the haplotype analyses in HBAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "only one nuclear family per pedigree."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028574:Nuclear Family [Family Group]
   753   C0015576:Family [Family Group]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.229: This resulted in a reduction of the sample to 2156 individuals (84.3% of the total sample). 

Phrase: "This"

Phrase: "resulted in a reduction of the sample"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0370003:Sample [Substance]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C2347026:Sample [Conceptual Entity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "to 2156 individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: "(84.3% of the total sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0370003:Sample [Substance]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C2347026:Sample [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.230: We tested eight polymorphisms, and analyzed the sample as a whole, two strata based on age of onset and two strata based on APOE-4 status, as described above. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "eight polymorphisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the sample as a whole, two strata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "based on age of onset"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "two strata"

Phrase: "based on APOE-4 status,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   760   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0449438:Status [Qualitative Concept]
   760   C0523511:APOE [Laboratory Procedure]
   760   C1412481:APOE [Gene or Genome]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.231: To account for multiple testing, we used the Bonferroni method, and corrected for 24 tests (i.e. eight polymorphisms tested in the full sample and in strata based on onset age and APOE-4 status). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for multiple testing,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Bonferroni method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "corrected for 24 tests"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0022885:Tests [Laboratory Procedure]
   770   C0205202:Corrected [Qualitative Concept]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "(i.e. eight polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "tested in the full sample"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0370003:Sample [Substance]
   760   C0392366:tested [Intellectual Product]
   760   C0443225:Full [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "and in strata"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "based on onset age"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0206132:Onset Age [Quantitative Concept]
   770   C0001779:Age [Organism Attribute]
   770   C0332162:Onset [Qualitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "APOE-4 status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449438:Status [Qualitative Concept]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: ")."
Processing 00000000.tx.232: We only counted each stratification once because each pair together comprises the total sample. 

Phrase: "We only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "each stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514983:Stratification [Research Activity]

Phrase: "once"

Phrase: "because"

Phrase: "each"

Phrase: "pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the total sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.233: Similarly, we did not consider haplotypes in calculating the number of tests because the haplotypes are composed of the individual polymorphisms. 

Phrase: "Similarly,"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "haplotypes in calculating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018591:Haplotypes [Organism Attribute]

Phrase: "the number of tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "because"

Phrase: "the haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "composed of the individual polymorphisms."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0027361:Individual [Population Group]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0237401:Individual [Human]
   726 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.234: Because of the extensive correlations among these polymorphisms due to LD, this is a particularly conservative choice, but in effect it sets a lower bound on the statistical significance for these findings.  

Phrase: "Because of the extensive correlations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "among these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "due to LD,"

Phrase: "this"

Phrase: "is"

Phrase: "a particularly conservative choice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008300:choice [Individual Behavior]
   827   C1707391:Choice [Activity]

Phrase: "but in effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0233535:but [Mental or Behavioral Dysfunction]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "a lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "bound on the statistical significance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0332297:bound [Spatial Concept]
   760   C0750502:Significance [Idea or Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "for these findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]
Processing 00000000.tx.235: ACKNOWLEDGEMENTS  This work was sponsored by grants from the NIMH, NIA (ADRC) and the Alzheimer's Association. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "sponsored by grants"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0018173:Grants [Quantitative Concept]
   756 E C1548284:Grant [Idea or Concept]
   756   C1711305:Sponsor [Human]
   756   C2347796:SPONSOR [Organization]

Phrase: "from the NIMH,"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
  1000   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   911   C0027468:national institute health [Health Care Related Organization]
   840   C0025353:mental health [Mental Process]
   840   C1555896:Mental Health [Intellectual Product]
   804   C0018684:Health [Idea or Concept]
   804   C0021622:institute [Organization]
   804   C0229992:mental [Mental Process]
   804   C1272753:Institute [Idea or Concept]
   804   C3245503:national [Intellectual Product]
   721 E C0229993:Psychic [Functional Concept]
   704 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C0031206:healthiness [Finding]
   704 E C0042241:DIAPHRAGM [Medical Device]
   704 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   704 E C1705367:Diaphragm [Medical Device]

Phrase: "NIA (ADRC"

Phrase: ")"

Phrase: "and"

Phrase: "the Alzheimer's Association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.236: A.J.S. was supported by a National Research Service Award from NIA and the Harvard Center for Neurodegeneration and Repair (HCNR). 

Phrase: "A.J.S."

Phrase: "was"

Phrase: "supported by a National Research Service Award"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C0035176:research supported [Quantitative Concept]
   748   C0004446:Award [Manufactured Object]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0557854:Service [Occupational Activity]
   748   C1521721:Supported [Conceptual Entity]
   748   C2825316:Service [Manufactured Object]
   748   C3245478:service [Idea or Concept]
   748   C3245503:national [Intellectual Product]
   714 E C0183683:Support [Medical Device]

Phrase: "from NIA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1074110:Nia [Fungus]
  1000   C1955974:NIA [Health Care Related Organization]

Phrase: "and"

Phrase: "the Harvard Center for Neurodegeneration and Repair (HCNR)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   748   C0043240:Repair, NOS [Organism Function]
   748   C0205099:Center [Spatial Concept]
   748   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.237: L.B. was supported by Deutsche Forschungsgemeinschaft (DFG) and is now a recipient of a translational research fellowship from the Harvard Center for Neurodegeneration and Repair (HCNR). 

Phrase: "L.B."

Phrase: "was"

Phrase: "supported by Deutsche Forschungsgemeinschaft (DFG)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "a recipient of a translational research fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709854:Recipient [Human]

Phrase: "from the Harvard Center for Neurodegeneration and Repair"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   793   C0043240:Repair, NOS [Organism Function]
   793   C0205099:Center [Spatial Concept]
   793   C0374711:Repair [Therapeutic or Preventive Procedure]
   793   C1517320:From [Qualitative Concept]

Phrase: "(HCNR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   753   C0043240:Repair, NOS [Organism Function]
   753   C0205099:Center [Spatial Concept]
   753   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.238: Data and biomaterials were collected in three projects that participated in the National Institute of Mental Health (NIMH) Alzheimer Disease Genetics Initiative. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "biomaterials"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0005479:Biomaterials [Biomedical or Dental Material]
   966 E C1704781:Biomaterial [Functional Concept]

Phrase: "were"

Phrase: "collected in three"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205449:Three [Quantitative Concept]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "projects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709701:Project [Conceptual Entity]

Phrase: "that"

Phrase: "participated in the National Institute of Mental Health (NIMH) Alzheimer Disease Genetics Initiative."
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
   810   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   767   C0027468:health national institute [Health Care Related Organization]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C0025353:mental health [Mental Process]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C1555896:Mental Health [Intellectual Product]
   751   C0004936:Mental disease [Mental or Behavioral Dysfunction]
   751   C0019247:genetics disease [Disease or Syndrome]
   751   C0679215:disease health [Natural Phenomenon or Process]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0017398:Genetics [Biomedical Occupation or Discipline]
   736   C0017399:genetics [Biologic Function]
   736   C0018684:Health [Idea or Concept]
   736   C0021622:institute [Organization]
   736   C0229992:mental [Mental Process]
   736   C0424093:Initiative [Mental Process]
   736   C1272753:Institute [Idea or Concept]
   736   C3245503:national [Intellectual Product]
   735   C0152097:DISEASES OF THE DIAPHRAGM [Disease or Syndrome]
           Disease of diaphragm
       E   diaphragm disease
   709 E C0277577:Psychic disease [Mental or Behavioral Dysfunction]
Processing 00000000.tx.239: From 1991 to 1998, the Principal Investigators and Co-Investigators were: Massachusetts General Hospital, Boston, MA, Marilyn S. 

Phrase: "From 1991"

Phrase: "to 1998,"

Phrase: "the Principal Investigators"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521895:Principal Investigator [Professional or Occupational Group]
   861   C0035173:Investigators [Professional or Occupational Group]
   861   C0205225:Principal [Qualitative Concept]
   861   C0401925:Principal [Professional or Occupational Group]

Phrase: "and"

Phrase: "Co-Investigators"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1707421:Co-Investigator [Professional or Occupational Group]
   861   C0035173:Investigators [Professional or Occupational Group]

Phrase: "were"

Phrase: ":"

Phrase: "Massachusetts General Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "Marilyn S."
Processing 00000000.tx.240: Albert and Deborah Blacker; 

Phrase: "Albert"

Phrase: "and"

Phrase: "Deborah"

Phrase: "Blacker"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.241: Johns Hopkins University, Baltimore, MD, Susan S. 

Phrase: "Johns Hopkins University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD,"

Phrase: "Susan S."
Processing 00000000.tx.242: Bassett, Gary A. 

Phrase: "Bassett,"

Phrase: "Gary A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.243: Chase and Marshal F. 

Phrase: "Chase"

Phrase: "and"

Phrase: "Marshal F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.244: Folstein; 

Phrase: "Folstein"

Phrase: ";"
Processing 00000000.tx.245: University of Alabama, Birmingham, AL, Rodney C.P. 

Phrase: "University of Alabama,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001895:Alabama [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1551894:Alabama [Language]
   827   C2825084:Alabama [Eukaryote]

Phrase: "Birmingham,"

Phrase: "AL,"

Phrase: "Rodney"

Phrase: "C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.246: Go and Lindy E. 

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "and"

Phrase: "Lindy E."
Processing 00000000.tx.247: Harrell.  

Phrase: "Harrell."
Processing 00000000.tx.248: FOOTNOTES  * To whom correspondence should be addressed at: Genetics and Aging Research Unit, C3809, 114 16th St, Charlestown, MA 02129, USA. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "Aging Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "C3809,"

Phrase: "114 16th St,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3272372:ST [Intellectual Product]

Phrase: "Charlestown,"

Phrase: "MA 02129,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.249: Tel: +1 617 726 6845; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 617 726 6845"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.250: Fax: +1 617 724 1823; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 617 724 1823"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.251: Email: tanzi{at}helix.mgh.harvard.edu The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "tanzi{at}helix.mgh.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint First Authors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0022417:Joint [Body Space or Junction]
   760   C0205435:First [Quantitative Concept]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1279901:First [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.252: Present address: Department of Bioscience and Biotechnology, Drexel University, 3141 Chestnut St, Philadelphia, PA 19104, USA.  

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Bioscience"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Drexel University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "3141 Chestnut St,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3272372:ST [Intellectual Product]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA 19104,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.253: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Daw, E.W., Payami, H., Nemens, E.J., Nochlin, D., Bird, T.D., Schellenberg, G.D. and Wijsman, E.M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Daw,"

Phrase: "E.W., Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nemens,"

Phrase: "E.J.,"

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]

Phrase: "and"

Phrase: "Wijsman,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: (2000) The number of trait loci in late-onset Alzheimer disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The number of trait loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.255: Am. 

Phrase: "Am."
Processing 00000000.tx.256: J. 

Phrase: "J."
Processing 00000000.tx.257: Hum. 

Phrase: "Hum."
Processing 00000000.tx.258: Genet., 66, 196204.[CrossRef][ISI][Medline] Mayeux, R., Lee, J.H., Romas, S.N., Mayo, D., Santana, V., Williamson, J., Ciappa, A., Rondon, H.Z., Estevez, P., Lantigua, R. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "66,"

Phrase: "196204."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Romas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0445583:Roma [Intellectual Product]
  1000   C1514862:ROMA [Molecular Biology Research Technique]

Phrase: "S."

Phrase: "N., Mayo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454788:Mayo [Geographic Area]
   861   C1077578:mayo [Plant]

Phrase: "D."

Phrase: ","

Phrase: "Santana,"

Phrase: "V.,"

Phrase: "Williamson,"

Phrase: "J.,"

Phrase: "Ciappa,"

Phrase: "A.,"

Phrase: "Rondon,"

Phrase: "H.Z.,"

Phrase: "Estevez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lantigua,"

Phrase: "R. et al."
Processing 00000000.tx.259: (2002) Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Chromosome-12 mapping of late-onset Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   744   C1283195:Mapping [Activity]

Phrase: "among Caribbean Hispanics."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0086409:Hispanics [Population Group]
   827 E C0019576:Hispanic [Population Group]
Processing 00000000.tx.260: Am. 

Phrase: "Am."
Processing 00000000.tx.261: J. 

Phrase: "J."
Processing 00000000.tx.262: Hum. 

Phrase: "Hum."
Processing 00000000.tx.263: Genet., 70, 237243.[CrossRef][ISI][Medline] Myers, A., Wavrant De-Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "70,"

Phrase: "237243."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Myers,"

Phrase: "A.,"

Phrase: "Wavrant De-Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hamshere,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Compton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1467391:compton [Eukaryote]

Phrase: "D."

Phrase: ","

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Meyer,"

Phrase: "D."

Phrase: ","

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Booth,"

Phrase: "J. et al."
Processing 00000000.tx.264: (2002) Full genome screen for Alzheimer disease: Stage II analysis. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Full genome screen for Alzheimer disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: ":"

Phrase: "Stage II analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0441767:Stage II [Intellectual Product]
Processing 00000000.tx.265: Am. 

Phrase: "Am."
Processing 00000000.tx.266: J. 

Phrase: "J."
Processing 00000000.tx.267: Hum. 

Phrase: "Hum."
Processing 00000000.tx.268: Genet., 114, 235244. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "114,"

Phrase: "235244."
Processing 00000000.tx.269: Pericak-Vance, M.A., Bass, M.P., Yamaoka, L.H., Gaskell, P.C., Scott, W.K., Terwedow, H.A., Menold, M.M., Conneally, P.M., Small, G.W., Vance, J.M. et al. 

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Bass,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004830:Bass [Fish]

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Terwedow,"

Phrase: "H.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Menold,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Vance,"

Phrase: "J.M. et al."
Processing 00000000.tx.270: (1997) Complete genomic screen in late-onset familial Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "genomic screen in late-onset familial Alzheimer disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0220908:screen [Health Care Activity]
   744   C1305399:screen [Functional Concept]
   744   C1705053:Screen [Medical Device]
   703   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
Processing 00000000.tx.271: Evidence for a new locus on chromosome 12. 

Phrase: "Evidence for a new locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.272: JAMA, 278, 12371241.[Abstract] Poduslo, S.E. and Yin, X. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "278,"

Phrase: "12371241."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Poduslo,"

Phrase: "S."

Phrase: "E."

Phrase: "and"

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "X."
Processing 00000000.tx.273: (2001) Chromosome 12 and late-onset Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Chromosome 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "and"

Phrase: "late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.274: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.275: Lett., 310, 188190.[CrossRef][ISI][Medline] Rogaeva, E., Premkumar, S., Song, Y., Sorbi, S., Brindle, N., Paterson, A., Duara, R., Levesque, G., Yu, G., Nishimura, M. et al. 

Phrase: "Lett.,"

Phrase: "310,"

Phrase: "188190."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaeva,"

Phrase: "E.,"

Phrase: "Premkumar,"

Phrase: "S."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "Y.,"

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Brindle,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Paterson,"

Phrase: "A.,"

Phrase: "Duara,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nishimura,"

Phrase: "M. et al."
Processing 00000000.tx.276: (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Evidence for an Alzheimer disease susceptibility locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "and for further locus heterogeneity."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C2986542:Locus Heterogeneity [Qualitative Concept]
   760   C0019409:Heterogeneity [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1517331:Further [Spatial Concept]
   760   C1708726:Locus [Gene or Genome]
   726 E C0205108:far [Spatial Concept]
Processing 00000000.tx.277: JAMA, 280, 614618.[Abstract/Free FullText] Scott, W.K., Grubber, J.M., Abou-Donia, S.M., Church, T.D., Saunders, A.M., Roses, A.D., Pericak-Vance, M.A., Conneally, P.M., Small, G.W. and Haines, J.L. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "280,"

Phrase: "614618."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grubber,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Abou-Donia,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Church,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562324:Church [Manufactured Object]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W."

Phrase: "and"

Phrase: "Haines,"

Phrase: "J.L."
Processing 00000000.tx.278: (1999) Further evidence linking late-onset Alzheimer disease with chromosome 12. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "late-onset Alzheimer disease with chromosome 12."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   870   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   804   C1970209:Alzheimer Disease 12 [Disease or Syndrome]
   800   C0814122:late disease onset [Finding]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   738   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
Processing 00000000.tx.279: JAMA, 281, 513514.[Free FullText] Scott, W.K., Grubber, J.M., Conneally, P.M., Small, G.W., Hulette, C.M., Rosenberg, C.K., Saunders, A.M., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "281,"

Phrase: "513514."

Phrase: "[Free FullText"

Phrase: "] Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grubber,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Hulette,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Rosenberg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979969:Rosenberg [Spatial Concept]

Phrase: "C.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: "A."
Processing 00000000.tx.280: (2000) Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Fine mapping of the chromosome 12 late-onset Alzheimer disease locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   738   C1283195:Mapping [Activity]

Phrase: ":"

Phrase: "potential genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "phenotypic heterogeneity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1852220:Phenotypic heterogeneity [Finding]
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]
Processing 00000000.tx.281: Am. 

Phrase: "Am."
Processing 00000000.tx.282: J. 

Phrase: "J."
Processing 00000000.tx.283: Hum. 

Phrase: "Hum."
Processing 00000000.tx.284: Genet., 66, 922932.[CrossRef][ISI][Medline] Wu, W.S., Holmans, P., Wavrant-DeVrieze, F., Shears, S., Kehoe, P., Crook, R., Booth, J., Williams, N., Perez-Tur, J., Roehl, K. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "66,"

Phrase: "922932."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W.S.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wavrant-DeVrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shears,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175735:shears [Medical Device]
   966 E C0205013:shear [Therapeutic or Preventive Procedure]

Phrase: "S."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Booth,"

Phrase: "J.,"

Phrase: "Williams,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Roehl,"

Phrase: "K. et al."
Processing 00000000.tx.285: (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic studies on chromosome 12"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1273411:Chromosome studies [Laboratory Procedure]
   790   C2827447:Genetic Study [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.286: JAMA, 280, 619622.[Abstract/Free FullText] Blacker, D., Wilcox, M.A., Laird, N.M., Rodes, L., Horvath, S.M., Go, R.C., Perry, R., Watson, B., Jr., Bassett, S.S., McInnis, M.G. et al. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "280,"

Phrase: "619622."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N.M.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C., Perry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Bassett,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "McInnis,"

Phrase: "M."

Phrase: "G. et al."
Processing 00000000.tx.287: (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "genetically"

Phrase: "associated with Alzheimer disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.288: Nat. 

Phrase: "Nat."
Processing 00000000.tx.289: Genet., 19, 357360.[CrossRef][ISI][Medline] Borth, W. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "19,"

Phrase: "357360."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Borth,"

Phrase: "W."
Processing 00000000.tx.290: (1992) Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Alpha 2-macroglobulin,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "a multifunctional binding protein with targeting characteristics."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0033618:Protein Binding [Molecular Function]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C1159372:Protein Targeting [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.291: FASEB J., 6, 33453353.[Abstract/Free FullText] Barrett, A.J. and Starkey, P.M. 

Phrase: "FASEB J.,"

Phrase: "6,"

Phrase: "33453353."

Phrase: "[Abstract/Free FullText"

Phrase: "] Barrett,"

Phrase: "A.J."

Phrase: "and"

Phrase: "Starkey,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.292: (1973) The interaction of alpha 2-macroglobulin with proteinases. 

Phrase: "(1973"

Phrase: ")"

Phrase: "The interaction of alpha 2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with proteinases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   966 E C1622131:proteinase [Molecular Function]
   966 E C1947941:Proteinase [Enzyme]
Processing 00000000.tx.293: Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. 

Phrase: "Characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "specificity of the reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "a hypothesis concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699424:Concern [Idea or Concept]

Phrase: "its molecular mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.294: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.295: J., 133, 709724.[ISI][Medline] Harpel, P.C. 

Phrase: "J.,"

Phrase: "133,"

Phrase: "709724."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harpel,"

Phrase: "P.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: (1973) Studies on human plasma alpha 2-macroglobulin-enzyme interactions. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Studies on human plasma alpha 2-macroglobulin-enzyme interactions."
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   790   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   764   C0544357:Human plasma [Pharmacologic Substance]
   764   C1373066:Enzyme Interactions [Molecular Function]
   764   C1979845:Alpha 2 [Qualitative Concept]
   762   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0178693:human studies [Research Activity]
   748 E C3537101:Enzyme Interaction [Molecular Function]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0032105:Plasma [Body Substance]
   742   C0086418:Human [Human]
   742   C0439095:Alpha [Intellectual Product]
   742   C0557651:Study [Manufactured Object]
   742   C0947630:studies [Laboratory Procedure]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C2003941:Alpha [Intellectual Product]
   742   C2350010:Alpha [Qualitative Concept]
   742   C2603343:Study [Research Activity]
   708   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.297: Evidence for proteolytic modification of the subunit chain structure. 

Phrase: "Evidence for proteolytic modification of the subunit chain structure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.298: J. 

Phrase: "J."
Processing 00000000.tx.299: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.300: Med., 138, 508521.[Medline] Sottrup-Jensen, L., Sand, O., Kristensen, L. and Fey, G.H. 

Phrase: "Med.,"

Phrase: "138,"

Phrase: "508521."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037098:Sand [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kristensen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Fey, G.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0560020:g h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.301: (1989) The alpha-macroglobulin bait region. 

Phrase: "(1989"

Phrase: ")"

Phrase: "The alpha-macroglobulin bait region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.302: Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha- macroglobulins. 

Phrase: "Sequence diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "localization of cleavage sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "for proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   966 E C1622131:proteinase [Molecular Function]
   966 E C1947941:Proteinase [Enzyme]

Phrase: "in five mammalian alpha- macroglobulins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002215:alpha-Macroglobulins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0024420:Macroglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.303: J. 

Phrase: "J."
Processing 00000000.tx.304: Biol. 

Phrase: "Biol."
Processing 00000000.tx.305: Chem., 264, 1578115789.[Abstract/Free FullText] Lauer, D., Reichenbach, A. and Birkenmeier, G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "264,"

Phrase: "1578115789."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lauer,"

Phrase: "D."

Phrase: ","

Phrase: "Reichenbach,"

Phrase: "A."

Phrase: "and"

Phrase: "Birkenmeier,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.306: (2001) Alpha 2-macroglobulin-mediated degradation of amyloid beta 142: a mechanism to enhance amyloid beta catabolism. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Alpha 2-macroglobulin-mediated degradation of amyloid beta 142"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "a mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "amyloid beta catabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0543484:catabolism [Functional Concept]
   827   C0699900:Catabolism [Organism Function]
   827   C1516314:Catabolism [Physiologic Function]
   734   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.307: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.308: Neurol., 167, 385392.[CrossRef][ISI][Medline] Qiu, W.Q., Borth, W., Ye, Z., Haass, C., Teplow, D.B. and Selkoe, D.J. 

Phrase: "Neurol.,"

Phrase: "167,"

Phrase: "385392."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Qiu,"

Phrase: "W.Q., Borth,"

Phrase: "W.,"

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "Z.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.309: (1996) Degradation of amyloid beta-protein by a serine protease-alpha2macroglobulin complex. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Degradation of amyloid beta-protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by a serine protease-alpha2macroglobulin complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.310: J. 

Phrase: "J."
Processing 00000000.tx.311: Biol. 

Phrase: "Biol."
Processing 00000000.tx.312: Chem., 271, 84438451.[Abstract/Free FullText] Strickland, D.K., Ashcom, J.D., Williams, S., Burgess, W.H., Migliorini, M. and Argraves, W.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "84438451."

Phrase: "[Abstract/Free FullText"

Phrase: "] Strickland,"

Phrase: "D."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ashcom,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Williams,"

Phrase: "S."

Phrase: ","

Phrase: "Burgess,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Migliorini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Argraves,"

Phrase: "W.S."
Processing 00000000.tx.313: (1990) Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "identity between the alpha 2-macroglobulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0424215:Identity [Mental Process]
   748   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "a multifunctional receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.314: J. 

Phrase: "J."
Processing 00000000.tx.315: Biol. 

Phrase: "Biol."
Processing 00000000.tx.316: Chem., 265, 1740117404.[Abstract/Free FullText] Du, Y., Bales, K.R., Dodel, R.C., Liu, X., Glinn, M.A., Horn, J.W., Little, S.P. and Paul, S.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "265,"

Phrase: "1740117404."

Phrase: "[Abstract/Free FullText"

Phrase: "] Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dodel,"

Phrase: "R.C., Liu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "X.,"

Phrase: "Glinn,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Horn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "J.W., Little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   827   C0700321:Little [Quantitative Concept]
   827   C2700395:Little [Quantitative Concept]

Phrase: "S.P."

Phrase: "and"

Phrase: "Paul,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.317: (1998) Alpha2-macroglobulin attenuates beta-amyloid peptide 140 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha2-macroglobulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1879648:Alpha2 [Qualitative Concept]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "beta-amyloid peptide 140 fibril formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   904   C2247791:beta-amyloid formation [Molecular Function]
   885   C3544412:amyloid fibril formation [Molecular Function]
   858   C1327133:peptide formation [Molecular Function]
   799   C0220781:formation [Biologic Function]
   799   C0439634:formation [Spatial Concept]
   799   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "associated neurotoxicity of cultured fetal rat cortical neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Neurochem., 70, 11821188.[ISI][Medline] Hughes, S.R., Khorkova, O., Goyal, S., Knaeblein, J., Heroux, J., Riedel, N.G. and Sahasrabudhe, S. 

Phrase: "Neurochem.,"

Phrase: "70,"

Phrase: "11821188."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Khorkova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Goyal,"

Phrase: "S."

Phrase: ","

Phrase: "Knaeblein,"

Phrase: "J.,"

Phrase: "Heroux,"

Phrase: "J.,"

Phrase: "Riedel,"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sahasrabudhe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: (1998) Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Alpha2-macroglobulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1879648:Alpha2 [Qualitative Concept]

Phrase: "associates with beta-amyloid peptide"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   835   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
   835   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   806   C2825879:Amyloid, Beta [Laboratory Procedure]
   797 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "fibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.321: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.322: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.323: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.324: USA, 95, 32753280.[Abstract/Free FullText] Narita, M., Holtzman, D.M., Schwartz, A.L. and Bu, G. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "32753280."

Phrase: "[Abstract/Free FullText"

Phrase: "] Narita,"

Phrase: "M."

Phrase: ","

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Schwartz,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.325: (1997) Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor- related protein. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha2-macroglobulin complexes with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the endocytosis of beta-amyloid peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014139:Endocytosis [Cell Function]
   753   C2984285:Endocytosis [Functional Concept]

Phrase: "via cell surface low-density lipoprotein receptor- related protein."
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   878   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   864   C0242972:low protein [Therapeutic or Preventive Procedure]
   864   C0748025:low protein [Finding]
   861   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   861   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   836   C0162339:Cell Density [Quantitative Concept]
   835   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   822   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   812   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   793   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0178587:density [Quantitative Concept]
   793   C0205251:low [Qualitative Concept]
   793   C0439849:Related [Qualitative Concept]
   793   C0445223:Related [Finding]
   793   C1299352:Low [Qualitative Concept]
   793   C1550472:low [Idea or Concept]
   760 E C0163712:Relate [Organic Chemical]
   721 E C0080103:Relation [Family Group]
   721 E C0439794:Dense [Qualitative Concept]
   721 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.326: J. 

Phrase: "J."
Processing 00000000.tx.327: Neurochem., 69, 19041911.[ISI][Medline] Carter, D.B., Dunn, E., McKinley, D.D., Stratman, N.C., Boyle, T.P., Kuiper, S.L., Oostveen, J.A., Weaver, R.J., Boller, J.A. and Gurney, M.E. 

Phrase: "Neurochem.,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "19041911."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carter,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dunn,"

Phrase: "E.,"

Phrase: "McKinley,"

Phrase: "D.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stratman,"

Phrase: "N.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2349138:N/C [Quantitative Concept]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Boyle,"

Phrase: "T.P.,"

Phrase: "Kuiper,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Oostveen,"

Phrase: "J.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boller,"

Phrase: "J.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Gurney,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150789:gurney [Medical Device]
  1000   C0183644:Gurney [Medical Device]

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.328: (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Human apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "beta-amyloid deposition in APPsw transgenic mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011560:Amyloid deposition [Pathologic Function]
   770   C1705760:Amyloid Deposition [Finding]
   744   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.329: Ann. 

Phrase: "Ann."
Processing 00000000.tx.330: Neurol., 50, 468475.[CrossRef][ISI][Medline] Krimbou, L., Tremblay, M., Davignon, J. and Cohn, J.S. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "468475."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krimbou,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tremblay,"

Phrase: "M."

Phrase: ","

Phrase: "Davignon,"

Phrase: "J."

Phrase: "and"

Phrase: "Cohn,"

Phrase: "J.S."
Processing 00000000.tx.331: (1998) Association of apolipoprotein E with alpha2-macroglobulin in human plasma. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Association of apolipoprotein E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with alpha2-macroglobulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1879648:Alpha2 [Qualitative Concept]

Phrase: "in human plasma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0544357:Human plasma [Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0086418:Human [Human]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
Processing 00000000.tx.332: J. 

Phrase: "J."
Processing 00000000.tx.333: Lipid Res., 39, 23732386.[Abstract/Free FullText] Blacker, D., Bertram, L., Saunders, A.J., Moscarillo, T.J., Albert, M., Wiener, H., Perry, R., Collins, J.S., Harrell, L.E., Go, R.C.P. et al. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "39,"

Phrase: "23732386."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Bertram,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.J.,"

Phrase: "Moscarillo,"

Phrase: "T.J.,"

Phrase: "Albert,"

Phrase: "M."

Phrase: ","

Phrase: "Wiener,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "J.S.,"

Phrase: "Harrell,"

Phrase: "L.E.,"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C.P. et al."
Processing 00000000.tx.334: (2003) Results of a high resolution genome screen of 437 Alzheimer's disease families. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Results of a high resolution genome screen of 437 Alzheimer's disease families."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]
Processing 00000000.tx.335: Hum. 

Phrase: "Hum."
Processing 00000000.tx.336: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.337: Genet., 12, 2332.[Abstract/Free FullText] Blacker, D., Crystal, A.S., Wilcox, M.A., Laird, N.M. and Tanzi, R.E. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "2332."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Crystal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0427896:Crystal [Body Substance]
  1000   C0444626:Crystal [Chemical Viewed Structurally]
  1000   C1533132:Crystal [Body Substance]
  1000   C1704641:Crystal [Manufactured Object]

Phrase: "A."

Phrase: "S."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R.E."
Processing 00000000.tx.338: (1999) In reply. 

Phrase: "(1999"

Phrase: ")"

Phrase: "In reply."
Processing 00000000.tx.339: Nat. 

Phrase: "Nat."
Processing 00000000.tx.340: Genet., 22, 2122.[CrossRef][ISI] Poduslo, S.E., Shook, B., Drigalenko, E. and Yin, X. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "2122."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Poduslo,"

Phrase: "S."

Phrase: "E.,"

Phrase: "Shook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0040822:shake [Sign or Symptom]
   966   C1883023:Shake [Activity]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Drigalenko,"

Phrase: "E."

Phrase: "and"

Phrase: "Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945618:yin [Idea or Concept]

Phrase: "X."
Processing 00000000.tx.341: (2002) Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Lack of association of the two polymorphisms"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0004083:Association [Mental Process]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0205448:Two [Quantitative Concept]
   748   C0332268:lack [Qualitative Concept]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in alpha-2 macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "with Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.342: Am. 

Phrase: "Am."
Processing 00000000.tx.343: J. 

Phrase: "J."
Processing 00000000.tx.344: Med. 

Phrase: "Med."
Processing 00000000.tx.345: Genet., 110, 3035. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "110,"

Phrase: "3035."
Processing 00000000.tx.346: Rudrasingham, V., Wavrant-De Vrieze, F., Lambert, J.C., Chakraverty, S., Kehoe, P., Crook, R., Amouyel, P., Wu, W., Rice, F., Perez-Tur, J. et al. 

Phrase: "Rudrasingham,"

Phrase: "V.,"

Phrase: "Wavrant-De Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W.,"

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Perez-Tur,"

Phrase: "J. et al."
Processing 00000000.tx.347: (1999) Alpha-2 macroglobulin gene and Alzheimer disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1537647:ALPHA GENE [Gene or Genome]
   902   C2985256:Alpha Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.348: Nat. 

Phrase: "Nat."
Processing 00000000.tx.349: Genet., 22, 1719.[CrossRef][ISI][Medline] Romas, S.N., Mayeux, R., Rabinowitz, D., Tang, M.X., Zadroga, H.R., Lantigua, R., Medrano, M., Tycko, B. and Knowles, J.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "1719."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Romas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0445583:Roma [Intellectual Product]
  1000   C1514862:ROMA [Molecular Biology Research Technique]

Phrase: "S."

Phrase: "N., Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rabinowitz,"

Phrase: "D."

Phrase: ","

Phrase: "Tang,"

Phrase: "M."

Phrase: "X.,"

Phrase: "Zadroga,"

Phrase: "H.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lantigua,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Medrano,"

Phrase: "M."

Phrase: ","

Phrase: "Tycko,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Knowles,"

Phrase: "J.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.350: (2000) The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The deletion polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Val1000Ile in alpha-2-macroglobulin"

Phrase: "and"

Phrase: "Alzheimer disease in Caribbean Hispanics."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.351: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.352: Lett., 279, 133136.[CrossRef][ISI][Medline] Rogaeva, E.A., Premkumar, S., Grubber, J., Serneels, L., Scott, W.K., Kawarai, T., Song, Y., Hill, D.L., Abou-Donia, S.M., Martin, E.R. et al. 

Phrase: "Lett.,"

Phrase: "279,"

Phrase: "133136."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogaeva,"

Phrase: "E.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Premkumar,"

Phrase: "S."

Phrase: ","

Phrase: "Grubber,"

Phrase: "J.,"

Phrase: "Serneels,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kawarai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "Y.,"

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "D."

Phrase: "L., Abou-Donia,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "E.R. et al."
Processing 00000000.tx.353: (1999) An alpha-2-macroglobulin insertiondeletion polymorphism in Alzheimer disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "An alpha-2-macroglobulin insertiondeletion polymorphism in Alzheimer disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032529:Polymorphism [Genetic Function]
   742   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.354: Nat. 

Phrase: "Nat."
Processing 00000000.tx.355: Genet., 22, 1922.[CrossRef][ISI][Medline] Zappia, M., Cittadella, R., Manna, I., Nicoletti, G., Andreoli, V., Bonavita, S., Gambardella, A. and Quattrone, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "1922."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zappia,"

Phrase: "M."

Phrase: ","

Phrase: "Cittadella,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Manna,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043572:manna [Carbohydrate,Pharmacologic Substance]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nicoletti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Andreoli,"

Phrase: "V.,"

Phrase: "Bonavita,"

Phrase: "S."

Phrase: ","

Phrase: "Gambardella,"

Phrase: "A."

Phrase: "and"

Phrase: "Quattrone,"

Phrase: "A."
Processing 00000000.tx.356: (2002) Genetic association of alpha-2-macroglobulin polymorphisms with AD in southern Italy. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genetic association of alpha-2-macroglobulin polymorphisms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1328885:genetic association [Occupation or Discipline]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "in southern Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022277:Italy [Geographic Area]
Processing 00000000.tx.357: Neurology, 59, 756758. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "59,"

Phrase: "756758."
Processing 00000000.tx.358: Nacmias, B., Tedde, A., Cellini, E., Forleo, P., Orlacchio, A., Guarnieri, B.M., Petruzzi, C., D'Andrea, F., Serio, A. and Sorbi, S. 

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tedde,"

Phrase: "A.,"

Phrase: "Cellini,"

Phrase: "E.,"

Phrase: "Forleo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Orlacchio,"

Phrase: "A.,"

Phrase: "Guarnieri,"

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Petruzzi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "D'"

Phrase: "Andrea,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Serio,"

Phrase: "A."

Phrase: "and"

Phrase: "Sorbi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.359: (2001) Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Alpha2-macroglobulin polymorphisms in Italian sporadic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.360: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.361: Lett., 299, 912.[CrossRef][ISI][Medline] Jhoo, J.H., Kim, K.W., Lee, D.Y., Lee, K.U., Lee, J.H., Kim, S.Y., Youn, J.Y., Youn, J.C. and Woo, J.I. 

Phrase: "Lett.,"

Phrase: "299,"

Phrase: "912."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jhoo,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "K.W., Lee,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Lee,"

Phrase: "K.U.,"

Phrase: "Lee,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."

Phrase: "Y.,"

Phrase: "Youn,"

Phrase: "J.Y.,"

Phrase: "Youn,"

Phrase: "J.C."

Phrase: "and"

Phrase: "Woo,"

Phrase: "J.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.362: (2001) Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Association of alpha-2-macroglobulin deletion polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with sporadic Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "in Koreans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556095:Koreans [Population Group]
Processing 00000000.tx.363: J. 

Phrase: "J."
Processing 00000000.tx.364: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.365: Sci., 184, 2125.[CrossRef][ISI][Medline] Dodel, R.C., Du, Y., Bales, K.R., Gao, F., Eastwood, B., Glazier, B., Zimmer, R., Cordell, B., Hake, A., Evans, R. et al. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "184,"

Phrase: "2125."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dodel,"

Phrase: "R.C., Du,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3540681:DU [Idea or Concept]
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "Y.,"

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gao,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Eastwood,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Glazier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336386:Glazier [Professional or Occupational Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zimmer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cordell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452985:Hake [Food]
  1000   C1021854:hake [Fish]

Phrase: "A.,"

Phrase: "Evans,"

Phrase: "R. et al."
Processing 00000000.tx.366: (2000) Alpha2 macroglobulin and the risk of Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Alpha2 macroglobulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1879648:Alpha2 [Qualitative Concept]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.367: Neurology, 54, 438442.[Abstract/Free FullText] Alvarez, V., Alvarez, R., Lahoz, C.H., Martinez, C., Pena, J., Guisasola, L.M., Salas-Puig, J., Moris, G., Uria, D., Menes, B.B. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "438442."

Phrase: "[Abstract/Free FullText"

Phrase: "] Alvarez,"

Phrase: "V.,"

Phrase: "Alvarez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lahoz,"

Phrase: "C.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pena,"

Phrase: "J.,"

Phrase: "Guisasola,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salas-Puig,"

Phrase: "J.,"

Phrase: "Moris,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Uria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Uria [Bird]

Phrase: "D."

Phrase: ","

Phrase: "Menes,"

Phrase: "B.B. et al."
Processing 00000000.tx.368: (1999) Association between an alpha(2) macroglobulin DNA polymorphism and late- onset Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Association between an alpha(2) macroglobulin DNA polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "late- onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.369: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.370: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.371: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.372: Commun., 264, 4850.[CrossRef][ISI][Medline] Liao, A., Nitsch, R.M., Greenberg, S.M., Finckh, U., Blacker, D., Albert, M., Rebeck, G.W., Gomez-Isla, T., Clatworthy, A., Binetti, G. et al. 

Phrase: "Commun.,"

Phrase: "264,"

Phrase: "4850."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liao,"

Phrase: "A.,"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Finckh,"

Phrase: "U.,"

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Albert,"

Phrase: "M."

Phrase: ","

Phrase: "Rebeck,"

Phrase: "G.W., Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clatworthy,"

Phrase: "A.,"

Phrase: "Binetti,"

Phrase: "G. et al."
Processing 00000000.tx.373: (1998) Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Genetic association of an alpha2-macroglobulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1328885:genetic association [Occupation or Discipline]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(Val1000lle"

Phrase: ")"

Phrase: "polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.374: Hum. 

Phrase: "Hum."
Processing 00000000.tx.375: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.376: Genet., 7, 19531956.[Abstract/Free FullText] Myllykangas, L., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Crook, R., Tienari, P.J., Pusa, A.K., Niinisto, L., O'Brien, P., Kontula, K. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "19531956."

Phrase: "[Abstract/Free FullText"

Phrase: "] Myllykangas,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Polvikoski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sulkava,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoniemi,"

Phrase: "A.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tienari,"

Phrase: "P.J.,"

Phrase: "Pusa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2806186:Pusa [Mammal]

Phrase: "A.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0636163:amyloid K [Amino Acid, Peptide, or Protein]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Niinisto,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Brien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kontula,"

Phrase: "K. et al."
Processing 00000000.tx.377: (1999) Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic association of alpha2-macroglobulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1328885:genetic association [Occupation or Discipline]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in a Finnish elderly population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.378: Ann. 

Phrase: "Ann."
Processing 00000000.tx.379: Neurol., 46, 382390.[CrossRef][ISI][Medline] Tang, G., Zhang, M., Xie, H., Jiang, S., Wang, Z., Xu, L., Hao, Y., Lin, D., Lan, H., Wang, Y. et al. 

Phrase: "Neurol.,"

Phrase: "46,"

Phrase: "382390."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tang,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "M."

Phrase: ","

Phrase: "Xie,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jiang,"

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "Z.,"

Phrase: "Xu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1324275:HAO [Molecular Function]

Phrase: "Y.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "D."

Phrase: ","

Phrase: "Lan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "Y. et al."
Processing 00000000.tx.380: (2002) Aplha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Aplha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0032529:Polymorphism [Genetic Function]
   738   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.381: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.382: Lett., 328, 195197. 

Phrase: "Lett.,"

Phrase: "328,"

Phrase: "195197."
Processing 00000000.tx.383: Wang, X., Luedecking, E.K., Minster, R.L., Ganguli, M., DeKosky, S.T. and Kamboh, M.I. 

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Luedecking,"

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Minster,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ganguli,"

Phrase: "M."

Phrase: ","

Phrase: "DeKosky,"

Phrase: "S."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kamboh,"

Phrase: "M.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: (2001) Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Lack of association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0332268:lack [Qualitative Concept]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "between alpha2-macroglobulin polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]
   734   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.385: Hum. 

Phrase: "Hum."
Processing 00000000.tx.386: Genet., 108, 105108.[CrossRef][ISI][Medline] Wavrant-DeVrieze, F., Rudrasingham, V., Lambert, J.C., Chakraverty, S., Kehoe, P., Crook, R., Amouyel, P., Wu, W., Holmans, P., Rice, F. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "108,"

Phrase: "105108."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wavrant-DeVrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rudrasingham,"

Phrase: "V.,"

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "J.C., Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Amouyel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "W.,"

Phrase: "Holmans,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "F. et al."
Processing 00000000.tx.387: (1999) No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "No association between the alpha-2 macroglobulin I1000V polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.388: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.389: Lett., 262, 137139.[CrossRef][ISI][Medline] Verpillat, P., Bouley, S., Hannequin, D., Belliard, S., Puel, M., Thomas-Anterion, C., Dubois, B., Agid, Y., Campion, D., Clerget-Darpoux, F. et al. 

Phrase: "Lett.,"

Phrase: "262,"

Phrase: "137139."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Verpillat,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Belliard,"

Phrase: "S."

Phrase: ","

Phrase: "Puel,"

Phrase: "M."

Phrase: ","

Phrase: "Thomas-Anterion,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Clerget-Darpoux,"

Phrase: "F. et al."
Processing 00000000.tx.390: (2000) Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Alpha2-macroglobulin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "confirmation of association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   790   C0750484:Confirmation [Idea or Concept]

Phrase: "by haplotypes analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.391: Ann. 

Phrase: "Ann."
Processing 00000000.tx.392: Neurol., 48, 400402. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "400402."
Processing 00000000.tx.393: Blacker, D., Haines, J.L., Rodes, L., Terwedow, H., Go, R.C., Harrell, L.E., Perry, R.T., Bassett, S.S., Chase, G., Meyers, D. et al. 

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J.L., Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Terwedow,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C., Harrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "L.E.,"

Phrase: "Perry,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bassett,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Chase,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Meyers,"

Phrase: "D. et al."
Processing 00000000.tx.394: (1997) ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. 

Phrase: "(1997"

Phrase: ")"

Phrase: "ApoE-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "age at onset of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0277793:disease onset [Temporal Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]

Phrase: ":"

Phrase: "the NIMH genetics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0017398:Genetics [Biomedical Occupation or Discipline]
   799   C0017399:genetics [Biologic Function]
   780   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   719   C0027468:national institute health [Health Care Related Organization]

Phrase: "initiative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0424093:Initiative [Mental Process]
Processing 00000000.tx.395: Neurology, 48, 139147.[Abstract] Risch, N.J. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "48,"

Phrase: "139147."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Risch,"

Phrase: "N.J."
Processing 00000000.tx.396: (2000) Searching for genetic determinants in the new millennium. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Searching for genetic determinants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1552603:search [Intellectual Product]
   737   C1706202:Search [Activity]

Phrase: "in the new millennium."
Processing 00000000.tx.397: Nature, 405, 847856.[CrossRef][ISI][Medline] Spielman, R.S., McGinnis, R.E. and Ewens, W.J. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "405,"

Phrase: "847856."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spielman,"

Phrase: "R.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "McGinnis,"

Phrase: "R.E."

Phrase: "and"

Phrase: "Ewens,"

Phrase: "W.J."
Processing 00000000.tx.398: (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). 

Phrase: "(1993"

Phrase: ")"

Phrase: "Transmission test for linkage disequilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: ":"

Phrase: "the insulin gene region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C1337112:Insulin Gene [Gene or Genome]

Phrase: "and"

Phrase: "insulin-dependent diabetes mellitus (IDDM)."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.399: Am. 

Phrase: "Am."
Processing 00000000.tx.400: J. 

Phrase: "J."
Processing 00000000.tx.401: Hum. 

Phrase: "Hum."
Processing 00000000.tx.402: Genet., 52, 506516.[ISI][Medline] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "52,"

Phrase: "506516."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.404: Neurology, 34, 939944.[Abstract] Blacker, D., Albert, M.S., Bassett, S.S., Go, R.C., Harrell, L.E. and Folstein, M.F. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Albert,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bassett,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C., Harrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "L.E."

Phrase: "and"

Phrase: "Folstein,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.405: (1994) Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Reliability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "validity of NINCDS-ADRDA criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2699472:Criterion Validity [Quantitative Concept]
   760   C2349101:Validity [Quantitative Concept]

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.406: The National Institute of Mental Health Genetics Initiative. 

Phrase: "The National Institute of Mental Health Genetics Initiative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0424093:Initiative [Mental Process]
   747   C0027466:National Institute of Mental Health [Health Care Related Organization]
           national institute mental health
   701   C0027468:national institute health [Health Care Related Organization]
Processing 00000000.tx.407: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.408: Neurol., 51, 11981204.[Abstract] Chen, X., Levine, L. and Kwok, P.Y. 

Phrase: "Neurol.,"

Phrase: "51,"

Phrase: "11981204."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Levine,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kwok,"

Phrase: "P.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: (1999) Fluorescence polarization in homogeneous nucleic acid analysis. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Fluorescence polarization in homogeneous nucleic acid analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0016316:Fluorescence Polarization [Laboratory Procedure]
   748   C0946292:Polarization [Clinical Attribute]
Processing 00000000.tx.410: Genome Res., 9, 492498.[Abstract/Free FullText] Rabinowitz, D. and Laird, N. 

Phrase: "Genome Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "9,"

Phrase: "492498."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rabinowitz,"

Phrase: "D."

Phrase: "and"

Phrase: "Laird,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.411: (2000) A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A unified approach to adjusting association tests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]

Phrase: "for population admixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510816:Admixture [Qualitative Concept]

Phrase: "with arbitrary pedigree structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "arbitrary missing marker information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1533716:Information [Idea or Concept]
   741 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.412: Hum. 

Phrase: "Hum."
Processing 00000000.tx.413: Hered., 50, 211223.[CrossRef][ISI][Medline] Laird, N.M., Horvath, S. and Xu, X. 

Phrase: "Hered.,"

Phrase: "50,"

Phrase: "211223."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Laird,"

Phrase: "N.M.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Xu,"

Phrase: "X."
Processing 00000000.tx.414: (2000) Implementing a unified approach to family-based tests of association. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Implementing"

Phrase: "a unified approach to family-based tests of association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.415: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.416: Epidemiol., 19, S3642.[CrossRef] Tu, I.P., Balise, R.R. and Whittemore, A.S. 

Phrase: "Epidemiol.,"

Phrase: "19,"

Phrase: "S3642."

Phrase: "[CrossRef"

Phrase: "] Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "I.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Balise,"

Phrase: "R.R."

Phrase: "and"

Phrase: "Whittemore,"

Phrase: "A.S."
Processing 00000000.tx.417: (2000) Detection of disease genes by use of family data. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Detection of disease genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0683509:detection disease [Health Care Activity]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of family data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.418: II. 

Phrase: "II."
Processing 00000000.tx.419: Application to nuclear families. 

Phrase: "Application to nuclear families."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.420: Am. 

Phrase: "Am."
Processing 00000000.tx.421: J. 

Phrase: "J."
Processing 00000000.tx.422: Hum. 

Phrase: "Hum."
Processing 00000000.tx.423: Genet., 66, 13411350.[CrossRef][ISI][Medline] Lake, S.L., Blacker, D. and Laird, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "66,"

Phrase: "13411350."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337049:Lake [Geographic Area]
  1000   C1036400:Lake [Amphibian]

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Laird,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.424: (2000) Family-based tests of association in the presence of linkage. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Family-based tests of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0392366:Tests [Intellectual Product]
   726 E C0039593:Test [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]
Processing 00000000.tx.425: Am. 

Phrase: "Am."
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: Hum. 

Phrase: "Hum."
Processing 00000000.tx.428: Genet., 67, 15151525.[CrossRef][ISI][Medline] Whittaker, J.C. and Lewis, C.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "67,"

Phrase: "15151525."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Whittaker,"

Phrase: "J.C."

Phrase: "and"

Phrase: "Lewis,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: (1998) The effect of family structure on linkage tests using allelic association. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The effect of family structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on linkage tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "allelic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.430: Am. 

Phrase: "Am."
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: Hum. 

Phrase: "Hum."
Processing 00000000.tx.433: Genet., 63, 889897.[CrossRef][ISI][Medline] Lunetta, K.L., Faraone, S.V., Biederman, J. and Laird, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "63,"

Phrase: "889897."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lunetta,"

Phrase: "K.L., Faraone,"

Phrase: "S.V.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1018233:S. V [Bacterium]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Biederman,"

Phrase: "J."

Phrase: "and"

Phrase: "Laird,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.434: (2000) Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Family-based tests of association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0392366:Tests [Intellectual Product]
   726 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "that use unaffected sibs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0037047:Sib [Family Group]

Phrase: "covariates,"

Phrase: "and"

Phrase: "interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.435: Am. 

Phrase: "Am."
Processing 00000000.tx.436: J. 

Phrase: "J."
Processing 00000000.tx.437: Hum. 

Phrase: "Hum."
Processing 00000000.tx.438: Genet., 66, 605614.[CrossRef][ISI][Medline] Lange, C. and Laird, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "66,"

Phrase: "605614."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lange,"

Phrase: "C."

Phrase: "and"

Phrase: "Laird,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.439: (2002) On a general class of conditional tests for family-based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations. 

Phrase: "(2002"

Phrase: ")"

Phrase: "On a general class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "of conditional tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "for family-based association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0544093:Association, familial [Finding]
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "studies in genetics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0017398:Genetics [Biomedical Occupation or Discipline]
   790   C0017399:genetics [Biologic Function]
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "the asymptotic distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "the conditional power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "and"

Phrase: "optimality considerations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]
Processing 00000000.tx.440: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.441: Epidemiol., 23, 165180.[CrossRef][ISI][Medline] Witte, J.S., Gauderman, W.J. and Thomas, D.C. 

Phrase: "Epidemiol.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "165180."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Witte,"

Phrase: "J.S.,"

Phrase: "Gauderman,"

Phrase: "W.J."

Phrase: "and"

Phrase: "Thomas,"

Phrase: "D.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.442: (1999) Asymptotic bias and efficiency in casecontrol studies of candidate genes and geneenvironment interactions: basic family designs. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Asymptotic bias"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0242568:Bias [Idea or Concept]
   861   C1504315:Bias [Bird]
   827 E C1061346:Bia [Eukaryote]
   827 E C1704746:BIA [Diagnostic Procedure]

Phrase: "and"

Phrase: "efficiency in casecontrol studies of candidate genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013682:Efficiency [Quantitative Concept]

Phrase: "and"

Phrase: "geneenvironment interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: ":"

Phrase: "basic family designs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1707689:Design [Activity]
   793   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.443: Am. 

Phrase: "Am."
Processing 00000000.tx.444: J. 

Phrase: "J."
Processing 00000000.tx.445: Epidemiol., 149, 693705.[Abstract] Siegmund, K.D., Langholz, B., Kraft, P. and Thomas, D.C. 

Phrase: "Epidemiol.,"

Phrase: "149,"

Phrase: "693705."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Siegmund,"

Phrase: "K.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Langholz,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kraft,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Thomas,"

Phrase: "D.C."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.446: (2000) Testing linkage disequilibrium in sibships. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Testing linkage disequilibrium in sibships."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.447: Am. 

Phrase: "Am."
Processing 00000000.tx.448: J. 

Phrase: "J."
Processing 00000000.tx.449: Hum. 

Phrase: "Hum."
Processing 00000000.tx.450: Genet., 67, 244248.[CrossRef][Medline] Clayton, D. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "67,"

Phrase: "244248."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clayton,"

Phrase: "D."
Processing 00000000.tx.451: (1999) A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A generalization of the transmission/disequilibrium test"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017324:Generalization [Mental Process]

Phrase: "for uncertain-haplotype transmission."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040722:transmission [Idea or Concept]
   827   C0242781:Transmission [Pathologic Function]
   827   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.452: Am. 

Phrase: "Am."
Processing 00000000.tx.453: J. 

Phrase: "J."
Processing 00000000.tx.454: Hum. 

Phrase: "Hum."
Processing 00000000.tx.455: Genet., 65, 11701177.[CrossRef][ISI][Medline] Akey, J., Jin, L. and Xiong, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "11701177."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akey,"

Phrase: "J.,"

Phrase: "Jin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Xiong,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? 

Phrase: "(2001"

Phrase: ")"

Phrase: "Haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "vs"

Phrase: "single marker linkage disequilibrium tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0022885:Tests [Laboratory Procedure]
   804   C0392366:Tests [Intellectual Product]
   771 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "what"

Phrase: "do"

Phrase: "we"

Phrase: "gain?"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.457: Eur. 

Phrase: "Eur."
Processing 00000000.tx.458: J. 

Phrase: "J."
Processing 00000000.tx.459: Hum. 

Phrase: "Hum."
Processing 00000000.tx.460: Genet., 9, 291300.[CrossRef][ISI][Medline] Horvath, S., Xu, X., Lake, S.L., Silverman, E.K., Weiss, S.T. and Laird, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "291300."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horvath,"

Phrase: "S."

Phrase: ","

Phrase: "Xu,"

Phrase: "X.,"

Phrase: "Lake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337049:Lake [Geographic Area]
  1000   C1036400:Lake [Amphibian]

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Silverman,"

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Weiss,"

Phrase: "S."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Laird,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.461: (2003) Family based tests for associating haplotypes with general phenotype data: application to asthma genetics. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Family based tests for associating haplotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0022885:Tests [Laboratory Procedure]
   753   C0392366:Tests [Intellectual Product]
   719 E C0039593:Test [Functional Concept]

Phrase: "with general phenotype data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: ":"

Phrase: "application to asthma genetics."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.462: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.463: Epidemiol., in press. 

Phrase: "Epidemiol.,"

Phrase: "in press."
Processing 00000000.tx.464: Bagli, M., Papassotiropoulos, A., Jessen, F., Schmitz, S., Rao, M.L., Maier, W. and Heun, R. 

Phrase: "Bagli,"

Phrase: "M."

Phrase: ","

Phrase: "Papassotiropoulos,"

Phrase: "A.,"

Phrase: "Jessen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Schmitz,"

Phrase: "S."

Phrase: ","

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maier,"

Phrase: "W."

Phrase: "and"

Phrase: "Heun,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: (2000) Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0520511:distribution [Idea or Concept]
   742   C1704711:Distribution [Functional Concept]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "controls in a German population."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1556085:german population [Population Group]
           German
   797   C0032662:Population Control [Occupation or Discipline]
   760   C0032659:Population [Quantitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1257890:Population [Population Group]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.466: Am. 

Phrase: "Am."
Processing 00000000.tx.467: J. 

Phrase: "J."
Processing 00000000.tx.468: Med. 

Phrase: "Med."
Processing 00000000.tx.469: Genet., 96, 775777.[CrossRef][ISI][Medline] Blennow, K., Ricksten, A., Prince, J.A., Brookes, A.J., Emahazion, T., Wasslavik, C., Bogdanovic, N., Andreasen, N., Batsman, S., Marcusson, J. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "96,"

Phrase: "775777."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blennow,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ricksten,"

Phrase: "A.,"

Phrase: "Prince,"

Phrase: "J.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Brookes,"

Phrase: "A.J.,"

Phrase: "Emahazion,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wasslavik,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bogdanovic,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Andreasen,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Batsman,"

Phrase: "S."

Phrase: ","

Phrase: "Marcusson,"

Phrase: "J. et al."
Processing 00000000.tx.470: (2000) No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. 

Phrase: "(2000"

Phrase: ")"

Phrase: "No association between the alpha2-macroglobulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: ")"

Phrase: "deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "no change in A2M mRNA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0442739:No change [Finding]
   778   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.471: J. 

Phrase: "J."
Processing 00000000.tx.472: Neural. 

Phrase: "Neural."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0599851:Neural [Functional Concept]
   944 E C0027740:Nerve [Tissue]
   944 E C0027757:NERVE [Tissue]
   944 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   907 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.473: Transm., 107, 10651079.[CrossRef][ISI] Bullido, M.J., Guallar-Castillon, P., Artiga, M.J., Ramos, M.C., Sastre, I., Aldudo, J., Frank, A., Coria, F., Rodriguez-Artalejo, F. and Valdivieso, F. 

Phrase: "Transm.,"

Phrase: "107,"

Phrase: "10651079."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Guallar-Castillon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Ramos,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Aldudo,"

Phrase: "J.,"

Phrase: "Frank,"

Phrase: "A.,"

Phrase: "Coria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0011646:Corium [Tissue]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rodriguez-Artalejo,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Valdivieso,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.474: (2000) Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Alzheimer's risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "associated with human apolipoprotein E,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086418:Human [Human]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "alpha-2 macroglobulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "lipoprotein receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "protein polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ":"

Phrase: "absence of genetic interactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "modulation by gender."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.475: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.476: Lett., 289, 213216.[CrossRef][ISI][Medline] Chen, L., Baum, L., Ng, H.K., Chan, L.Y., Sastre, I., Artiga, M.J., Valdivieso, F., Bullido, M.J., Chiu, H.F. and Pang, C.P. 

Phrase: "Lett.,"

Phrase: "289,"

Phrase: "213216."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Baum,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ng,"

Phrase: "H.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chan,"

Phrase: "L.Y.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551080:l.y. [Temporal Concept]

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Valdivieso,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Chiu,"

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Pang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "C.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.477: (1999) Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Apolipoprotein E promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "alpha2-macroglobulin polymorphisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]
   734   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "are"

Phrase: "not genetically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with Chinese late onset Alzheimer's disease."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   861   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   800   C0814122:late disease onset [Finding]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0008120:chinese [Language]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0152035:Chinese [Population Group]
   748   C0205087:Late [Temporal Concept]
   748   C0332162:Onset [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.478: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.479: Lett., 269, 173177.[CrossRef][ISI][Medline] Crawford, F., Town, T., Freeman, M., Schinka, J., Gold, M., Duara, R. and Mullan, M. 

Phrase: "Lett.,"

Phrase: "269,"

Phrase: "173177."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Town,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557750:Town [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Freeman,"

Phrase: "M."

Phrase: ","

Phrase: "Schinka,"

Phrase: "J.,"

Phrase: "Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: "M."

Phrase: ","

Phrase: "Duara,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mullan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.480: (1999) The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a casecontrol sample. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The alpha-2 macroglobulin gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1537647:ALPHA GENE [Gene or Genome]
   902   C2985256:Alpha Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in a casecontrol sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.481: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.482: Lett., 270, 133136.[CrossRef][ISI][Medline] Dow, D.J., Lindsey, N., Cairns, N.J., Brayne, C., Robinson, D., Huppert, F.A., Paykel, E.S., Xuereb, J., Wilcock, G., Whittaker, J.L. et al. 

Phrase: "Lett.,"

Phrase: "270,"

Phrase: "133136."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Dow"

Phrase: ","

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lindsey,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cairns,"

Phrase: "N.J.,"

Phrase: "Brayne,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "D."

Phrase: ","

Phrase: "Huppert,"

Phrase: "F.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Paykel,"

Phrase: "E.S.,"

Phrase: "Xuereb,"

Phrase: "J.,"

Phrase: "Wilcock,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Whittaker,"

Phrase: "J.L. et al."
Processing 00000000.tx.483: (1999) Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]
   756   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Alzheimer disease risk in the UK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.484: Nat. 

Phrase: "Nat."
Processing 00000000.tx.485: Genet., 22, 1617; 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "22,"

Phrase: "1617"

Phrase: ";"
Processing 00000000.tx.486: discussion 2112.[CrossRef][ISI][Medline] Gibson, A.M., Singleton, A.B., Smith, G., Woodward, R., McKeith, I.G., Perry, R.H., Ince, P.G., Ballard, C.G., Edwardson, J.A. and Morris, C.M. 

Phrase: "discussion 2112."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gibson,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Woodward,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ince,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ballard,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Edwardson,"

Phrase: "J.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Morris,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: (2000) Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Lack of association of the alpha2-macroglobulin locus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   744   C0004083:Association [Mental Process]
   744   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332268:lack [Qualitative Concept]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1708726:Locus [Gene or Genome]
   744   C1879648:Alpha2 [Qualitative Concept]

Phrase: "on chromosome 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008654:Chromosome 12 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in AD."
Processing 00000000.tx.488: Neurology, 54, 433438.[Abstract/Free FullText] Halimi, G., Duplan, L., Bideau, C., Iniesta, D., Berthezene, P., Oddoze, C., Verdier, J.M., Michel, B. and Berge-Lefranc, J.L. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "433438."

Phrase: "[Abstract/Free FullText"

Phrase: "] Halimi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Duplan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bideau,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iniesta,"

Phrase: "D."

Phrase: ","

Phrase: "Berthezene,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Oddoze,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Verdier,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Michel,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Berge-Lefranc,"

Phrase: "J.L."
Processing 00000000.tx.489: (2000) Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association of APOE promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "but"

Phrase: "not A2M polymorphisms with risk of developing Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0032529:polymorphisms [Genetic Function]
   704 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.490: Neuroreport, 11, 35993601.[ISI][Medline] Higuchi, S., Matsushita, S., Nakane, J., Arai, H., Matsui, T., Urakami, K., Yuzuriha, T. and Takeda, A. 

Phrase: "Neuroreport,"

Phrase: "11,"

Phrase: "35993601."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Higuchi,"

Phrase: "S."

Phrase: ","

Phrase: "Matsushita,"

Phrase: "S."

Phrase: ","

Phrase: "Nakane,"

Phrase: "J.,"

Phrase: "Arai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsui,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Urakami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yuzuriha,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Takeda,"

Phrase: "A."
Processing 00000000.tx.491: (2000) Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Alpha2-macroglobulin gene polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0678951:gene polymorphisms [Genetic Function]
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "racial diversity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880371:Diversity [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with Alzheimer's disease."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.492: Neuroreport, 11, 11671171.[ISI][Medline] Hu, C.J., Sung, S.M., Liu, H.C., Hsu, W.C., Lee, L.S., Lee, C.C., Tsai, C.H. and Chang, J.G. 

Phrase: "Neuroreport,"

Phrase: "11,"

Phrase: "11671171."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "C.J.,"

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Liu,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hsu,"

Phrase: "W.C., Lee,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Lee,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chang,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.493: (2000) Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genetic risk factors of sporadic Alzheimer's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C0850664:risk factor (of) disease [Finding]
           disease factors risk
   814   C0814299:genetic risk factors [Qualitative Concept]
   778   C0035648:risk factors [Quantitative Concept]
   778   C1553898:risk factors [Idea or Concept]
   774   C0679238:disease factors [Functional Concept]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "among Chinese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008120:chinese [Language]
  1000   C0152035:Chinese [Population Group]

Phrase: "in Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.496: Sci., 181, 127131.[CrossRef][ISI][Medline] Hu, C.J., Sung, S.M., Liu, H.C., Lee, K.Y., Hsu, W.C., Wong, W.K., Lee, C.C., Tsai, C.H. and Chang, J.G. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "181,"

Phrase: "127131."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "C.J.,"

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Liu,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "K.Y.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hsu,"

Phrase: "W.C., Wong,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chang,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.497: (1999) No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese. 

Phrase: "(1999"

Phrase: ")"

Phrase: "No association of alpha-2 macroglobulin gene five-nucleotide deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "with AD"

Phrase: "in Taiwan Chinese."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008120:chinese [Language]
   861   C0152035:Chinese [Population Group]
Processing 00000000.tx.498: Neurology, 53, 642643.[Abstract/Free FullText] Ki, C.S., Na, D.L., Kim, H.J. and Kim, J.W. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "53,"

Phrase: "642643."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ki,"

Phrase: "C.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Na,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1272460:{NA} [Qualitative Concept]

Phrase: "D."

Phrase: "L., Kim,"

Phrase: "H.J."

Phrase: "and"

Phrase: "Kim,"

Phrase: "J.W."
Processing 00000000.tx.499: (2001) Alpha-1 anti-chymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Alpha-1 anti-chymotrypsin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   902   C0764105:alpha-chymotrypsin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1879647:Alpha1 [Qualitative Concept]
   861   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   812   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0439095:Alpha [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "alpha-2 macroglobulin gene polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C0678951:gene polymorphisms [Genetic Function]
   804   C0032529:polymorphisms [Genetic Function]
   771 E C1882417:Polymorphism [Qualitative Concept]
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   708   C1537647:ALPHA GENE [Gene or Genome]
   708   C2985256:Alpha Gene [Gene or Genome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with Korean late-onset Alzheimer's disease."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   861   C0494463:Alzheimer's disease with late onset [Mental or Behavioral Dysfunction]
           Alzheimer Disease, Late Onset
   800   C0814122:late disease onset [Finding]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0243083:associated disease [Pathologic Function]
   774   C0277793:disease onset [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205087:Late [Temporal Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1556095:Korean [Population Group]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.500: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.501: Lett., 302, 6972.[CrossRef][ISI][Medline] Korovaitseva, G.I., Premkumar, S., Grigorenko, A., Molyaka, Y., Galimbet, V., Selezneva, N., Gavrilova, S.I., Farrer, L.A. and Rogaev, E.I. 

Phrase: "Lett.,"

Phrase: "302,"

Phrase: "6972."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Korovaitseva,"

Phrase: "G.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Premkumar,"

Phrase: "S."

Phrase: ","

Phrase: "Grigorenko,"

Phrase: "A.,"

Phrase: "Molyaka,"

Phrase: "Y.,"

Phrase: "Galimbet,"

Phrase: "V.,"

Phrase: "Selezneva,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gavrilova,"

Phrase: "S.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Farrer,"

Phrase: "L.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Rogaev,"

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.502: (1999) Alpha-2 macroglobulin gene in early- and late-onset Alzheimer disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alpha-2 macroglobulin gene in early-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1537647:ALPHA GENE [Gene or Genome]
   783   C2985256:Alpha Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "late-onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.503: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.504: Lett., 271, 129131.[CrossRef][ISI][Medline] Koster, M.N., Dermaut, B., Cruts, M., Houwing-Duistermaat, J.J., Roks, G., Tol, J., Ott, A., Hofman, A., Munteanu, G., Breteler, M.M. et al. 

Phrase: "Lett.,"

Phrase: "271,"

Phrase: "129131."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koster,"

Phrase: "M."

Phrase: "N., Dermaut,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Houwing-Duistermaat,"

Phrase: "J.J.,"

Phrase: "Roks,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tol,"

Phrase: "J.,"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "Munteanu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Breteler,"

Phrase: "M."

Phrase: "M. et al."
Processing 00000000.tx.505: (2000) The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. 

Phrase: "(2000"

Phrase: ")"

Phrase: "The alpha2-macroglobulin gene in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "a population-based study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "meta-analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0282458:Meta-Analysis [Intellectual Product]
  1000   C0920317:Meta-Analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1042496:Meta [Eukaryote]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.506: Neurology, 55, 678684.[Abstract/Free FullText] Kovacs, T., Cairns, N.J. and Lantos, P.L. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "678684."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kovacs,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cairns,"

Phrase: "N.J."

Phrase: "and"

Phrase: "Lantos,"

Phrase: "P.L."
Processing 00000000.tx.507: (1999) Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alpha-2-macroglobulin intronic polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0032529:Polymorphism [Genetic Function]
   804   C1882417:Polymorphism [Qualitative Concept]
   717   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with autopsy-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0004398:Autopsy [Diagnostic Procedure]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.508: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.509: Lett., 273, 6183.[CrossRef][ISI][Medline] McIlroy, S.P., Dynan, K.B., Vahidassr, D.J., Lawson, J.T., Patterson, C.C. and Passmore, P. 

Phrase: "Lett.,"

Phrase: "273,"

Phrase: "6183."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McIlroy,"

Phrase: "S.P.,"

Phrase: "Dynan,"

Phrase: "K.B.,"

Phrase: "Vahidassr,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lawson,"

Phrase: "J.T.,"

Phrase: "Patterson,"

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Passmore,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.510: (2001) Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Common polymorphisms in LRP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0032529:polymorphisms [Genetic Function]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "A2M"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]
   913   C0002215:alpha macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1979845:Alpha 2 [Qualitative Concept]
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "genetic risk for Alzheimer disease"
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
   806   C1517512:Genetic Risk [Quantitative Concept]
   797   C0019247:Genetic disease [Disease or Syndrome]
   797   C1281905:disease risk [Finding]
   760   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   760   C0035647:Risk [Qualitative Concept]
   760   C0314603:Genetic [Functional Concept]
   756 E C2316203:Genetic diseases [Finding]
   756 E C2924406:Genetic diseases [Laboratory Procedure]
   704 E C0005615:Birth [Organism Function]
   704 E C0035150:Reproduction [Organism Function]
   704 E C0079946:origin [Classification]
   704 E C0439659:Origin [Temporal Concept]
   704 E C1550512:origin [Intellectual Product]
   704 E C1550722:birth [Idea or Concept]
   704 E C3245487:birth [Intellectual Product]

Phrase: "in Northern Ireland."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028415:Northern Ireland [Geographic Area]
   861   C0022067:Ireland [Geographic Area]
   861   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.511: Am. 

Phrase: "Am."
Processing 00000000.tx.512: J. 

Phrase: "J."
Processing 00000000.tx.513: Med. 

Phrase: "Med."
Processing 00000000.tx.514: Genet., 105, 502506.[CrossRef][ISI][Medline] Perry, R.T., Collins, J.S., Harrell, L.E., Acton, R.T. and Go, R.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "105,"

Phrase: "502506."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perry,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Collins,"

Phrase: "J.S.,"

Phrase: "Harrell,"

Phrase: "L.E.,"

Phrase: "Acton,"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0722969:R & C [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.515: (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Investigation of association of 13 polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "in eight genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "in southeastern African American Alzheimer disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]

Phrase: "as"

Phrase: "compared to age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.516: Am. 

Phrase: "Am."
Processing 00000000.tx.517: J. 

Phrase: "J."
Processing 00000000.tx.518: Med. 

Phrase: "Med."
Processing 00000000.tx.519: Genet., 105, 332342.[CrossRef][ISI][Medline] Shibata, N., Ohnuma, T., Takahashi, T., Ohtsuka, E., Ueki, A. and Arai, H. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "105,"

Phrase: "332342."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shibata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ohnuma,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ohtsuka,"

Phrase: "E.,"

Phrase: "Ueki,"

Phrase: "A."

Phrase: "and"

Phrase: "Arai,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.520: (1999) Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genetic association between alpha-2 macroglobulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1328885:genetic association [Occupation or Discipline]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Japanese sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0205422:Sporadic [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.521: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.522: Lett., 271, 132134.[CrossRef][ISI][Medline] Singleton, A.B., Gibson, A.M., McKeith, I.G., Ballard, C.A., Perry, R.H., Ince, P.G., Edwardson, J.A. and Morris, C.M. 

Phrase: "Lett.,"

Phrase: "271,"

Phrase: "132134."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"

Phrase: "Gibson,"

Phrase: "A."

Phrase: "M."

Phrase: ","

Phrase: "McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ballard,"

Phrase: "C.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Perry,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ince,"

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Edwardson,"

Phrase: "J.A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Morris,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.523: (1999) Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alpha2-macroglobulin polymorphisms in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.524: Neuroreport, 10, 15071510.[ISI][Medline] Sodeyama, N., Yamada, M., Itoh, Y., Suematsu, N., Matsushita, M., Otomo, E. and Mizusawa, H. 

Phrase: "Neuroreport,"

Phrase: "10,"

Phrase: "15071510."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sodeyama,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Itoh,"

Phrase: "Y.,"

Phrase: "Suematsu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsushita,"

Phrase: "M."

Phrase: ","

Phrase: "Otomo,"

Phrase: "E."

Phrase: "and"

Phrase: "Mizusawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.525: (2000) Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Alpha2-macroglobulin polymorphism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C0002198:alpha 2-Macroglobulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1412046:ALPHA-2-MACROGLOBULIN [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "AD-type neuropathology in the Japanese."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   753   C1540677:neuropathology [Pathologic Function]
   753   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.526: Neurology, 54, 443446.[Abstract/Free FullText] Zill, P., Burger, K., Behrens, S., Hampel, H., Padberg, F., Boetsch, T., Moller, H.J., Ackenheil, M. and Bondy, B. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "54,"

Phrase: "443446."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zill,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Burger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452929:Burger [Food]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Behrens,"

Phrase: "S."

Phrase: ","

Phrase: "Hampel,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Padberg,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Boetsch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Moller,"

Phrase: "H.J.,"

Phrase: "Ackenheil,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bondy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.527: (2000) Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Polymorphisms in the alpha-2 macroglobulin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in psychogeriatric patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.528: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.529: Lett., 294, 6972.[CrossRef][ISI][Medline] Shibata, N., Ohnuma, T., Takahashi, T., Ohtsuka, E., Ueki, A., Nagao, M. and Arai, H. 

Phrase: "Lett.,"

Phrase: "294,"

Phrase: "6972."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shibata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ohnuma,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ohtsuka,"

Phrase: "E.,"

Phrase: "Ueki,"

Phrase: "A.,"

Phrase: "Nagao,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Arai,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.530: (2000) No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "No genetic association between alpha-2 macroglobulin I1000V polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1328885:genetic association [Occupation or Discipline]
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "Japanese sporadic Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0205422:Sporadic [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.531: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.532: Lett., 290, 154156.[CrossRef][ISI][Medline] Styczynska, M., Religa, D., Pfeffer, A., Luczywek, E., Wasiak, B., Styczynski, G., Peplonska, B., Gabryelewicz, T., Golebiowski, M., Kobrys, M. et al. 

Phrase: "Lett.,"

Phrase: "290,"

Phrase: "154156."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Styczynska,"

Phrase: "M."

Phrase: ","

Phrase: "Religa,"

Phrase: "D."

Phrase: ","

Phrase: "Pfeffer,"

Phrase: "A.,"

Phrase: "Luczywek,"

Phrase: "E.,"

Phrase: "Wasiak,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Styczynski,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Peplonska,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gabryelewicz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Golebiowski,"

Phrase: "M."

Phrase: ","

Phrase: "Kobrys,"

Phrase: "M. et al."
Processing 00000000.tx.533: (2003) Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Simultaneous analysis of five genetic risk factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0085801:analysis factors [Quantitative Concept]
   774   C0679560:genetic analysis [Laboratory Procedure]
   774   C0796344:Genetic Analysis [Laboratory Procedure]
   774   C0814767:risk analysis [Qualitative Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in Polish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.534: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.535: Lett., 344, 99102.

Phrase: "Lett.,"

Phrase: "344,"

Phrase: "99102."

